Updated on 2025/04/17

写真a

 
NAKAMURA HIROYUKI
 
Organization
Institute of Integrated Research Laboratory for Chemistry and Life Science Professor
Title
Professor
External link

News & Topics

▼display all

Degree

  • Ph.D ( Tohoku University )

Research Interests

  • 有機化学、創薬化学、ケミカルバイオロジー

  • 中性子捕捉療法

  • ホウ素

  • 遷移金属触媒

  • 分子標的治療薬

  • 酵素阻害剤

  • Transition-metal Catalyst

  • Neutron Capture Therapy

  • Kinase Inhibitor

  • Boron

  • 低酸素細胞応答

Research Areas

  • Nanotechnology/Materials / Synthetic organic chemistry

  • Life Science / Pharmaceutical chemistry and drug development sciences

  • Nanotechnology/Materials / Chemical biology

Education

  • Tohoku University

    1991.3 - 1995.2

      More details

    Country: Japan

    researchmap

  • Tohoku University   Faculty of Science   Department of Chemistry

    - 1991

      More details

    Country: Japan

    researchmap

Research History

  • Tokyo Institute of Technology   Institute of Innovative Research   Professor

    2016.4

      More details

  • Tokyo Institute of Technology   Chemical Resources Laboratory   Professor

    2013.9 - 2016.3

      More details

  • Gakushuin University   Faculty of Science, Department of Chemistry   Professor

    2006.4 - 2013.8

      More details

  • Gakushuin University   Faculty of Science Department of Chemistry   Associate Professor

    2002.4 - 2006.3

      More details

  • University of Pittsberg   Department of Chemistry   Visiting Assistant Professor

    2000.5 - 2001.5

      More details

    Country:United States

    researchmap

  • Tohoku University   Graduate School of Science   Research Associate

    1997.4 - 2002.3

      More details

▼display all

Professional Memberships

▼display all

Committee Memberships

  • 有機合成化学協会   関東支部監事  

    2020.1   

      More details

    Committee type:Academic society

    researchmap

  • 日本薬学会   関東支部評議員  

    2019.1   

      More details

    Committee type:Academic society

    researchmap

  • International Society of Neutron Capture Therapy   Technical Board of Chemistry  

    2018.9   

      More details

  • 有機合成化学協会   関東支部常任幹事  

    2018.1 - 2020.1   

      More details

    Committee type:Academic society

    researchmap

  • 経済産業省「医療機器開発ガイドライン評価検討委員会」   「ホウ素中性子捕捉療法(BNCT)開発ワーキンググループ」委員  

    2017.9 - 2019.3   

      More details

    Committee type:Government

    researchmap

  • 厚生労働省「次世代医療機器評価指標検討会」   ホウ素中性子捕捉療法(BNCT)審査ワーキンググループ委員  

    2017.5 - 2019.3   

      More details

    Committee type:Government

    researchmap

  • BNCT推進協議会   委員  

    2016.3 - 2021.3   

      More details

    Committee type:Municipal

    researchmap

  • Japanese Society of Neutron Capture Therapy   President  

    2015.9 - 2019.10   

      More details

    Committee type:Academic society

    researchmap

  • 科学技術振興機構   国際科学技術共同研究推進事業アドバイザー  

    2014.9 - 2016.3   

      More details

    Committee type:Government

    researchmap

  • 日本学術振興会科学研究費委員会   専門委員  

    2013.4   

      More details

    Committee type:Government

    researchmap

  • 有機合成化学協会   関東支部幹事  

    2013.1 - 2018.1   

      More details

    Committee type:Academic society

    researchmap

  • International Society of Boron Chemistry   International Committee  

    2011.7   

      More details

    Committee type:Academic society

    researchmap

  • 癌研-国際化学療法シンポジウム   運営会員  

    2011.1   

      More details

    Committee type:Academic society

    researchmap

  • 日本薬学会   関東支部評議員  

    2010.1 - 2014.1   

      More details

  • 日本がん分子標的治療学会   評議員(2009年7月~)  

    2009.7   

      More details

    Committee type:Academic society

    日本がん分子標的治療学会

    researchmap

  • International Society of Neutron Capture Therapy   Board of Councilor  

    2005   

      More details

    Committee type:Academic society

    researchmap

  • 日本中性子捕捉療法学会   幹事  

    2003   

      More details

    Committee type:Academic society

    日本中性子捕捉療法学会

    researchmap

▼display all

Papers

  • Boron neutron capture therapy with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP) for a head and neck squamous cell carcinoma (SAS) model mice. International journal

    Kazuki Miura, Kai Nishimura, Minoru Suzuki, Hiroyuki Nakamura

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine   221   111837 - 111837   2025.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Boron neutron capture therapy (BNCT) is an attractive therapeutic approach for treating refractory cancers. Currently, 4-borono-L-phenylalanine (BPA) is the only boron carrier approved for BNCT, specifically for unresectable, locally advanced, or recurrent head and neck cancers in Japan. However, efficacy of BPA relies on the L-type amino acid transporter (LAT1), which is highly expressed in many cancers, limiting its broader application. In this study, we investigated the potential of a novel boron carrier, pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP), designed to the folate receptors (FRs), as an alternative for BNCT in head and neck cancers. PBC-IP was injected into human head and neck squamous cell carcinoma SAS xenograft mice to assess its biodistribution and therapeutic efficacy compared to BPA. Our results showed that PBC-IP achieved selective tumor accumulation, although the boron concentration in tumors was lower than that of BPA (5 μg [10B]/g vs. 15 μg [10B]/g, respectively). PBC-IP underwent significant hepatic metabolism. BNCT treatment with PBC-IP suppressed tumor growth in mice, whereas BPA showed superior efficacy, nearly eliminating tumors. Importantly, no significant toxicity was observed in either group. These findings suggest that while PBC-IP exhibits some potential for BNCT targeting FR-expressing tumors, BPA remains the more effective option for head and neck cancer.

    DOI: 10.1016/j.apradiso.2025.111837

    PubMed

    researchmap

  • Discovery of niclosamide as a p300/transcription factor protein–protein interaction inhibitor

    Dhina Fitriastuti, Kazuki Miura, Satoshi Okada, Hiroyuki Hirano, Hiroyuki Osada, Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry   121   118114 - 118114   2025.4

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bmc.2025.118114

    researchmap

  • A Water-Soluble Small Molecule Boron Carrier Targeting Biotin Receptors for Neutron Capture Therapy. International journal

    Kai Nishimura, Shota Tanaka, Kazuki Miura, Satoshi Okada, Minoru Suzuki, Hiroyuki Nakamura

    ACS omega   9 ( 52 )   51631 - 51640   2024.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A critical challenge in boron neutron capture therapy (BNCT) is expanding its effectiveness through the development of novel boron agents with different mechanisms of action than the approved drug 4-borono-l-phenylalanine (BPA). In this study, we developed a small molecule boron carrier, biotinyl-closo-dodecaborate conjugate with an iodophenyl moiety (BBC-IP), incorporating biotin as a ligand for biotin receptors overexpressed in various cancer cells, alongside an albumin ligand and boron source. BBC-IP exhibited high water solubility, minimal cytotoxicity, and superior cellular uptake compared to BPA in both human and mouse cancer cells. Biodistribution studies revealed that BBC-IP achieved enhanced tumor accumulation (9.7 μg [B]/g, 3 h) in mouse colon tumors, surpassing BPA's accumulation levels (7.2 μg [B]/g, 3 h) at a dose of 15 mg [B]/kg. However, despite this improved tumor accumulation, BPA demonstrated superior BNCT efficacy. The intracellular localization of boron agents in tumor cells revealed that BPA localized throughout the cell, whereas BBC-IP localized mainly in the cytoplasm. These results indicate the intratumoral localization, as well as tumor accumulation are critical for the efficacy of novel BNCT agents.

    DOI: 10.1021/acsomega.4c09388

    PubMed

    researchmap

  • Intracellular Photocatalytic Proximity Labeling (iPPL) for Dynamic Analysis of Chromatin-Binding Proteins Targeting Histone H3. International journal

    Kazuki Miura, Hikaru Niimi, Tatsuya Niwa, Hideki Taguchi, Hiroyuki Nakamura

    ACS chemical biology   19 ( 12 )   2412 - 2417   2024.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We demonstrated a novel approach for protein-protein interaction (PPI) profiling of histone H3 using intracellular photocatalytic-proximity labeling (iPPL). This approach identified that the combination of acriflavine as a photocatalyst and 1-methyl-4-arylurazol (MAUra) as a protein labeling agent was the most efficient strategy to proceed the protein proximity labeling reaction. Furthermore, the identification of the labeled amino acids in histone H3 interacting proteins, histone lysine N-methyltransferase EZH2, showed that the amino acid in EZH2 within a few nanometers from histone H3 is labeled by iPPL. This restricted labeling radius allows for more-focused PPI profiling, compared to conventional proximity labeling methods.

    DOI: 10.1021/acschembio.4c00680

    PubMed

    researchmap

  • Synthesis and Optimization of Ethylenediamine-Based Zwitterion on Polymer Side Chain for Recognizing Narrow Tumorous pH Windows

    Masahiro Toyoda, Yutaka Miura, Motoaki Kobayashi, Masato Tsuda, Takahiro Nomoto, Yuto Honda, Hiroyuki Nakamura, Hiroyasu Takemoto, Nobuhiro Nishiyama

    Biomacromolecules   2024.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

    DOI: 10.1021/acs.biomac.4c01086

    researchmap

  • ASCT2標的としたBNCTにおける悪性神経膠腫の治療

    江座 健一郎, 辻野 晃平, 川端 信司, 藤川 喜貴, 柏木 秀基, 二村 元, 平松 亮, 田中 浩基, 鈴木 実, 宮武 伸一, 荒木 倫之, 盛田 大輝, 中村 浩之, 鰐渕 昌彦

    日本癌治療学会学術集会抄録集   62回   O87 - 1   2024.10

     More details

    Language:English   Publisher:(一社)日本癌治療学会  

    researchmap

  • Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrier. International journal

    Kohei Tsujino, Hideki Kashiwagi, Kai Nishimura, Yoshiki Fujikawa, Ryo Kayama, Yusuke Fukuo, Ryo Hiramatsu, Naosuke Nonoguchi, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Naonori Hu, Koji Ono, Masahiko Wanibuchi, Kei Nakai, Hiroyuki Nakamura, Shinji Kawabata

    Neuro-oncology advances   6 ( 1 )   vdae062   2024

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Boron neutron capture therapy (BNCT) is a precise particle radiation therapy known for its unique cellular targeting ability. The development of innovative boron carriers is crucial for the advancement of BNCT technologies. Our previous study demonstrated the potential of PBC-IP administered via convection-enhanced delivery (CED) in an F98 rat glioma model. This approach significantly extended rat survival in neutron irradiation experiments, with half achieving long-term survival, akin to a cure, in a rat brain tumor model. Our commitment to clinical applicability has spurred additional nonclinical pharmacodynamic research, including an investigation into the effects of cannula position and the time elapsed post-CED administration. METHODS: In comprehensive in vivo experiments conducted on an F98 rat brain tumor model, we meticulously examined the boron distribution and neutron irradiation experiments at various sites and multiple time intervals following CED administration. RESULTS: The PBC-IP showed substantial efficacy for BNCT, revealing minimal differences in tumor boron concentration between central and peripheral CED administration, although a gradual decline in intratumoral boron concentration post-administration was observed. Therapeutic efficacy remained robust, particularly when employing cannula insertion at the tumor margin, compared to central injections. Even delayed neutron irradiation showed notable effectiveness, albeit with a slightly reduced survival period. These findings underscore the robust clinical potential of CED-administered PBC-IP in the treatment of malignant gliomas, offering adaptability across an array of treatment protocols. CONCLUSIONS: This study represents a significant leap forward in the quest to enhance BNCT for the management of malignant gliomas, opening promising avenues for clinical translation.

    DOI: 10.1093/noajnl/vdae062

    PubMed

    researchmap

  • Development of a Gadolinium–Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy

    Satoshi Okada, Kai Nishimura, Qarri Ainaya, Kouichi Shiraishi, Sergey A. Anufriev, Igor B. Sivaev, Yoshinori Sakurai, Minoru Suzuki, Masayuki Yokoyama, Hiroyuki Nakamura

    Molecular Pharmaceutics   20 ( 12 )   6311 - 6318   2023.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

    DOI: 10.1021/acs.molpharmaceut.3c00726

    researchmap

  • Boron neutron capture therapy anti-tumor effect of nanostructured boron carbon nitride: A new potential candidate

    Manjot Kaur, Ramovatar Meena, Kai Nishimura, Kazuki Miura, Hiroyuki Nakamura, Minoru Suzuki, Ram K. Sharma, Akshay Kumar

    Inorganic Chemistry Communications   157   111318 - 111318   2023.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.inoche.2023.111318

    researchmap

  • Discovery of three-dimensional bicyclo[3.3.1]nonanols as novel heat shock protein 90 inhibitors

    Kazuki Miura, Manjusha Joshi, Taiki Morita, Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry   93   117463 - 117463   2023.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bmc.2023.117463

    researchmap

  • 悪性神経膠腫に対する葉酸受容体標的ホウ素キャリアを用いたホウ素中性子捕捉療法

    辻野 晃平, 川端 信司, 柏木 秀基, 香山 諒, 藤川 喜貴, 福尾 祐介, 平松 亮, 宮武 伸一, 呼 尚徳, 高田 卓志, 田中 浩基, 鈴木 実, 西村 開, 中村 浩之, 鰐渕 昌彦

    日本癌治療学会学術集会抄録集   61回   O23 - 4   2023.10

     More details

    Language:English   Publisher:(一社)日本癌治療学会  

    researchmap

  • 悪性神経膠腫に対する葉酸受容体標的ホウ素キャリアを用いたホウ素中性子捕捉療法

    辻野 晃平, 川端 信司, 柏木 秀基, 香山 諒, 藤川 喜貴, 福尾 祐介, 平松 亮, 宮武 伸一, 呼 尚徳, 高田 卓志, 田中 浩基, 鈴木 実, 西村 開, 中村 浩之, 鰐渕 昌彦

    日本癌治療学会学術集会抄録集   61回   O23 - 4   2023.10

     More details

    Language:English   Publisher:(一社)日本癌治療学会  

    researchmap

  • Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated closo-Dodecaborate on a Rat Brain Tumor Model. International journal

    Yoshiki Fujikawa, Yusuke Fukuo, Kai Nishimura, Kohei Tsujino, Hideki Kashiwagi, Ryo Hiramatsu, Naosuke Nonoguchi, Motomasa Furuse, Toshihiro Takami, Naonori Hu, Shin-Ichi Miyatake, Takushi Takata, Hiroki Tanaka, Tsubasa Watanabe, Minoru Suzuki, Shinji Kawabata, Hiroyuki Nakamura, Masahiko Wanibuchi

    Biology   12 ( 9 )   2023.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    High-grade gliomas present a significant challenge in neuro-oncology because of their aggressive nature and resistance to current therapies. Boron neutron capture therapy (BNCT) is a potential treatment method; however, the boron used by the carrier compounds-such as 4-borono-L-phenylalanine (L-BPA)-have limitations. This study evaluated the use of boron-conjugated 4-iodophenylbutanamide (BC-IP), a novel boron compound in BNCT, for the treatment of glioma. Using in vitro drug exposure experiments and in vivo studies, we compared BC-IP and BPA, with a focus on boron uptake and retention characteristics. The results showed that although BC-IP had a lower boron uptake than BPA, it exhibited superior retention. Furthermore, despite lower boron accumulation in tumors, BNCT mediated by BC-IP showed significant survival improvement in glioma-bearing rats compared to controls (not treated animals and neutrons only). These results suggest that BC-IP, with its unique properties, may be an alternative boron carrier for BNCT. Further research is required to optimize this potential treatment modality, which could significantly contribute to advancing the treatment of high-grade gliomas.

    DOI: 10.3390/biology12091240

    PubMed

    researchmap

  • 葉酸受容体標的ホウ素化合物の局所投与を用いたホウ素中性子捕捉療法のラット脳腫瘍モデルを用いた検討(Boron neutron capture therapy using local delivery of folate receptor targeted boron carrier on rat brain tumor model)

    川端 信司, 辻野 晃平, 柏木 秀基, 古瀬 元雅, 平松 亮, 藤城 高広, 小野 公二, 西村 開, 中村 浩之, 鰐渕 昌彦

    日本癌学会総会記事   82回   1546 - 1546   2023.9

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP). International journal

    Kai Nishimura, Hideki Kashiwagi, Taiki Morita, Yusuke Fukuo, Satoshi Okada, Kazuki Miura, Yoshitaka Matsumoto, Yu Sugawara, Takayuki Enomoto, Minoru Suzuki, Kei Nakai, Shinji Kawabata, Hiroyuki Nakamura

    Journal of controlled release : official journal of the Controlled Release Society   360   249 - 259   2023.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Boron neutron capture therapy (BNCT) has been applied for clinical trials on glioblastoma patients since 1950s, however, the low survival rate under the treatments has hampered the widespread use of BNCT. In this study, we developed a novel boron agent, PBC-IP, which consists of three functional groups: FRα-targeting, 10B resource (twelve 10B atoms in the molecule), and albumin-binding moieties. PBC-IP was selectively taken up by glioma cell lines such as C6, F98, and U87MG cells and accumulated 10- to 20-fold higher than L-4‑boronophenylalanine (BPA). PBC-IP administrated intravenously to the human glioblastoma (U87MG) xenograft model showed higher boron accumulation in tumors (29.8 μg [10B]/g at 6 h) than BPA (9.6 μg [10B]/g at 3 h) at a 25 mg [10B]/kg dose, effectively suppressing tumor growth after thermal neutron irradiation. PBC-IP administrated via convection-enhanced delivery (CED) accumulated in the F98 glioma orthotopic rat model, achieving 26.5 μg [10B]/g in tumors with tumor/normal (T/N) brain and tumor/blood (T/B) boron ratios of 37.8 and 94.6, respectively, 3 h after CED. Survival at 180 days after BNCT was 50% in the PBC-IP group and 70% in the combined BPA and PBC-IP groups, with no residual brain tumors.

    DOI: 10.1016/j.jconrel.2023.06.022

    PubMed

    researchmap

  • Development of a Peptide Sensor Derived from Human ACE2 for Fluorescence Polarization Assays of the SARS-CoV-2 Receptor Binding Domain

    Satoshi Okada, Yuka Muto, Bo Zhu, Hiroshi Ueda, Hiroyuki Nakamura

    Analytical Chemistry   2023.4

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

    DOI: 10.1021/acs.analchem.2c05818

    researchmap

  • Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model

    Kohei Tsujino, Hideki Kashiwagi, Kai Nishimura, Ryo Kayama, Kohei Yoshimura, Yusuke Fukuo, Hiroyuki Shiba, Ryo Hiramatsu, Naosuke Nonoguchi, Motomasa Furuse, Toshihiro Takami, Shin-Ichi Miyatake, Naonori Hu, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Shinji Kawabata, Hiroyuki Nakamura, Masahiko Wanibuchi

    Biology   12 ( 3 )   377 - 377   2023.2

     More details

    Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Integrin αvβ3 is more highly expressed in high-grade glioma cells than in normal tissues. In this study, a novel boron-10 carrier containing maleimide-functionalized closo-dodecaborate (MID), serum albumin as a drug delivery system, and cyclic arginine-glycine-aspartate (cRGD) that can target integrin αvβ3 was developed. The efficacy of boron neutron capture therapy (BNCT) targeting integrin αvβ3 in glioma cells in the brain of rats using a cRGD-functionalized MID-albumin conjugate (cRGD-MID-AC) was evaluated. F98 glioma cells exposed to boronophenylalanine (BPA), cRGD-MID-AC, and cRGD + MID were used for cellular uptake and neutron-irradiation experiments. An F98 glioma-bearing rat brain tumor model was used for biodistribution and neutron-irradiation experiments after BPA or cRGD-MID-AC administration. BNCT using cRGD-MID-AC had a sufficient cell-killing effect in vitro, similar to that with BNCT using BPA. In biodistribution experiments, cRGD-MID-AC accumulated in the brain tumor, with the highest boron concentration observed 8 h after administration. Significant differences were observed between the untreated group and BNCT using cRGD-MID-AC groups in the in vivo neutron-irradiation experiments through the log-rank test. Long-term survivors were observed only in BNCT using cRGD-MID-AC groups 8 h after intravenous administration. These findings suggest that BNCT with cRGD-MID-AC is highly selective against gliomas through a mechanism that is different from that of BNCT with BPA.

    DOI: 10.3390/biology12030377

    researchmap

  • Synthesis of diazatricycloundecane scaffold via gold(I)-catalysed Conia-ene-type 5-exo-dig cyclization and stepwise substituent assembly for construction of sp3-rich compound library

    Tomoya Doi, Kohei Umedera, Kazuki Miura, Taiki Morita, Hiroyuki Nakamura

    Organic & Biomolecular Chemistry   2023

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry (RSC)  

    The bridged diazatricycloundecane sp3-rich scaffold was synthesized via gold(I)-catalysed Conia-ene reaction. The electron-donating property of the siloxymethyl group on the alkyne 1 gave 6-endo-dig cyclization, whereas the ethoxy carbonyl group...

    DOI: 10.1039/d3ob01534c

    researchmap

  • インテグリン標的を有した新規ホウ素化合物を使用するホウ素中性子捕捉療法

    辻野 晃平, 川端 信司, 柏木 秀基, 吉村 亘平, 香山 諒, 福尾 祐介, 竹内 孝治, 平松 亮, 西村 開, 田中 浩基, 渡邉 翼, 鈴木 実, 宮武 伸一, 中村 浩之, 鰐渕 昌彦

    日本癌治療学会学術集会抄録集   60回   P25 - 3   2022.10

     More details

    Language:English   Publisher:(一社)日本癌治療学会  

    researchmap

  • Photodynamic Therapy by Glucose Transporter 1-Selective Light Inactivation

    Kazuki Miura, Yijin Wen, Michihiko Tsushima, Hiroyuki Nakamura

    ACS Omega   7 ( 38 )   34685 - 34692   2022.9

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

    DOI: 10.1021/acsomega.2c05042

    researchmap

  • Iodophenyl-conjugated closo-dodecaborate as a promising small boron molecule that binds to serum albumin and accumulates in tumor

    Kai Nishimura, Suzanna Harrison, Kazuki Kawai, Taiki Morita, Kazuki Miura, Satoshi Okada, Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry Letters   72   128869 - 128869   2022.9

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bmcl.2022.128869

    researchmap

  • Boron Neutron Capture Therapy (BNCT) Mediated by Maleimide-Functionalized Closo-Dodecaborate Albumin Conjugates (MID:BSA) for Oral Cancer: Biodistribution Studies and In Vivo BNCT in the Hamster Cheek Pouch Oral Cancer Model

    Andrea Monti Hughes, Jessica A. Goldfinger, Mónica A. Palmieri, Paula Ramos, Iara S. Santa Cruz, Luciana De Leo, Marcela A. Garabalino, Silvia I. Thorp, Paula Curotto, Emiliano C. C. Pozzi, Kazuki Kawai, Shinichi Sato, María E. Itoiz, Verónica A. Trivillin, Juan S. Guidobono, Hiroyuki Nakamura, Amanda E. Schwint

    Life   12 ( 7 )   1082 - 1082   2022.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Background: BNCT (Boron Neutron Capture Therapy) is a tumor-selective particle radiotherapy that combines preferential boron accumulation in tumors and neutron irradiation. Although p-boronophenylalanine (BPA) has been clinically used, new boron compounds are needed for the advancement of BNCT. Based on previous studies in colon tumor-bearing mice, in this study, we evaluated MID:BSA (maleimide-functionalized closo-dodecaborate conjugated to bovine serum albumin) biodistribution and MID:BSA/BNCT therapeutic effect on tumors and associated radiotoxicity in the hamster cheek pouch oral cancer model. Methods: Biodistribution studies were performed at 30 mg B/kg and 15 mg B/kg (12 h and 19 h post-administration). MID:BSA/BNCT (15 mg B/kg, 19 h) was performed at three different absorbed doses to precancerous tissue. Results: MID:BSA 30 mg B/kg protocol induced high BSA toxicity. MID:BSA 15 mg B/kg injected at a slow rate was well-tolerated and reached therapeutically useful boron concentration values in the tumor and tumor/normal tissue ratios. The 19 h protocol exhibited significantly lower boron concentration values in blood. MID:BSA/BNCT exhibited a significant tumor response vs. the control group with no significant radiotoxicity. Conclusions: MID:BSA/BNCT would be therapeutically useful to treat oral cancer. BSA toxicity is a consideration when injecting a compound conjugated to BSA and depends on the animal model studied.

    DOI: 10.3390/life12071082

    researchmap

  • 中性子捕捉療法のための血清アルブミンを利用したホウ素キャリアの開発

    中村 浩之, 西村 開, 盛田 大輝, 岡田 智, 三浦 一輝, 柏木 秀基, 福尾 祐介, 中井 啓, 鈴木 実, 川端 信司

    日本DDS学会学術集会プログラム予稿集   38回   87 - 87   2022.6

     More details

    Language:Japanese   Publisher:日本DDS学会  

    researchmap

  • BODIPY Catalyzes Proximity‐Dependent Histidine Labelling

    Keita Nakane, Tatsuya Niwa, Michihiko Tsushima, Shusuke Tomoshige, Hideki Taguchi, Hiroyuki Nakamura, Minoru Ishikawa, Shinichi Sato

    ChemCatChem   14 ( 9 )   2022.5

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/cctc.202200077

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cctc.202200077

  • Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model Reviewed International journal

    Hideki Kashiwagi, Shinji Kawabata, Kohei Yoshimura, Yusuke Fukuo, Takuya Kanemitsu, Koji Takeuchi, Ryo Hiramatsu, Kai Nishimura, Kazuki Kawai, Takushi Takata, Hiroki Tanaka, Tsubasa Watanabe, Minoru Suzuki, Shin Ichi Miyatake, Hiroyuki Nakamura, Masahiko Wanibuchi

    Investigational New Drugs   40 ( 2 )   255 - 264   2022.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Introduction Boron neutron capture therapy (BNCT) is a biologically targeted, cell-selective particle irradiation therapy that utilizes the nuclear capture reaction of boron and neutron. Recently, accelerator neutron generators have been used in clinical settings, and expectations for developing new boron compounds are growing. Methods and Results In this study, we focused on serum albumin, a well-known drug delivery system, and developed maleimide-functionalized closo-dodecaborate albumin conjugate (MID-AC) as a boron carrying system for BNCT. Our biodistribution experiment involved F98 glioma-bearing rat brain tumor models systemically administered with MID-AC and demonstrated accumulation and long retention of boron. Our BNCT study with MID-AC observed statistically significant prolongation of the survival rate compared to the control groups, with results comparable to BNCT study with boronophenylalanine (BPA) which is the standard use of in clinical settings. Each median survival time was as follows: untreated control group; 24.5 days, neutron-irradiated control group; 24.5 days, neutron irradiation following 2.5 h after termination of intravenous administration (i.v.) of BPA; 31.5 days, and neutron irradiation following 2.5 or 24 h after termination of i.v. of MID-AC; 33.5 or 33.0 days, respectively. The biological effectiveness factor of MID-AC for F98 rat glioma was estimated based on these survival times and found to be higher to 12. This tendency was confirmed in BNCT 24 h after MID-AC administration. Conclusion MID-AC induces an efficient boron neutron capture reaction because the albumin contained in MID-AC is retained in the tumor and has a considerable potential to become an effective delivery system for BNCT in treating high-grade gliomas.

    DOI: 10.1007/s10637-021-01201-7

    Scopus

    PubMed

    researchmap

  • 中性子捕捉療法のための、アルブミンリガンドを基軸としたホウ素キャリアの開発

    西村 開, 盛田 大輝, 岡田 智, 三浦 一輝, 柏木 秀基, 福尾 祐介, 松本 孔貴, 高田 卓志, 鈴木 実, 中井 啓, 川端 信司, 中村 浩之

    日本薬学会年会要旨集   142年会   27T - pm17S   2022.3

     More details

    Language:Japanese   Publisher:(公社)日本薬学会  

    researchmap

  • Intracellular photocatalytic-proximity labeling for profiling protein-protein interactions in microenvironments. International journal

    Michihiko Tsushima, Shinichi Sato, Kazuki Miura, Tatsuya Niwa, Hideki Taguchi, Hiroyuki Nakamura

    Chemical communications (Cambridge, England)   58 ( 12 )   1926 - 1929   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Intracellular photocatalytic-proximity labeling (iPPL) was developed to profile protein-protein interactions in the microenvironment of living cells. Acriflavine was found to be an efficient cell-membrane-permeable photocatalyst for introduction into the genetically HaloTag-fused protein of interest for iPPL with a radical labeling reagent, 1-methyl-4-arylurazole. iPPL was applied to the histone-associated protein H2B in HaloTag-H2B expressing HEK293FT cells. The proteins directly interacting with histones and RNA-binding proteins were selectively labeled in the intracellular environment, suggesting that the iPPL method has a smaller labeling radius (CA. 6 nm) than the BioID and APEX methods.

    DOI: 10.1039/d1cc05764b

    PubMed

    researchmap

  • Detoxification of amyloid β fibrils by curcumin derivatives and their verification in a Drosophila Alzheimer's model

    Rohmad Yudi Utomo, Atsushi Sugie, Satoshi Okada, Kazuki Miura, Hiroyuki Nakamura

    Chemical Communications   2022

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry (RSC)  

    Curcumin derivatives B and N developed as disaggregation agents of amyloid β (Aβ) fibrils significantly rescued locomotion dysfunction in an Aβ-expressing <italic>Drosophila</italic> model of Alzheimer's disease.

    DOI: 10.1039/d1cc07000b

    researchmap

  • Development of an MRI contrast agent for both detection and inhibition of the amyloid-β fibrillation process

    Rohmad Yudi Utomo, Satoshi Okada, Akira Sumiyoshi, Ichio Aoki, Hiroyuki Nakamura

    RSC Advances   12 ( 8 )   5027 - 5030   2022

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry (RSC)  

    A curcumin derivative conjugated with Gd-DO3A (Gd-DO3A-Comp.B) was developed to significantly inhibit the amyloid-β (Aβ) aggregation and detect the fibril growth by <italic>T</italic>1-weighted MR imaging.

    DOI: 10.1039/d2ra00614f

    researchmap

  • Chronic pathophysiological changes in the normal brain parenchyma caused by radiotherapy accelerate glioma progression. Reviewed International journal

    Yuichiro Tsuji, Naosuke Nonoguchi, Daisuke Okuzaki, Yusuke Wada, Daisuke Motooka, Yuki Hirota, Taichiro Toho, Nobuhiko Yoshikawa, Motomasa Furuse, Shinji Kawabata, Shin-Ichi Miyatake, Hiroyuki Nakamura, Ryohei Yamamoto, Shota Nakamura, Toshihiko Kuroiwa, Masahiko Wanibuchi

    Scientific reports   11 ( 1 )   22110 - 22110   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Radiation therapy is one of standard treatment for malignant glioma after surgery. The microenvironment after irradiation is considered not to be suitable for the survival of tumor cells (tumor bed effect). This study investigated whether the effect of changes in the microenvironment of parenchymal brain tissue caused by radiotherapy affect the recurrence and progression of glioma. 65-Gy irradiation had been applied to the right hemisphere of Fisher rats. After 3 months from irradiation, we extracted RNA and protein from the irradiated rat brain. To study effects of proteins extracted from the brains, we performed WST-8 assay and tube formation assay in vitro. Cytokine production were investigated for qPCR. Additionally, we transplanted glioma cell into the irradiated and sham animals and the median survival time of F98 transplanted rats was also examined in vivo. Immunohistochemical analyses and invasiveness of implanted tumor were evaluated. X-ray irradiation promoted the secretion of cytokines such as CXCL12, VEGF-A, TGF-β1 and TNFα from the irradiated brain. Proteins extracted from the irradiated brain promoted the proliferation and angiogenic activity of F98 glioma cells. Glioma cells implanted in the irradiated brains showed significantly high proliferation, angiogenesis and invasive ability, and the post-irradiation F98 tumor-implanted rats showed a shorter median survival time compared to the Sham-irradiation group. The current study suggests that the microenvironment around the brain tissue in the chronic phase after exposure to X-ray radiation becomes suitable for glioma cell growth and invasion.

    DOI: 10.1038/s41598-021-01475-0

    PubMed

    researchmap

    Other Link: https://www.nature.com/articles/s41598-021-01475-0

  • Carborane as an Alternative Efficient Hydrophobic Tag for Protein Degradation

    Yasunobu Asawa, Kei Nishida, Kazuki Kawai, Kiyotaka Domae, Hyun Seung Ban, Akihiro Kitazaki, Hiroya Asami, Jun-Ya Kohno, Satoshi Okada, Hiraku Tokuma, Daisuke Sakano, Shoen Kume, Masaru Tanaka, Hiroyuki Nakamura

    Bioconjugate Chemistry   2021.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

    DOI: 10.1021/acs.bioconjchem.1c00431

    researchmap

  • Preparation of an antigen-responsive fluorogenic immunosensor by tyrosine chemical modification of the antibody complementarity determining region. International journal

    Shinichi Sato, Masaki Matsumura, Hiroshi Ueda, Hiroyuki Nakamura

    Chemical communications (Cambridge, England)   57 ( 76 )   9760 - 9763   2021.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Full-length pharmaceutical antibodies, trastuzumab and rituximab, were chemically modified into Quenchbody, a fluorescent immunosensor, using a two-step reaction: (1) selective tyrosine residue modification of antibody complementarity determining regions (CDRs), and (2) introduction of fluorescent dye molecules by Cu-free click reaction. Without the need for genetic manipulation and time-consuming examination of protein expression conditions, the antibody-dye combination with good antigen response efficiency was examined in a simple two-hour operation.

    DOI: 10.1039/d1cc03231c

    PubMed

    researchmap

  • Development of curcumin-based amyloid β aggregation inhibitors for Alzheimer's disease using the SAR matrix approach

    Rohmad Yudi Utomo, Yasunobu Asawa, Satoshi Okada, Hyun Seung Ban, Atsushi Yoshimori, Jürgen Bajorath, Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry   46   116357 - 116357   2021.9

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bmc.2021.116357

    researchmap

  • Synthesis of Three-Dimensional (Di)Azatricyclododecene Scaffold and Its Application to Peptidomimetics. International journal

    Kohei Umedera, Taiki Morita, Atsushi Yoshimori, Kentaro Yamada, Akira Katoh, Hiroyuki Kouji, Hiroyuki Nakamura

    Chemistry (Weinheim an der Bergstrasse, Germany)   27 ( 46 )   11888 - 11894   2021.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A novel sp3 carbon-rich tricyclic 3D scaffold-based peptide mimetic compound library was constructed to target protein-protein interactions. Tricyclic framework 7 was synthesized from 9-azabicyclo[3,3,1]nonan-3-one (11) via a gold(I)-catalyzed Conia-ene reaction. The electron-donating group on the pendant alkyne of cyclization precursor 12 b-e was the key to forming 6-endo-dig cyclized product 7 with complete regioselectivity. Using the synthetic strategy for regioselective construction of bridged tricyclic framework 7, a diazatricyclododecene 3D-scaffold 8 a, which enables the introduction of substituents into the scaffold to mimic amino acid side chains, was designed and synthesized. The peptide mimetics 21 a-u were synthesized via step-by-step installation of three substituents on diazatricyclododecene scaffold 8 a. Compounds 21 a-h were synthesized as α-helix peptide mimics of hydrophobic ZZxxZ and ZxxZZ sequences (Z=Leu or Phe) and subjected to cell-based assays: antiproliferative activity, HIF-1 transcriptional activity which is considered to affect cancer malignancy, and antiviral activity against rabies virus. Compound 21 a showed the strongest inhibitory activity of HIF-1 transcriptional activity (IC50 =4.1±0.8 μM), whereas compounds 21 a-g showed antiviral activity with IC50 values of 4.2-12.4 μM, suggesting that the 3D-scaffold 8 a has potential as a versatile peptide mimic skeleton.

    DOI: 10.1002/chem.202101440

    PubMed

    researchmap

  • Suzuki-Miyaura cross-coupling of 3,4-disubstituted 5-bromoisoxazoles: An efficient access to trisubstituted isoxazoles

    Masato Tsuda, Taiki Morita, Hiroyuki Nakamura

    Tetrahedron Letters   75   2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier Ltd  

    The Suzuki-Miyaura cross-coupling of 3,4-disubstituted 5-bromoisoxazoles 1 at the C5 position has successfully proceeded in the presence of Pd2(dba)3 and P(t-Bu)3·HBF4 catalysts to give the corresponding trisubstituted isoxazoles 3 in good to high yields while suppressing the formation of ketone 4 as a byproduct. The use of bulky phosphine ligand P(t-Bu)3·HBF4 is essential for the current transformation, and the formation of ketone 4, which was a major product in the previous report, was able to be suppressed under the current conditions.

    DOI: 10.1016/j.tetlet.2021.153185

    Scopus

    researchmap

  • Rapid and Mild Lactamization Using Highly Electrophilic Triphosgene in a Microflow Reactor

    Shinichiro Fuse, Keiji Komuro, Yuma Otake, Hisashi Masui, Hiroyuki Nakamura

    Chemistry - A European Journal   27 ( 27 )   7525 - 7532   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:John Wiley and Sons Inc  

    Lactams are cyclic amides that are indispensable as drugs and as drug candidates. Conventional lactamization includes acid-mediated and coupling-agent-mediated approaches that suffer from narrow substrate scope, much waste, and/or high cost. Inexpensive, less-wasteful approaches mediated by highly electrophilic reagents are attractive, but there is an imminent risk of side reactions. Herein, a methods using highly electrophilic triphosgene in a microflow reactor that accomplishes rapid (0.5–10 s), mild, inexpensive, and less-wasteful lactamization are described. Methods A and B, which use N-methylmorpholine and N-methylimidazole, respectively, were developed. Various lactams and a cyclic peptide containing acid- and/or heat-labile functional groups were synthesized in good to high yields without the need for tedious purification. Undesired reactions were successfully suppressed, and the risk of handling triphosgene was minimized by the use of microflow technology.

    DOI: 10.1002/chem.202100059

    Scopus

    PubMed

    researchmap

  • Proximity Histidine Labeling by Umpolung Strategy Using Singlet Oxygen. International journal

    Keita Nakane, Shinichi Sato, Tatsuya Niwa, Michihiko Tsushima, Shusuke Tomoshige, Hideki Taguchi, Minoru Ishikawa, Hiroyuki Nakamura

    Journal of the American Chemical Society   2021.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    While electrophilic reagents for histidine labeling have been developed, we report an umpolung strategy for histidine functionalization. A nucleophilic small molecule, 1-methyl-4-arylurazole, selectively labeled histidine under singlet oxygen (1O2) generation conditions. Rapid histidine labeling can be applied for instant protein labeling. Utilizing the short diffusion distance of 1O2 and a technique to localize the 1O2 generator, a photocatalyst in close proximity to the ligand-binding site, we demonstrated antibody Fc-selective labeling on magnetic beads functionalized with a ruthenium photocatalyst and Fc ligand, ApA. Three histidine residues located around the ApA binding site were identified as labeling sites by liquid chromatography-mass spectrometry analysis. This result suggests that 1O2-mediated histidine labeling can be applied to a proximity labeling reaction on the nanometer scale.

    DOI: 10.1021/jacs.1c01626

    PubMed

    researchmap

  • Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016–2020)

    Hyun Seung Ban, Yoshikazu Uto, Hiroyuki Nakamura

    Expert Opinion on Therapeutic Patents   2021.1

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Informa {UK} Limited  

    DOI: 10.1080/13543776.2021.1874345

    researchmap

  • Synthesis of 4-amino-5-allenylisoxazoles via gold(i)-catalysed propargyl aza-Claisen rearrangement

    Masato Tsuda, Taiki Morita, Shintaro Fukuhara, Hiroyuki Nakamura

    Organic & Biomolecular Chemistry   2021

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    DOI: 10.1039/D0OB02544E

    researchmap

  • Synthesis of bis(carboranyl)amides 1,1'-µ-(CH2NH(O)C(CH2)n-1,2-C2B10H11)2 (n = 0, 1) and attempt of synthesis of gadolinium bis(dicarbollide)

    Yasunobu Asawa, Aleksandra V. Arsent’eva, Sergey A. Anufriev, Alexei A. Anisimov, K. Yu Suponitsky, Oleg A. Filippov, Hiroyuki Nakamura, Igor B. Sivaev

    Molecules   26 ( 5 )   2021

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Bis(carboranyl)amides 1,1'-µ-(CH2NH(O)C(CH2)n-1,2-C2B10H11)2 (n = 0, 1) were prepared by the reactions of the corresponding carboranyl acyl chlorides with ethylenediamine. Crystal molecular structure of 1,1'-µ-(CH2NH(O)C-1,2-C2B10H11)2 was determined by single crystal X-ray diffraction. Treatment of bis(carboranyl)amides 1,1'-µ-(CH2NH(O)C(CH2)n-1,2-C2B10H11)2 with ammonium or cesium fluoride results in partial deboronation of the ortho-carborane cages to the nidocarborane ones with formation of [7,7'(8')-µ-(CH2NH(O)C(CH2)n-7,8-C2B9H11)2]2-. The attempted reaction of [7,7'(8')-µ-(CH2NH(O)CCH2-7,8-C2B9H11)2]2- with GdCl3 in 1,2-dimethoxy- ethane did not give the expected metallacarborane. The stability of different conformations of Gd-containing metallacarboranes has been estimated by quantum-chemical calculations using [3,3-µ-DME-3,30- Gd(1,2-C2B9H11)2]- as a model. It was found that in the most stable conformation the CH groups of the dicarbollide ligands are in anti,anti-orientation with respect to the DME ligand, while any rotation of the dicarbollide ligand reduces the stability of the system. This makes it possible to rationalize the design of carborane ligands for the synthesis of gadolinium metallacarboranes on their base.

    DOI: 10.3390/molecules26051321

    Scopus

    PubMed

    researchmap

  • Recent Advances in Continuous-Flow Reactions Using Metal-Free Homogeneous Catalysts

    Naoto Sugisawa, Hiroyuki Nakamura, Shinichiro Fuse

    Catalysts   2020.11

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/catal10111321

    researchmap

  • Size-Controllable and Scalable Production of Liposomes Using a V-Shaped Mixer Micro-Flow Reactor

    Jun Kawamura, Hiroshi Kitamura, Yuma Otake, Shinichiro Fuse, Hiroyuki Nakamura

    Organic Process Research & Development   24 ( 10 )   2122 - 2127   2020.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society ({ACS})  

    DOI: 10.1021/acs.oprd.0c00174

    researchmap

  • Cyclic RGD-Functionalized closo-Dodecaborate Albumin Conjugates as Integrin Targeting Boron Carriers for Neutron Capture Therapy

    Kazuki Kawai, Kai Nishimura, Satoshi Okada, Shinichi Sato, Minoru Suzuki, Takushi Takata, Hiroyuki Nakamura

    Molecular Pharmaceutics   17 ( 10 )   3740 - 3747   2020.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society ({ACS})  

    DOI: 10.1021/acs.molpharmaceut.0c00478

    researchmap

  • Labeling of Peroxide-Induced Oxidative Stress Hotspots by Hemin-Catalyzed Tyrosine Click

    Shinichi Sato, Hiroyuki Nakamura

    Chemical and Pharmaceutical Bulletin   68 ( 9 )   885 - 890   2020.9

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Pharmaceutical Society of Japan  

    DOI: 10.1248/cpb.c20-00434

    researchmap

  • Target Protein Identification on Photocatalyst‐Functionalized Magnetic Affinity Beads

    Michihiko Tsushima, Shinichi Sato, Keita Nakane, Hiroyuki Nakamura

    Current Protocols in Protein Science   101 ( 1 )   2020.9

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/cpps.108

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cpps.108

  • Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors

    Sei-ichi Tanuma, Kiyotaka Katsuragi, Takahiro Oyama, Atsushi Yoshimori, Yuri Shibasaki, Yasunobu Asawa, Hiroaki Yamazaki, Kosho Makino, Miwa Okazawa, Yoko Ogino, Yoshimi Sakamoto, Miyuki Nomura, Akira Sato, Hideaki Abe, Hiroyuki Nakamura, Hideyo Takahashi, Nobuhiro Tanuma, Fumiaki Uchiumi

    Molecules   25 ( 16 )   3633 - 3633   2020.8

     More details

    Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) is an attractive therapeutic strategy for targeting cancer metabolism. So far, many potent NAMPT inhibitors have been developed and shown to bind to two unique tunnel-shaped cavities existing adjacent to each active site of a NAMPT homodimer. However, cytotoxicities and resistances to NAMPT inhibitors have become apparent. Therefore, there remains an urgent need to develop effective and safe NAMPT inhibitors. Thus, we designed and synthesized two close structural analogues of NAMPT inhibitors, azaindole–piperidine (3a)- and azaindole–piperazine (3b)-motif compounds, which were modified from the well-known NAMPT inhibitor FK866 (1). Notably, 3a displayed considerably stronger enzyme inhibitory activity and cellular potency than did 3b and 1. The main reason for this phenomenon was revealed to be due to apparent electronic repulsion between the replaced nitrogen atom (N1) of piperazine in 3b and the Nδ atom of His191 in NAMPT by our in silico binding mode analyses. Indeed, 3b had a lower binding affinity score than did 3a and 1, although these inhibitors took similar stable chair conformations in the tunnel region. Taken together, these observations indicate that the electrostatic enthalpy potential rather than entropy effects inside the tunnel cavity has a significant impact on the different binding affinity of 3a from that of 3b in the disparate enzymatic and cellular potencies. Thus, it is better to avoid or minimize interactions with His191 in designing further effective NAMPT inhibitors.

    DOI: 10.3390/molecules25163633

    researchmap

  • N‐Methylated Peptide Synthesis via Generation of an Acyl N‐Methylimidazolium Cation Accelerated by a Brønsted Acid

    Yuma Otake, Yusuke Shibata, Yoshihiro Hayashi, Susumu Kawauchi, Hiroyuki Nakamura, Shinichiro Fuse

    Angewandte Chemie International Edition   132 ( 31 )   13025 - 13030   2020.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/anie.202002106

    researchmap

  • Investigation into the influence of an acrylic acid acceptor in organic D-π-A sensitizers against phototoxicity. International journal

    Shinichiro Fuse, Wataru Moriya, Shinichi Sato, Hiroyuki Nakamura

    Bioorganic & medicinal chemistry   28 ( 13 )   115558 - 115558   2020.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Photodynamic therapy (PDT) is a non-invasive, selective, and cost-effective cancer therapy. We previously reported that thiophene-based organic D-π-A sensitizers consist of an electron-donating (D) moiety, a π-conjugated bridge (π) moiety, and an electron-accepting (A) moiety, and are readily accessible and stable templates for photosensitizers that could be used in PDT. In addition, acrylic acid acceptor-containing photosensitizers exert a high level of phototoxicity. This study was an investigation into 1) the possibility of increasing phototoxicity by introducing another carboxyl group or by replacing a carboxyl group with a pyridinium group, and 2) the importance of an alkene in the acrylic acid acceptor for phototoxicity. A review of the design, synthesis, and evaluation of sensitizers revealed that neither dicarboxylic acid nor pyridinium photosensitizers enhance phototoxicity. An evaluation of a photosensitizer without an alkene in the acrylic acid moiety revealed that the alkene was not indispensable in the pursuit of phototoxicity. The obtained results provided new insight into the design of ideal D-π-A photosensitizers for PDT.

    DOI: 10.1016/j.bmc.2020.115558

    PubMed

    researchmap

  • Water-Soluble closo-Docecaborate-Containing Pteroyl Derivatives Targeting Folate Receptor-Positive Tumors for Boron Neutron Capture Therapy

    Fumiko Nakagawa, Hidehisa Kawashima, Taiki Morita, Hiroyuki Nakamura

    Cells   9 ( 7 )   1615 - 1615   2020.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:{MDPI} {AG}  

    DOI: 10.3390/cells9071615

    researchmap

  • Site-Selective Protein Chemical Modification of Exposed Tyrosine Residues Using Tyrosine Click Reaction International journal

    Shinichi Sato, Masaki Matsumura, Tetsuya Kadonosono, Satoshi Abe, Takafumi Ueno, Hiroshi Ueda, Hiroyuki Nakamura

    Bioconjugate Chemistry   31 ( 5 )   1417 - 1424   2020.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society ({ACS})  

    Targeting less abundant amino acid residues on the protein surface may realize site-selective protein modification of natural proteins. The relative hydrophobicity of tyrosine combined with the π-π stacking tendency of the aromatic rings results in generally low accessibility. In this study, site-selective protein modification was achieved by targeting surface-exposed tyrosine residues without using a genetic encoding system. Tyrosine residues were modified with N-methylated luminol derivative under single-electron transfer (SET) reaction conditions. Horseradish peroxidase (HRP)-catalyzed SET and electrochemically activated SET modified surface-exposed tyrosine residues selectively. N-Methylated luminol derivative modified tyrosine residues more efficiently than 4-arylurazole under tyrosine click conditions using HRP and electrochemistry. Tyrosine residues that are evolutionarily exposed only in the complementarity-determining region (CDR) of an antibody were selectively modified by tyrosine click reactions. CDR-modified antibodies were applied to in vivo imaging and antibody-drug conjugated (ADC).

    DOI: 10.1021/acs.bioconjchem.0c00120

    PubMed

    researchmap

  • Photochemical Conversion of Isoxazoles to 5-Hydroxyimidazolines

    Taiki Morita, Shinichiro Fuse, Hiroyuki Nakamura

    Organic Letters   2020.5

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society ({ACS})  

    DOI: 10.1021/acs.orglett.0c00910

    researchmap

  • Boron Neutron Capture Therapy Study of 10B Enriched Nanostructured Boron Carbide Against Cervical Cancer and Glioblastoma Cell Line

    Hiroyuki Nakamura

    Journal of Cluster Science   2020.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10876-020-01773-z

    researchmap

  • Carrier proteins-based boron delivery to tumor

    Hiroyuki Nakamura

    Applied Radiation and Isotopes   157   109011 - 109011   2020.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.apradiso.2019.109011

    researchmap

  • Suppression of HIF-1α accumulation by betulinic acid through proteasome activation in hypoxic cervical cancer

    Hiroyuki Nakamura

    Biochemical and Biophysical Research Communications   523 ( 3 )   2020.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bbrc.2020.01.031

    researchmap

  • 2-Dimensional Nanomaterials with Imaging and Diagnostic Functions for Nanomedicine; A Review

    Hiroyuki Nakamura

    Bulletin of the Chemical Society of Japan   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1246/bcsj.20190270

    researchmap

  • Cover Feature: Single‐Step, Rapid, and Mild Synthesis of β‐Amino Acid N ‐Carboxy Anhydrides Using Micro‐Flow Technology (Chem. Asian J. 1/2020)

    Naoto Sugisawa, Yuma Otake, Hiroyuki Nakamura, Shinichiro Fuse

    Chemistry – An Asian Journal   15 ( 1 )   2 - 2   2020.1

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/asia.201901586

    researchmap

  • Single‐Step, Rapid, and Mild Synthesis of β‐Amino Acid N ‐Carboxy Anhydrides Using Micro‐Flow Technology

    Naoto Sugisawa, Yuma Otake, Hiroyuki Nakamura, Shinichiro Fuse

    Chemistry – An Asian Journal   15 ( 1 )   79 - 84   2020.1

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/asia.201901429

    researchmap

  • Boron nitride (10BN) a prospective material for treatment of cancer by boron neutron capture therapy (BNCT)

    Hiroyuki Nakamura

    Materials Letters   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.matlet.2019.126832

    researchmap

  • Design, synthesis, and evaluation of indeno[2,1-c]pyrazolones for use as inhibitors against hypoxia-inducible factor (HIF)-1 transcriptional activity International journal

    Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry   28 ( 1 )   115207 - 115207   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    HIF-1 is regarded as a promising target for the drugs used in cancer chemotherapy, and creating readily accessible templates for the development of synthetic drug candidates that could inhibit HIF-1 transcriptional activity is an important pursuit. In this study, indeno[2,1-c]pyrazolones were designed as readily available synthetic inhibitors of HIF-1 transcriptional activity. Nine compounds were synthesized in 4-5 steps from commercially available starting materials. In evaluations of the ability to inhibit the hypoxia-induced transcriptional activity of HIF-1, compound 3c showed a higher level compared with that of known inhibitor, YC-1. The compound 3c suppressed HIF-1α protein accumulation without affecting the levels of HIF-1α mRNA.

    DOI: 10.1016/j.bmc.2019.115207

    PubMed

    researchmap

  • Micro-flow synthesis of β-amino acid derivatives via a rapid dual activation approach

    Naoto Sugisawa, Hiroyuki Nakamura, Shinichiro Fuse

    Chemical Communications   2020

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    DOI: 10.1039/D0CC01403F

    researchmap

  • Design, synthesis, and evaluation of azo D–π-A dyes as photothermal agents

    Shinichiro Fuse, Tsukasa Oishi, Keisuke Matsumura, Yoshihiro Hayashi, Susumu Kawauchi, Hiroyuki Nakamura

    Organic & Biomolecular Chemistry   2020

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    DOI: 10.1039/C9OB02066G

    researchmap

  • Rhodium(iii)-catalysed decarboxylative C–H functionalization of isoxazoles with alkenes and sulfoxonium ylides

    Somaraju Yugandar, Taiki Morita, Hiroyuki Nakamura

    Organic & Biomolecular Chemistry   2020

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    DOI: 10.1039/D0OB02027C

    researchmap

  • A laccase-catalysed tyrosine click reaction International journal

    Shinichi Sato, Keita Nakane, Hiroyuki Nakamura

    Organic & Biomolecular Chemistry   18 ( 19 )   3664 - 3668   2020

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    A laccase-catalysed tyrosine click reaction proceeded between the tyrosine modification reagent N-methyl luminol and tyrosine residues in peptides/proteins. Laccase-catalysed tyrosine-specific modification under mild reaction conditions (shaking at 37 °C) was more efficient than previously reported tyrosine click reactions using hemin, horseradish peroxidase (HRP) or electrochemistry.

    DOI: 10.1039/D0OB00650E

    PubMed

    researchmap

  • Strategic design to create HER2-targeting proteins with target-binding peptides immobilized on a fibronectin type III domain scaffold

    Wanaporn Yimchuen, Tetsuya Kadonosono, Yumi Ota, Shinichi Sato, Maika Kitazawa, Tadashi Shiozawa, Takahiro Kuchimaru, Masumi Taki, Yuji Ito, Hiroyuki Nakamura, Shinae Kizaka-Kondoh

    RSC Advances   10 ( 26 )   15154 - 15162   2020

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ROYAL SOC CHEMISTRY  

    Tumor-binding peptides such as human epidermal growth factor receptor 2 (HER2)-binding peptides are attractive therapeutic and diagnostic options for cancer. However, the HER2-binding peptides (HBPs) developed thus far are susceptible to proteolysis and lose their affinity to HER2 in vivo. In this report, a method to create a HER2-binding fluctuation-regulated affinity protein (HBP-FLAP) consisting of a fibronectin type III domain (FN3) scaffold with a structurally immobilized HBP is presented. HBPs were selected by phage-library screening and grafted onto FN3 to create FN3-HBPs, and the HBP-FLAP with the highest affinity (HBP sequence: YCAHNM) was identified after affinity maturation of the grafted HBP. HBP-FLAP containing the YCAHNM peptide showed increased proteolysis-resistance, binding to HER2 with a dissociation constant (K-D) of 58 nM in ELISA and 287 nM in biolayer interferometry and specifically detects HER2-expressing cancer cells. In addition, HBP-FLAP clearly delineated HER2-expressing tumors with a half-life of 6 h after intravenous injection into tumor-bearing mice. FN3-based FLAP is an excellent platform for developing target-binding small proteins for clinical applications.

    DOI: 10.1039/D0RA00427H

    Web of Science

    researchmap

  • G-quadruplex-proximity protein labeling based on peroxidase activity

    Tatsuki Masuzawa, Shinichi Sato, Tatsuya Niwa, Hideki Taguchi, Hiroyuki Nakamura, Takanori Oyoshi

    Chemical Communications   56 ( 78 )   11641 - 11644   2020

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    <p>G-quadruplex-proximity protein labeling was performed using a hemin-parallel G-quadruplex (G4) complex. A tyrosine labeling reaction was accelerated in close proximity to the hemin with enhanced peroxidase activity by binding to parallel G4.</p>

    DOI: 10.1039/D0CC02571B

    researchmap

  • Zinc(ii)-catalyzed intramolecular hydroarylation-redox cross-dehydrogenative coupling of N-propargylanilines with diverse carbon pronucleophiles: facile access to functionalized tetrahydroquinolines

    Guangzhe Li, Chengdong Wang, Yueqing Li, Kun Shao, Guo Yu, Shisheng Wang, Xiuhan Guo, Weijie Zhao, Hiroyuki Nakamura

    Chemical Communications   2020

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    DOI: 10.1039/D0CC02921A

    researchmap

  • Peptide‐Chain Elongation Using Unprotected Amino Acids in a Micro‐Flow Reactor

    Shinichiro Fuse, Koshiro Masuda, Yuma Otake, Hiroyuki Nakamura

    Chemistry – A European Journal   2019.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/chem.201903531

    researchmap

  • Protein Chemical Labeling Using Biomimetic Radical Chemistry

    Hiroyuki Nakamura

    Molecules   24 ( 21 )   3980 - 3980   2019.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    <jats:p>Chemical labeling of proteins with synthetic low-molecular-weight probes is an important technique in chemical biology. To achieve this, it is necessary to use chemical reactions that proceed rapidly under physiological conditions (i.e., aqueous solvent, pH, low concentration, and low temperature) so that protein denaturation does not occur. The radical reaction satisfies such demands of protein labeling, and protein labeling using the biomimetic radical reaction has recently attracted attention. The biomimetic radical reaction enables selective labeling of the C-terminus, tyrosine, and tryptophan, which is difficult to achieve with conventional electrophilic protein labeling. In addition, as the radical reaction proceeds selectively in close proximity to the catalyst, it can be applied to the analysis of protein–protein interactions. In this review, recent trends in protein labeling using biomimetic radical reactions are discussed.</jats:p>

    DOI: 10.3390/molecules24213980

    researchmap

  • Imaging of cellular uptake of boron cluster compound by stimulated Raman scattering microscopy

    Takuya Asai, Hanqin Liu, Yasuyuki Ozeki, Shinichi Sato, Tomohiro Hayashi, Hiroyuki Nakamura

    Applied Physics Express   12 ( 11 )   112004 - 112004   2019.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Japan Society of Applied Physics  

    DOI: 10.7567/1882-0786/ab4a5d

    researchmap

    Other Link: http://iopscience.iop.org/article/10.7567/1882-0786/ab4a5d/pdf

  • Structure-based drug design of novel carborane-containing nicotinamide phosphoribosyltransferase inhibitors

    Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry   2019.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmc.2019.05.013

    researchmap

  • Folate receptor-targeted novel boron compound for boron neutron capture therapy on F98 glioma-bearing rats

    Hiroyuki Nakamura

    Radiation and Environmental Biophysics   58 ( 1 )   59 - 67   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Folic acid (FA) has high affinity for the folate receptor (FR), which is limited expressed in normal human tissues, but over-expressed in several tumor cells, including glioblastoma cells. In the present work, a novel pteroyl–closo-dodecaborate conjugate (PBC) was developed, in which the pteroyl group interacts with FR, and the efficacy of boron neutron capture therapy (BNCT) using PBC was investigated. Thus, in vitro and in vivo studies were performed using F98 rat glioma cells and F98 glioma-bearing rats. For the in vivo study, boronophenylalanine (BPA) was intravenously administered, while PBC was administered by convection-enhanced delivery (CED)—a method for direct local drug infusion into the brain of rats. Furthermore, a combination of PBC administered by CED and BPA administered by intravenous (i.v.) injection was also investigated. In the biodistribution experiment, PBC administration at 6 h after CED termination showed the highest cellular boron concentrations (64.6 ± 29.6 µg B/g). Median survival time (MST) of untreated controls was 23.0 days (range 21–24 days). MST of rats administered PBC (CED) followed by neutron irradiation was 31 days (range 26–36 days), which was similar to that of rats administered i.v. BPA (30 days; range 25–37 days). Moreover, the combination group [PBC (CED) and i.v. BPA] showed the longest MST (38 days; range 28–40 days). It is concluded that a significant MST increase was noted in the survival time of the combination group of PBC (CED) and i.v. BPA compared to that in the single-boron agent groups. These findings suggest that the combination use of PBC (CED) has additional effects.

    DOI: 10.1007/s00411-018-0765-2

    Scopus

    PubMed

    researchmap

  • N’-acyl-N-methylphenylenediamine as a novel proximity labeling agent for signal amplification in immunohistochemistry

    Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmc.2019.01.036

    researchmap

  • Catalyst-proximity protein chemical labelling on affinity beads targeting endogenous lectins Reviewed

    Michihiko Tsushima, Shinichi Sato, Tatsuya Niwa, Hideki Taguchi, Hiroyuki Nakamura

    Chemical Communications   55 ( 88 )   13275 - 13278   2019

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    DOI: 10.1039/C9CC05231C

    PubMed

    researchmap

  • Utilization of single electron transfer reaction in protein chemical labeling Reviewed

    Sato, S., Tsushima, M., Nakamura, H.

    Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry   77 ( 5 )   463 - 471   2019

     More details

    Publishing type:Research paper (scientific journal)  

    © 2019 Society of Synthetic Organic Chemistry. All rights reserved. The chemical labeling of proteins with synthetic small compound is an important technique in chemical biology. To achieve reliable bioconjugation. rapid reactions in aqueous under physiological pH and mild temperature are required. In the attempt to covalently label native proteins, various biorthogonal chemical reactions targeting not only nucleophilic amino acid residues such as lysine and cysteine, but also tyrosine, tryptophan, methionine, N-and C-terminal positions have been developed. The radical protein labeling reaction proceeds rapidly even in intracellular and physiological environment, and high reactivity of radical species enables local reaction control on the nanometer scale. In this paper, we introduce our recent studies on the labeling of protein tyrosine residues via single electron transfer initiated radical reaction, especially using ruthenium photocatalyst. We found the protein labeling at tyrosine residues with small compounds such as N-acyl-N,N-phenylenediamine and l-methyl-4-aryl-urazole under the reaction condition using ruthenium photocatalyst and visible light irradiation. Target-selective labeling using ligand-conju-gated ruthenium photocatalysts, and target-selective-purification and labeling from protein mixture using catalyst-functionalized affinity beads were achieved.

    DOI: 10.5059/yukigoseikyokaishi.77.463

    Scopus

    researchmap

  • Design of S–S bond containing maleimide-conjugated closo-dodecaborate (SSMID): identification of unique modification sites on albumin and investigation of intracellular uptake

    Satomu Ishii, Shinichi Sato, Hiroya Asami, Tomoko Hasegawa, Jun-Ya Kohno, Hiroyuki Nakamura

    Organic & Biomolecular Chemistry   2019

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    DOI: 10.1039/C9OB00584F

    researchmap

  • Raman cell imaging with boron cluster molecules conjugated with biomolecules Reviewed

    Masahito Mochizuki, Shinichi Sato, Syifa Asatyas, Zbigniew J. Leśnikowski, Tomohiro Hayashi, Hiroyuki Nakamura

    RSC Advances   9 ( 41 )   23973 - 23978   2019

     More details

    Publishing type:Research paper (scientific journal)  

    © 2019 The Royal Society of Chemistry. Raman spectroscopic measurements and theoretical calculation revealed that the Raman bands corresponding to the B-H stretching vibrations of two types of simple icosahedral boron clusters, ortho-carborane 3 and closo-dodecaborate 4 appeared at approximately 2450-2700 cm-1, and did not overlap with those of cellular components. Although ortho-carborane 3 possesses a possible property as a Raman probe, it was difficult to measure Raman imaging in the cell due to its poor water solubility. In fact, ortho-carborane derivative 6, which internally has an alkyne moiety, exhibited very weak Raman signals of the CC stretching and the B-H stretching vibrations were barely detected at a 400 ppm boron concentration in HeLa cells. In contrast, closo-dodecaborate derivatives such as BSH (5) were found to be a potential Raman imaging probe cluster for target molecules in the cell. BSH-conjugated cholesterol 7 (BSH-Chol) was synthesized and used in Raman imaging in cells. Raman imaging and spectral analysis revealed that BSH-based Raman tags provide a versatile platform for quantitative Raman imaging.

    DOI: 10.1039/C9RA04228H

    Scopus

    researchmap

  • Rhodium(iii)-catalysed carboxylate-directed C–H functionalizations of isoxazoles with alkynes

    Hiroyuki Nakamura

    Chemical Communications   55 ( 58 )   8382 - 8385   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    <p>Isoxazolyl-4-carboxylic acids underwent rhodium(<sc>iii</sc>)-catalysed carboxylate-directed C–H functionalizations with internal alkynes to produce pyranoisoxazolones, isoquinolines, and 5-alkenylisoxazoles controlled by oxidants.</p>

    DOI: 10.1039/c9cc03283e

    researchmap

  • Elucidating the mode of action for thiophene-based organic D-π-A sensitizers for use in photodynamic therapy

    Shinichiro Fuse, Miori Takizawa, Shinichi Sato, Shigetoshi Okazaki, Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry   27 ( 2 )   2019

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmc.2018.12.006

    researchmap

  • Synthesis of 3-Hydroxy-4-Substituted Picolinonitriles from 4-Propargylaminoisoxazoles via Stepwise and One-Pot Isoxazolopyridine Formation/N–O Bond Cleavage Sequence

    Shintaro Fukuhara, Somaraju Yugandar, Shinichiro Fuse, Hiroyuki Nakamura

    ACS Omega   2018.12

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/acsomega.8b03114

    researchmap

  • Peptide Synthesis Utilizing Micro-flow Technology

    Shinichiro Fuse, Yuma Otake, Hiroyuki Nakamura

    Chemistry - An Asian Journal   2018.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/asia.201801488

    researchmap

  • Frontispiece: Metallacarboranes on the Road to Anticancer Therapies: Cellular Uptake, DNA Interaction, and Biological Evaluation of Cobaltabisdicarbollide [COSAN]−

    Isabel Fuentes, Tania García-Mendiola, Shinichi Sato, Marcos Pita, Hiroyuki Nakamura, Encarnación Lorenzo, Francesc Teixidor, Fernanda Marques, Clara Viñas

    Chemistry - A European Journal   24 ( 65 )   17239 - 17254   2018.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/chem.201886564

    researchmap

  • The design, synthesis, and evaluation of organic dithienopyrrole-based D-π-A dyes for use as sensitizers in photodynamic therapy

    Shinichiro Fuse, Keisuke Matsumura, Miori Takizawa, Shinichi Sato, Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry Letters   28 ( 18 )   3099 - 3104   2018.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier {BV}  

    DOI: 10.1016/j.bmcl.2018.07.025

    researchmap

  • Rapid and Mild Synthesis of Amino Acid N -Carboxy Anhydrides: Basic-to-Acidic Flash Switching in a Microflow Reactor

    Yuma Otake, Hiroyuki Nakamura, Shinichiro Fuse

    Angewandte Chemie International Edition   57 ( 35 )   11389 - 11393   2018.8

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/anie.201803549

    researchmap

  • Rapid and Mild Synthesis of Amino Acid N -Carboxy Anhydrides: Basic-to-Acidic Flash Switching in a Microflow Reactor

    Yuma Otake, Hiroyuki Nakamura, Shinichiro Fuse

    Angewandte Chemie   130 ( 35 )   11559 - 11563   2018.8

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/ange.201803549

    researchmap

  • Synthesis and biological evaluation of closo-dodecaborate ibuprofen conjugate (DIC) as a new boron agent for neutron capture therapy

    Satomu Ishii, Hiroyuki Nakamura

    Journal of Organometallic Chemistry   865   178 - 182   2018.6

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier {BV}  

    DOI: 10.1016/j.jorganchem.2018.02.026

    researchmap

  • Recent progresses in the synthesis of functionalized isoxazoles

    Taiki Morita, Somaraju Yugandar, Shinichiro Fuse, Hiroyuki Nakamura

    Tetrahedron Letters   59 ( 13 )   1159 - 1171   2018.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier {BV}  

    DOI: 10.1016/j.tetlet.2018.02.020

    researchmap

  • Gold(I)-Catalyzed Intramolecular SEAr Reaction: Efficient Synthesis of Isoxazole-Containing Fused Heterocycles

    Taiki Morita, Shintaro Fukuhara, Shinichiro Fuse, Hiroyuki Nakamura

    Organic Letters   2018.1

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society ({ACS})  

    DOI: 10.1021/acs.orglett.7b03760

    researchmap

  • o-Carboranylalkoxy-1,3,5-Triazine Derivatives: Synthesis, Characterization, X-ray Structural Studies, and Biological Activity

    Hiroyuki Nakamura

    Molecules   2018

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/molecules23092194

    researchmap

  • Closo-Dodecaborate-conjugated human serum albumins: Preparation and in vivo selective boron delivery to tumor Reviewed

    Nakamura, H., Kikuchi, S., Kawai, K., Ishii, S., Sato, S.

    Pure and Applied Chemistry   90 ( 4 )   745 - 753   2018

     More details

    Publishing type:Research paper (scientific journal)  

    © 2018 IUPAC & De Gruyter. Maleimide-functionalized closo-dodecaborate (MID) and isothiocyanate-functionalized closo-dodecaborate (ISD) were synthesized from closo-dodecaborate via ring opening reaction of 1,4-dioxane-closo-dedecaborate complex 1 with ammonia. MID was found to possess highest conjugation efficacy to bovine serum albumin among three closo-dodecaborate derivatives, MID, ISD, and 1. The conjugation reaction of MID to human serum albumin (HSA) proceeded under PBS buffer conditions (pH 7.4). Boron distribution studies in colon 26 tumor-bearing mice revealed that HSA-MID was highly accumulated in tumor (23 ppm B), whereas boron concentrations in other organs such as liver, kidney and spleen were low (3~8 ppm B).

    DOI: 10.1515/pac-2017-1104

    Scopus

    researchmap

  • Target-protein-selective inactivation and labelling using an oxidative catalyst

    Shinichi Sato, Michihiko Tsushima, Hiroyuki Nakamura

    Organic & Biomolecular Chemistry   16 ( 34 )   6168 - 6179   2018

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    <p>Reactive oxygen species (ROS) and radical species generated by oxidative single-electron transfer (SET) catalysts induce local environmental oxidative reactions, resulting in protein inactivation and labelling in proximity to the catalysts.</p>

    DOI: 10.1039/C8OB01484A

    researchmap

  • 1-Methyl-4-aryl-urazole (MAUra) labels tyrosine in proximity to ruthenium photocatalysts

    Shinichi Sato, Kensuke Hatano, Michihiko Tsushima, Hiroyuki Nakamura

    Chemical Communications   2018

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    DOI: 10.1039/C8CC02891E

    researchmap

  • Synthesis of Pyrazolofuropyrazine via One-Pot S <inf>N</inf> Ar Reaction and Intramolecular Direct C-H Arylation Reviewed

    Fuse, S., Inaba, M., Sato, S., Joshi, M., Nakamura, H.

    Synthesis (Germany)   50 ( 7 )   1493 - 1498   2018

     More details

    Publishing type:Research paper (scientific journal)  

    © Georg Thieme Verlag Stuttgart New York. Fused-ring systems containing heterocycles are attractive templates for drug discovery. Biologically active 6-5-5+6 fused-ring systems that possess heterocycles are available, but these require a relatively large number of synthetic steps for preparation. Therefore, pyrazolofuropyrazine was designed as a 6-5-5+6 ring system template that incorporates ready accessibility for drug discovery. Pyrazolofuropyrazines were successfully constructed in only a few steps via one-pot S N Ar reaction/intramolecular C-H direct arylation. As a drug candidate, pyrazolofuropyrazine has earned a favorable LogP, although significant biological activity has yet to be established; the ready accessibility of pyrazolofuropyrazine template, however, offers an opportunity for the rapid development of promising new drug candidates.

    DOI: 10.1055/s-0036-1591885

    Scopus

    researchmap

  • Integrated Micro-Flow Synthesis Based on Photochemical Wolff Rearrangement

    Shinichiro Fuse, Yuma Otake, Hiroyuki Nakamura

    European Journal of Organic Chemistry   2017.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley-Blackwell  

    DOI: 10.1002/ejoc.201700789

    researchmap

  • Development of Albumin-closo -Dodecaborate Conjugates as Boron Carriers for Neutron-Capture Therapy by Ru(bpy)3 -Photocatalyzed Modification of Tyrosine

    Shinichi Sato, Satomu Ishii, Hiroyuki Nakamura

    European Journal of Inorganic Chemistry   2017 ( 38-39 )   4345 - 4345   2017.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley-Blackwell  

    DOI: 10.1002/ejic.201701118

    researchmap

  • Front Cover: Development of Albumin-closo -Dodecaborate Conjugates as Boron Carriers for Neutron-Capture Therapy by Ru(bpy)3 -Photocatalyzed Modification of Tyrosine (Eur. J. Inorg. Chem. 38-39/2017)

    Shinichi Sato, Satomu Ishii, Hiroyuki Nakamura

    European Journal of Inorganic Chemistry   2017 ( 38-39 )   4344 - 4344   2017.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley-Blackwell  

    DOI: 10.1002/ejic.201701117

    researchmap

  • Photodynamic therapy using a cytotoxic photosensitizer porphyrus envelope that targets the cell membrane International journal

    Inai, Mizuho, Honda, Norihiro, Hazama, Hisanao, Akter, Sharmin, Fuse, Shinichiro, Nakamura, Hiroyuki, Nishikawa, Tomoyuki, Kaneda, Yasufumi, Awazu, Kunio

    Photodiagnosis and photodynamic therapy   20   238 - 245   2017.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Subcellular localization of a photosensitizer is known to determine the therapeutic efficacy of photodynamic therapy (PDT). Cell membrane is an optimal target that promises an effective treatment outcome. OBJECTIVES: We previously developed a novel photosensitizer named porphyrus envelope (PE) by combining hemagglutinating virus of Japan envelope (HVJ-E) with lipidated protoporphyrin IX (PpIX lipid). In the current study, the cellular localization of PE and its ability to induce multiple anti-tumor effect were characterized. MATERIALS AND METHODS: The localization and uptake of PpIX lipid in cells were evaluated with confocal laser scanning microscopy and a cell-based fluorescent assay, respectively. The ability of PE to suppress the migration and proliferation of cancer cells was assessed using a scratch-wound assay. The synergistic effect of PDT and HVJ-E treatment was evaluated using an in vitro experiment with PC-3 cells. RESULTS: PE localized along the cell membrane and PpIX lipid accumulated selectively in the prostate cancer cells within 10min. Also, PE maintained the ability to undergo fusion and induce cancer cell death even after light irradiation at the dose for PDT. Incubation with PE resulted in delayed migratory and proliferative activity of PC-3 cells. PE-mediated PDT was twice as effective when cells were further incubated with PE following PDT. CONCLUSIONS: PE allows rapid drug delivery targeting the cell membrane. Because the cytotoxicity of HVJ-E was maintained, synergistic effect of HVJ-E and the photochemical reactions resulted in highly effective killing of prostate cancer cells in vitro and thus represents a promising treatment for prostate cancer.

    DOI: 10.1016/j.pdpdt.2017.10.017

    PubMed

    researchmap

  • Step-by-Step Multifunctionalization of Isoxazoles Based On SEAr Reactions and C-H Direct Arylations

    Shinichiro Fuse, Taiki Morita, Hiroyuki Nakamura

    Synthesis (Germany)   49 ( 11 )   2351 - 2360   2017.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Georg Thieme Verlag  

    Functionalized isoxazoles are important as pharmaceuticals and agrochemicals. Generally, electrophilic aromatic substitution or generation of carbanions/electrophilic trapping approach is used to introduce functional groups into unsubstituted heteroaromatics. However, these approaches have not been simple to apply to unsubstituted isoxazoles due to their poor nucleophilicity and instability under basic conditions. Recently several approaches have been reported to overcome these problems. This review summarizes the functionalization of isoxazoles, including SEAr reactions and C-H direct arylations, towards the step-by-step multifunctionalization of isoxazoles. 1 Introduction 2 SEAr Reaction of Isoxazoles 3 Preparation of Isoxazolyl Anions and Their Use for the Synthesis of Functionalized Isoxazoles 4 Other C-C and C-N Bond Formations of Isoxazoles 5 Transition-Metal-Catalyzed C-H Direct Functionalization of Isoxazoles 6 Step-by-Step Multifunctionalization of Isoxazoles 7 Summary and Outlook.

    DOI: 10.1055/s-0036-1588784

    Scopus

    researchmap

  • Inside Cover: Horseradish-Peroxidase-Catalyzed Tyrosine Click Reaction (ChemBioChem 5/2017)

    Shinichi Sato, Kosuke Nakamura, Hiroyuki Nakamura

    ChemBioChem   2017.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley-Blackwell  

    DOI: 10.1002/cbic.201700043

    researchmap

  • Horseradish-Peroxidase-Catalyzed Tyrosine Click Reaction

    Shinichi Sato, Kosuke Nakamura, Hiroyuki Nakamura

    ChemBioChem   2017.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley-Blackwell  

    DOI: 10.1002/cbic.201600649

    researchmap

  • Subcellular localization of novel photosensitizer named porphyrus envelope in human prostate cancer cell line PC-3 Reviewed

    Inai Mizuho, Honda Norihiro, Hazama Hisanao, Nakamura Hiroyuki, Yasuda Hidehiro, Nishikawa Tomoyuki, Kaneda Yasufumi, Awazu Kunio

    Nippon Laser Igakkaishi   37 ( 4 )   415 - 420   2017.1

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Japan Society for Laser Surgery and Medicine  

    <p>Photodynamic therapy (PDT), which utilizes laser light and photosensitizer (PS), is now arising as a potential modality for minimally invasive prostate cancer therapy due to its cancer selectivity. However, cancer selectivity and drug accumulation efficiency have to be enhanced to eliminate unwanted side effects and to shorten the time requirement for shielding from light. Therefore, to accomplish high accumulation and selective delivery, we have focused on the drug delivering system of replication-deficient Sendai virus particle, hemagglutinating virus of Japan envelope (HVJ-E). We are currently investigating the therapeutic effectiveness of PDT with a novel photosensitizer named porphyrus envelope, which can be created by combining HVJ-E and PS called protoporphyrin IX (PpIX). This paper will discuss about the drug delivering mechanism of this novel photosensitizer.</p>

    DOI: 10.2530/jslsm.jslsm-37_0028

    researchmap

  • Thiophene-Based Organic D–π–A Dyes as Potent Sensitizers for Photodynamic Therapy Reviewed

    Fuse, S., Takizawa, M., Matsumura, K., Sato, S., Okazaki, S., Nakamura, H.

    European Journal of Organic Chemistry   2017 ( 34 )   5170 - 5177   2017

     More details

    Publishing type:Research paper (scientific journal)  

    © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim In this study, synthetically readily accessible, thiophene-based organic D–π–A sensitizers exerted high phototoxicity and are valuable as sensitizer templates for use in photodynamic therapy (PDT). Evaluation of the antitumor activity of our previously synthesized D–π–A sensitizers under photoirradiation revealed their potent phototoxicity. The structural requirements of the D–π–A sensitizer for phototoxicity were elucidated with the rapid synthesis of structurally simplified analogues and evaluation of their antitumor activity under photoirradiation. Our developed sensitizers mainly accumulated in mitochondria and damaged cancer cells through both Type I and Type II mechanisms. The developed new template could be useful in the future development of sensitizers that could fulfil the requirements for PDT.

    DOI: 10.1002/ejoc.201701019

    Scopus

    researchmap

  • Selective purification and chemical labeling of a target protein on ruthenium photocatalyst-functionalized affinity beads

    Michihiko Tsushima, Shinichi Sato, Hiroyuki Nakamura

    Chemical Communications   53 ( 35 )   4838 - 4841   2017

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry ({RSC})  

    DOI: 10.1039/C7CC01595J

    researchmap

  • Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy

    Shunsuke Kikuchi, Daisuke Kanoh, Shinichi Sato, Yoshinori Sakurai, Minoru Suzuki, Hiroyuki Nakamura

    Journal of Controlled Release   237   160 - 167   2016.9

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier {BV}  

    DOI: 10.1016/j.jconrel.2016.07.017

    researchmap

  • フォトダイナミックセラノスティクスのためのポルフィリン薬剤の創成 ホウ素クラスター含有水溶性プロトポルフィリン誘導体の合成とPDT効果

    中村 浩之, 立川 将士, 平松 亮, 川端 信司, 黒岩 敏彦

    日本レーザー医学会誌   37 ( 2 )   210 - 210   2016.7

     More details

    Language:Japanese   Publisher:(NPO)日本レーザー医学会  

    researchmap

  • Novel Hyaluronan Formulation Enhances the Efficacy of Boron Neutron Capture Therapy for Murine Mesothelioma International journal

    Sasai, Masao, Nakamura, Hiroyuki, Sougawa, Nagako, Sakurai, Yoshinori, Suzuki, Minoru, Lee, Chun Man

    Anticancer research   36 ( 3 )   907 - 911   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:International Institute of Anticancer Research  

    BACKGROUND: Malignant pleural mesothelioma (MPM) is a refractory cancer of the pleura caused by asbestos exposure. MPM is difficult to treat because it easily disseminates. Boron neutron capture therapy (BNCT) is a radiotherapy in which cancer cells that selectively take up (10)Boron-containing compounds are destroyed, and normal cells are uninjured. Hyaluronan (HA) is a ligand of cluster of differentiation 44 (CD44), that is expressed on MPM cells. MATERIALS AND METHODS: In order to enhance BNCT for MPM tumors, we developed a novel HA-containing (10)B (sodium borocaptate: BSH) formulation (HA-BND-S). We examined the efficacy of HA-BND-S using MPM cells and a mouse MPM model. RESULTS: HA-BND-S preferentially bound MPM cells dose-dependently, and increased the cytotoxicity of BNCT compared to BSH in vitro. HA-BND-S administration significantly increased the survival of MPM tumor-bearing mice compared to BSH at the same (10)B dosage in BNCT. CONCLUSION: Modifying BSH with HA is a promising strategy for enhancing the efficacy of BNCT for therapy of MPM.

    PubMed

    researchmap

  • The Life of Pi Star: Exploring the Exciting and Forbidden Worlds of the Benzophenone Photophore

    Dormán, György, Nakamura, Hiroyuki, Pulsipher, Abigail, Prestwich, Glenn D.

    Chemical Reviews   116 ( 24 )   2016

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/acs.chemrev.6b00342

    researchmap

  • Total synthesis of feglymycin based on a linear/convergent hybrid approach using micro-flow amide bond formation

    Fuse, Shinichiro, Mifune, Yuto, Nakamura, Hiroyuki, Tanaka, Hiroshi

    Nature Communications   7   13491 - 13491   2016

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/ncomms13491

    Web of Science

    researchmap

  • Effective photodynamic therapy in drug-resistant prostate cancer cells utilizing a non-viral antitumor vector (a secondary publication).

    Yamauchi, Masaya, Honda, Norihiro, Hazama, Hisanao, Tachikawa, Shoji, Nakamura, Hiroyuki, Kaneda, Yasufumi, Awazu, Kunio

    Laser therapy   25 ( 1 )   55 - 62   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:International Phototherapy Association  

    Background and Aims: There is an urgent need to develop an efficient strategy for the treatment of drug-resistant prostate cancer. Photodynamic therapy (PDT), in which low incident levels of laser energy are used to activate a photosensitizer taken up by tumor cells, is expected as a novel therapy for the treatment of prostate cancer because of the minimal invasive nature of PDT. The present study was designed to assess the efficacy of a novel vector approach combined with a conventional porphyrin-based photosensitizer.Materials and Methods: Our group focused on a non-viral vector (hemagglutinating virus of Japan envelope; HVJ-E) combined with protoporphyrin IX (PpIX) lipid, termed the porphyrus envelope (PE). It has been previously confirmed that HVJ-E has drug-delivering properties and can induce cancer-specific cell death. The PE (HVJ-E contained in PpIX lipid) was developed as a novel photosensitizer. In this study, the antitumor and PDT efficacy of the PE against hormoneantagonistic human prostate cancer cells (PC-3) were evaluated.Results and Conclusions: Our results demonstrated that, under specific circumstances, PDT using the PE was very effective against PC-3 cells. A novel therapy for drug-resistant prostate cancer based on this vector approach is eagerly anticipated.

    DOI: 10.5978/islsm.16-OR-05

    researchmap

  • Development of 1-aryl-3-furanyl/thienyl-imidazopyridine templates for inhibitors against hypoxia inducible factor (HIF)-1 transcriptional activity

    Fuse, Shinichiro, Ohuchi, Toshiaki, Asawa, Yasunobu, Sato, Shinichi, Nakamura, Hiroyuki

    Bioorganic &amp; Medicinal Chemistry Letters   26 ( 24 )   2016

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmcl.2016.11.009

    researchmap

  • Synthesis of 2-Indolyltetrahydroquinolines by Zinc(II)-Catalyzed Intramolecular Hydroarylation-Redox Cross-Dehydrogenative Coupling of N-Propargylanilines with Indoles

    Li, Guangzhe, Nakamura, Hiroyuki

    Angewandte Chemie-International Edition   55 ( 23 )   6758 - 6761   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley Online Library  

    DOI: 10.1002/anie.201602416

    Web of Science

    researchmap

  • Generation of an 4-Isoxazolyl Anion Species: Facile Access to Multifunctionalized Isoxazoles

    Morita, Taiki, Fuse, Shinichiro, Nakamura, Hiroyuki

    Angewandte Chemie-International Edition   55 ( 43 )   2016

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/anie.201608039

    Web of Science

    researchmap

  • Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)

    Ban, Hyun Seung, Uto, Yoshikazu, Won, Misun, Nakamura, Hiroyuki

    Expert opinion on therapeutic patents   26 ( 3 )   309 - 322   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Taylor \& Francis  

    DOI: 10.1517/13543776.2016.1146252

    researchmap

  • A rapid and clean synthetic approach to cyclic peptides via micro-flow peptide chain elongation and photochemical cyclization: synthesis of a cyclic RGD peptide

    Mifune, Yuto, Nakamura, Hiroyuki, Fuse, Shinichiro

    Organic &amp; Biomolecular Chemistry   14 ( 47 )   2016

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/C6OB02391F

    researchmap

  • Localization-dependent cell-killing effects of protoporphyrin (PPIX)-lipid micelles and liposomes in photodynamic therapy

    Shoji Tachikawa, Shinichi Sato, Hisanao Hazama, Yasufumi Kaneda, Kunio Awazu, Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry   23 ( 24 )   7578 - 7584   2015.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier {BV}  

    The protoporphyron (PPIX)-lipid (PL-C17) liposomes were successfully prepared from the corresponding micelles by post-inserted method. Both the PL-C17 micelles and liposomes were distributed in plasma membrane and cytoplasm after incubation of the cells with PL-C17 liposomes for 1 h. They translocated from plasma membrane into a certain organelle in the cells after incubation in the photosensitizer-free medium. Higher photo-cytotoxicity was observed in the PL-C17 micelles and liposomes localized in plasma membrane in comparison with those localized in the cytoplasm under light irradiation. The LDH assay revealed that cytopathic damages of the plasma membrane were observed in the PL-C17 micelles and liposomes highly localized in plasma membrane. The fluorescent intensity of the calcein-encapsulating DOPC liposomes post-inserted with PL-C17 increased after light irradiation, suggesting that the membrane disruption is possibly caused by oxidation of membrane lipids with ROS generated from photosensitizers and affects the photo-cytotoxicity in PDT.

    DOI: 10.1016/j.bmc.2015.11.001

    Scopus

    PubMed

    researchmap

  • Synthesis and biological evaluation of meta -carborane-containing phenoxyacetanilides as inhibitors of hypoxia-inducible factor (HIF)-1 transcriptional activity

    Guangzhe Li, Soyoko Azuma, Hidemitsu Minegishi, Hiroyuki Nakamura

    Journal of Organometallic Chemistry   798   189 - 195   2015.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier {BV}  

    DOI: 10.1016/j.jorganchem.2015.05.029

    researchmap

  • Proteomic analysis of cellular response induced by boron neutron capture reaction in human squamous cell carcinoma SAS cells Reviewed

    Akira Sato, Tasuku Itoh, Shoji Imamichi, Sota Kikuhara, Hiroaki Fujimori, Takahisa Hirai, Soichiro Saito, Yoshinori Sakurai, Hiroki Tanaka, Hiroyuki Nakamura, Minoru Suzuki, Yasufumi Murakami, Diaz Baiseitov, Kulzhan Berikkhanova, Zhaxybay Zhumadilov, Yoshio Imahori, Jun Itami, Koji Ono, Shinichiro Masunaga, Mitsuko Masutani

    APPLIED RADIATION AND ISOTOPES   106   213 - 219   2015.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    To understand the mechanism of cell death induced by boron neutron capture reaction (BNCR), we performed proteome analyses of human squamous tumor SAS cells after BNCR. Cells were irradiated with thermal neutron beam at KUR after incubation under boronophenylalanine (BPA)(+) and BPA(-) conditions. BNCR mainly induced typical apoptosis in SAS cells 24 h post-irradiation. Proteomic analysis in SAS cells suggested that proteins functioning in endoplasmic reticulum, DNA repair, and RNA processing showed dynamic changes at early phase after BNCR and could be involved in the regulation of cellular response to BNCR. We found that the BNCR induces fragments of endoplasmic reticulum-localized lymphoid-restricted protein (LRMP). The fragmentation of LRMP was also observed in the rat tumor graft model 20 hours after BNCf treatment carried out at the National Nuclear Center of the Republic of Kazakhstan. These data suggest that dynamic changes of LRMP could be involved during cellular response to BNCR. (C) 2015 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.apradiso.2015.08.001

    Web of Science

    PubMed

    researchmap

  • ortho-Carboranylphenoxyacetanilides as inhibitors of hypoxia-inducible factor (HIF)-1 transcriptional activity and heat shock protein (HSP) 60 chaperon activity

    Guangzhe Li, Soyoko Azuma, Shinichi Sato, Hidemitsu Minegishi, Hiroyuki Nakamura

    Bioorganic & Medicinal Chemistry Letters   25 ( 13 )   2624 - 2628   2015.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier {BV}  

    DOI: 10.1016/j.bmcl.2015.04.088

    researchmap

  • Boron-Based Drug Design

    Ban, Hyun Seung, Nakamura, Hiroyuki

    The Chemical Record   15 ( 3 )   616 - 635   2015

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley Online Library  

    DOI: 10.1002/tcr.201402100

    researchmap

  • Historical development and current status of boron delivery agents for boron neutron capture therapy

    Nakamura, Hiroyuki

    Radioisotopes (Tokyo)   64 ( 1 )   47 - 58   2015

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.3769/radioisotopes.64.47

    researchmap

  • Tyrosine-Specific Chemical Modification with in situ Hemin-Activated Luminol Derivatives

    Sato, Shinichi, Nakamura, Kosuke, Nakamura, Hiroyuki

    ACS chemical biology   10 ( 11 )   2633 - 2640   2015

     More details

    Publishing type:Research paper (scientific journal)   Publisher:ACS Publications  

    DOI: 10.1021/acschembio.5b00440

    researchmap

  • Photodynamic therapy using hemagglutinating virus of Japan envelope (HVJ-E): a novel therapeutic approach for the treatment of hormone antagonistic prostate cancer Reviewed

    Mizuho Inai, Masaya Yamauchi, Norihiro Honda, Hisanao Hazama, Shoji Tachikawa, Hiroyuki Nakamura, Tomoki Nishida, Hidehiro Yasuda, Yasufumi Kaneda, Kunio Awazu

    OPTICAL METHODS FOR TUMOR TREATMENT AND DETECTION: MECHANISMS AND TECHNIQUES IN PHOTODYNAMIC THERAPY XXIV   9308   2015

     More details

    Language:English   Publishing type:Research paper (international conference proceedings)   Publisher:SPIE-INT SOC OPTICAL ENGINEERING  

    Traditional treatment options for prostate cancer are insufficient to cure advanced drug-resistant prostate cancer. Thus, as an alternative form of cancer therapy, photodynamic therapy (PDT) has become the main subject of intense investigation as a possible treatment modality. In this study, ultraviolet-inactivated viral vector, called hemagglutinating virus of Japan envelope (HVJ-E) was utilized to establish an effective delivery system for photosensitizer. Lipidated protoporphyrin IX (PpIX lipid) was inserted in HVJ-E by centrifugation to create a new drug delivering system that allows selective accumulation of photosensitizers in cancer cells. To study in vitro drug release mechanism of porphyrus envelope, the ultra-high voltage electron microscope tomography was applied. Next, to evaluate the photodynamic efficiency of porphyrus envelope for hormone antagonistic prostate cancer cells (PC-3), uptake of porphyrus envelope derived PpIX lipid and PpIX induced from exogenously administered precursor of 5-aminolevulinic acid hydrochloride (5-ALA) were compared by measuring fluorescence intensity of PpIX. Finally, to evaluate the efficacy of porphyrus envelope-PDT, laser light at a wavelength of 405 nm was irradiated to PC-3 cells. As a result, incorporation of porphyrus envelope-derived PpIX lipid occurred via membrane fusion, giving the highest fluorescence intensity when compared to 5-ALA-induced PpIX. Also, results from PDT experiment revealed the 28.6 x 10(3)-fold and 206-fold increase in therapeutic efficacy when compared to those of PDT using 5-ALA induced PpIX and PpIX lipid, respectively. Our findings suggest how porphyrus envelope can induce efficient accumulation of PpIX lipid, which can enhance the therapeutic efficacy of PDT against hormone antagonistic prostate cancer.

    DOI: 10.1117/12.2080692

    Web of Science

    researchmap

  • Regulation of target protein knockdown and labeling using ligand-directed Ru(bpy)<inf>3</inf> photocatalyst Reviewed

    Sato, S., Morita, K., Nakamura, H.

    Bioconjugate Chemistry   26 ( 2 )   250 - 256   2015

     More details

    Publishing type:Research paper (scientific journal)  

    © 2014 American Chemical Society. Ligand-directed Ru(bpy)3 photocatalysts induce chromophore-assisted light inactivation (CALI) of target proteins under visible light irradiation in vitro and within cells. Here, histidine, methionine, and tryptophan residues were oxidized by the singlet oxygen (1O2) generated by Ru(bpy)3 with light. The addition of a tyrosyl radical trapper (TRT), such as N'-acyl-N,N-dimethyl phenylenediamine, inhibited peptide/protein oxidation and induced labeling on the tyrosine residue. This mechanistic study suggests that TRT scavenges 1O2, concomitant with the coupling reaction to the tyrosyl radical generated by Ru(bpy)3. Both CALI and labeling can be regulated by the Ru(bpy)3 photocatalysts in the absence or presence of TRT. Ligand-conjugated Ru(bpy)3 photocatalysts (local environmental single-electron transfer catalysts: LSCs) were used not only for target-selective protein labeling, but also for protein knockdown by CALI.

    DOI: 10.1021/bc500518t

    Scopus

    PubMed

    researchmap

  • Diaryl-substituted carboranes as inhibitors of hypoxia inducible factor-1 transcriptional activity

    Nakamura, Hiroyuki, Tazaki, Lisa, Kanoh, Daisuke, Sato, Shinichi

    Pure and Applied Chemistry   87 ( 2 )   143 - 154   2015

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1515/pac-2014-0911

    researchmap

  • Methyl 3-((6-Methoxy-1, 4-dihydroindeno [1, 2-c] pyrazol-3-yl) amino) benzoate (GN39482) as a Tubulin Polymerization Inhibitor Identified by MorphoBase and ChemProteoBase Profiling Methods

    Minegishi, Hidemitsu, Futamura, Yushi, Fukashiro, Shinji, Muroi, Makoto, Kawatani, Makoto, Osada, Hiroyuki, Nakamura, Hiroyuki

    Journal of medicinal chemistry   58 ( 10 )   4230 - 4241   2015

     More details

    Publishing type:Research paper (scientific journal)   Publisher:ACS Publications  

    DOI: 10.1021/acs.jmedchem.5b00035

    researchmap

  • Synthesis of oligo-closo-dodecaborates by Hüisgen click reaction as encapsulated agents for the preparation of high-boron-content liposomes for neutron capture therapy

    Koganei, Hayato, Tachikawa, Shoji, Mohamed, E, Nakamura, Hiroyuki

    New Journal of Chemistry   39 ( 8 )   6388 - 6394   2015

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry  

    DOI: 10.1039/c5nj00856e

    researchmap

  • Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT

    Nakamura, Hiroyuki, Koganei, Hayato, Miyoshi, Tatsuro, Sakurai, Yoshinori, Ono, Koji, Suzuki, Minoru

    Bioorganic & Medicinal Chemistry Letters   25 ( 2 )   2015

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmcl.2014.12.005

    researchmap

  • C (sp3)--H versus C (sp3)--C (sp) in Activation of Propargylic Amines under Transition-Metal Catalysis

    Nakamura, Hiroyuki

    Synlett   26 ( 12 )   1649 - 1664   2015

     More details

    Publishing type:Research paper (scientific journal)   Publisher:{\copyright} Georg Thieme Verlag  

    DOI: 10.1055/s-0034-1380462

    researchmap

  • A novel photodynamic therapy for drug-resistant prostate cancer cells using porphyrus envelope as a novel photosensitizer

    Yamauchi, Masaya, Honda, Norihiro, Hazama, Hisanao, Tachikawa, Shoji, Nakamura, Hiroyuki, Kaneda, Yasufumi, Awazu, Kunio

    Photodiagnosis and Photodynamic Therapy   11 ( 1 )   48 - 54   2014

     More details

    Publishing type:Research paper (scientific journal)  

    Background: In the clinic, it is often very difficult to treat drug-resistant advanced prostate cancer by conventional treatments. Photodynamic therapy (PDT) is a minimally invasive treatment that takes advantage of photochemical reactions between a photosensitizer and light. On the basis of several of its key characteristics, PDT is considered to be a promising novel method for treating drug-resistant prostate cancer. Objectives: For effective treatment of drug-resistant prostate cancer, we developed a novel agent termed porphyrus envelope, which was produced from PpIX lipid and hemagglutinating virus of Japan envelope (HVJ-E). Materials and methods: We inserted PpIX lipid into HVJ-E by centrifugation, and used the resultant porphyrus envelope in PDT of two drug-resistant prostate cancer cell lines, PC-3 and PC-3-DR. Results: Porphyrus envelope enhanced uptake of PpIX, and cytotoxicity of PDT, relative to free PpIX lipid or PpIX induced by 5-ALA. Conclusion: PDT using porphyrus envelope has potential as a method for treating drug-resistant prostate cancer. © 2013.

    DOI: 10.1016/j.pdpdt.2013.10.001

    Scopus

    PubMed

    researchmap

  • V843I, a Lung Cancer Predisposing EGFR Mutation, Is Responsible for Resistance to EGFR Tyrosine Kinase Inhibitors International journal

    Matsushima, Satsuki, Ohtsuka, Kouki, Ohnishi, Hiroaki, Fujiwara, Masachika, Nakamura, Hiroyuki, Morii, Takeshi, Kishino, Tomonori, Goto, Hajime, Watanabe, Takashi

    Journal of Thoracic Oncology   9 ( 9 )   1377 - 84   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: We previously demonstrated that a family predisposed to lung cancer harbored a V843I substitution in the epidermal growth factor receptor (EGFR) protein. We report here the further characterization of this mutant EGFR protein in the context of tumorigenicity and resistance to tyrosine kinase inhibitors (TKIs) of EGFR activity. METHODS: Phosphorylation of EGFR and downstream signaling proteins of lung adenocarcinoma cell lines with EGFR mutations was assayed by flow cytometry. Susceptibility to TKIs of these cell lines, with or without suppression of mutant EGFR expression by small inhibitory RNA (siRNA), was investigated using a cellular viability assay. Furthermore, protein modeling was used to predict TKI binding to EGFR protein carrying the V843I mutation. RESULTS: Phosphorylation of EGFR and downstream signaling proteins was elevated upon transfection with an EGFR gene with the V843I. Although the cell line with V843I + L858R demonstrated resistance to EGFR-TKIs, the cells became susceptible to TKIs upon incubation with siRNA specific for the V843I allele. The structural analysis suggested that TKI binding to EGFR would be sterically hindered by Arg841 in the double-mutant (V843I + L858R) EGFR. CONCLUSIONS: The V843I mutation contributes to tumorigenesis by promoting phosphorylation of EGFR and its downstream signaling proteins. This mutation also appears to provide resistance to EGFR-TKIs through structural modification of EGFR. These features are comparable with those in EGFR T790M mutation, suggesting that cases with germ-line V843I or T790M mutations could be categorized as a class of familial lung cancer syndrome with resistance to EGFR-TKIs.

    DOI: 10.1097/JTO.0000000000000241

    PubMed

    researchmap

  • Reactivity of Propargylic Amines in the Presence of Transition Metals

    Sugiishi, Tsuyuka, Nakamura, Hiroyuki

    Journal of Synthetic Organic Chemistry Japan   72 ( 6 )   654 - 665   2014

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    CiNii Books

    researchmap

  • Diaryl-substituted ortho-carboranes as a new class of hypoxia inducible factor-1 alpha inhibitors

    Nakamura, Hiroyuki, Tasaki, Lisa, Kanoh, Daisuke, Sato, Shinichi, Ban, Hyun Seung

    Dalton Transactions   43 ( 13 )   2014

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c3dt52828f

    researchmap

  • Synthesis of protoporphyrin–lipids and biological evaluation of micelles and liposomes

    Tachikawa, Shoji, El-Zaria, Mohamed E., Inomata, Ryu, Sato, Shinichi, Nakamura, Hiroyuki

    Bioorganic & Medicinal Chemistry   22 ( 17 )   2014

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmc.2014.07.003

    researchmap

  • Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy

    Tachikawa, Shoji, Miyoshi, Tatsuro, Koganei, Hayato, El-Zaria, Mohamed E., Vinas, Clara, Suzuki, Minoru, Ono, Koji, Nakamura, Hiroyuki

    Chemical Communications   50 ( 82 )   2014

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c4cc04344h

    researchmap

  • Design of Photoaffinity Probe Molecules for Identification and Modification of Target Proteins

    Nakamura, Hiroyuki, Ban, Hyun Seung, Shimizu, Kazuki, Minegishi, Hidemitsu, Sato, Shinichi

    Journal of Photopolymer Science and Technology   27 ( 4 )   453 - 458   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:The Society of Photopolymer Science and Technology  

    CiNii Books

    researchmap

  • Amphiphilic COSAN and I2-COSAN crossing synthetic lipid membranes: planar bilayers and liposomes

    Verdia-Baguena, Carmina, Alcaraz, Antonio, Aguilella, Vicente M., Cioran, Ana M., Tachikawa, Shoji, Nakamura, Hiroyuki, Teixidor, Francesc, Vinas, Clara

    Chemical Communications   50 ( 51 )   2014

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c4cc01283f

    researchmap

  • YC-1の構造展開による高活性HIF-1α転写阻害剤の創製と作用機構解明

    佐藤 伸一, 竹内 彩乃, 堀 牧人, 潘 鉉承, 口丸 高弘, 近藤 科江, 矢守 隆夫, 中村 浩之

    日本薬学会年会要旨集   133年会 ( 2 )   88 - 88   2013.3

     More details

    Language:Japanese   Publisher:(公社)日本薬学会  

    researchmap

  • Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective

    Nakamura, Hiroyuki

    Future Medicinal Chemistry   5 ( 6 )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.4155/FMC.13.48

    researchmap

  • Towards new boron carriers for boron neutron capture therapy: Metallacarboranes bearing cobalt, iron and chromium and their cholesterol conjugates

    Bialek-Pietras, Magdalena, Olejniczak, Agnieszka B., Tachikawa, Shoji, Nakamura, Hiroyuki, Lesnikowski, Zbigniew J.

    Bioorganic & Medicinal Chemistry   21 ( 5 )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmc.2012.12.039

    researchmap

  • Synthesis and biological evaluation of ortho-carborane containing benzoxazole as an inhibitor of hypoxia inducible factor (HIF)-1 transcriptional activity

    Nakamura, Hiroyuki, Yasui, Yuka, Ban, Hyun Seung

    Journal of Organometallic Chemistry   747   2013

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jorganchem.2013.04.007

    researchmap

  • Toward development of innovative diagnostic/therapeutic system (theranostics) using nanotechnologies

    Ryo Suzuki, Hiroyuki Nakamura

    Yakugaku Zasshi   133 ( 12 )   1261 - 1262   2013

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1248/yakushi.13-00222-F

    Scopus

    PubMed

    researchmap

  • Development of hypoxia-inducible factor (HIF)-1α inhibitors: Effect of ortho-carborane substituents on HIF transcriptional activity under hypoxia

    Nakamura, Hiroyuki, Yasui, Yuka, Maruyama, Minako, Minegishi, Hidemitsu, Ban, Hyun Seung, Sato, Shinichi

    Bioorganic & Medicinal Chemistry Letters   23 ( 3 )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmcl.2012.11.081

    researchmap

  • Ligand-Directed Selective Protein Modification Based on Local Single-Electron-Transfer Catalysis

    Sato, Shinichi, Nakamura, Hiroyuki

    Angewandte Chemie-International Edition   52 ( 33 )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/anie.201303831

    researchmap

  • Synthesis and Biological Evaluation of Diaryl-Substituted Carboranes as Inhibitors of Hypoxia Inducible Factor (HIF)-1 Transcriptional Activity

    Minegishi, Hidemitsu, Matsukawa, Takuya, Nakamura, Hiroyuki

    Chemmedchem   8 ( 2 )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/cmdc.201200502

    researchmap

  • Discovery of Indenopyrazoles as a New Class of Hypoxia Inducible Factor (HIF)-1 Inhibitors

    Minegishi, Hidemitsu, Fukashiro, Shinji, Ban, Hyun Seung, Nakamura, Hiroyuki

    ACS Medicinal Chemistry Letters   4 ( 2 )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/ml3004632

    researchmap

  • Development of High Boron Content Liposomes and Their Promising Antitumor Effect for Neutron Capture Therapy of Cancers International journal

    Koganei, Hayato, Ueno, Manabu, Tachikawa, Shoji, Tasaki, Lisa, Ban, Hyun Seung, Suzuki, Minoru, Shiraishi, Kouichi, Kawano, Kumi, Yokoyama, Masayuki, Maitani, Yoshie, Ono, Koji, Nakamura, Hiroyuki

    Bioconjugate Chemistry   24 ( 1 )   124 - 32   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mercaptoundecahydrododecaborate (BSH)-encapsulating 10% distearoyl boron lipid (DSBL) liposomes were developed as a boron delivery vehicle for neutron capture therapy. The current approach is unique because the liposome shell itself possesses cytocidal potential in addition to its encapsulated agents. BSH-encapsulating 10% DSBL liposomes have high boron content (B/P ratio: 2.6) that enables us to prepare liposome solution with 5000 ppm boron concentration. BSH-encapsulating 10% DSBL liposomes displayed excellent boron delivery efficacy to tumor: boron concentrations reached 174, 93, and 32 ppm at doses of 50, 30, and 15 mg B/kg, respectively. Magnescope was also encapsulated in the 10% DSBL liposomes and the real-time biodistribution of the Magnescope-encapsulating DSBL liposomes was measured in a living body using MRI. Significant antitumor effect was observed in mice injected with BSH-encapsulating 10% DSBL liposomes even at the dose of 15 mg B/kg; the tumor completely disappeared three weeks after thermal neutron irradiation ((1.5-1.8) × 10(12) neutrons/cm(2)). The current results enabled us to reduce the total dose of liposomes to less than one-fifth compared with that of the BSH-encapsulating liposomes without reducing the efficacy of boron neutron capture therapy (BNCT).

    DOI: 10.1021/bc300527n

    PubMed

    researchmap

  • Development of High Boron Content Liposomes and Their Promising Antitumor Effect for Neutron Capture Therapy

    Nakamura, Hiroyuki

    Yakugaku Zasshi-Journal of the Pharmaceutical Society of Japan   133 ( 12 )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • HSP60 as a Drug Target

    Nakamura, Hiroyuki, Minegishi, Hidemitsu

    Current Pharmaceutical Design   19 ( 3 )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • Copper(I)-Catalysed Deacetylenative Cross-Coupling Reaction of Terminal Alkynes with Propargylic Amines via C(sp)-C(sp(3)) Bond Cleavage

    Kim, Yongeun, Nakamura, Hiroyuki

    Synlett   ( 11 )   2012

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1055/s-0031-1290376

    researchmap

  • Synthesis and biological activity of furanylindazoles as inhibitors of hypoxia inducible factor (HIF)-1 transcriptional activity

    Takeuchi, Ayano, Hori, Makihito, Sato, Shinichi, Ban, Hyun Seung, Kuchimaru, Takahiro, Kizaka-Kondoh, Shinae, Yamori, Takao, Nakamura, Hiroyuki

    MedChemComm   3 ( 11 )   2012

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c2md20134h

    researchmap

  • Synthesis and biological evaluation of boronic acid-containing phenstatin analogues

    Nakamura, Hiroyuki, Kuroda, Hirokazu, Minegishi, Hidemitsu

    Arkivoc   2012

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • Zinc(II)-Catalyzed Redox Cross-Dehydrogenative Coupling of Propargylic Amines and Terminal Alkynes for Synthesis of N-Tethered 1,6-Enynes

    Sugiishi, Tsuyuka, Nakamura, Hiroyuki

    Journal of the American Chemical Society   134 ( 5 )   2012

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/ja211092q

    researchmap

  • Discovery of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives as non-peptidic selective SUMO-sentrin specific protease (SENP)1 inhibitors

    Uno, Masaharu, Koma, Yosuke, Ban, Hyun Seung, Nakamura, Hiroyuki

    Bioorganic & Medicinal Chemistry Letters   22 ( 16 )   2012

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmcl.2012.06.084

    researchmap

  • In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope

    Sakai, Makoto, Fujimoto, Naohiro, Ishii, Katsunori, Nakamura, Hiroyuki, Kaneda, Yasufumi, Awazu, Kunio

    Journal of Biomedical Optics   17 ( 7 )   2012

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1117/1.JBO.17.7.078002

    researchmap

  • Identification of heat shock protein 60 as the regulator of the hypoxia-inducible factor subunit HIF-1 alpha

    Ban, Hyun Seung, Shimizu, Kazuki, Minegishi, Hidemitsu, Nakamura, Hiroyuki

    Pure and Applied Chemistry   84 ( 11 )   2012

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1351/PAC-CON-11-11-03

    researchmap

  • Design and synthesis of fluorescence-labeled closo-dodecaborate lipid: its liposome formation and in vivo imaging targeting of tumors for boron neutron capture therapy

    Nakamura, Hiroyuki, Ueda, Noriko, Ban, Hyun Seung, Ueno, Manabu, Tachikawa, Shoji

    Organic & Biomolecular Chemistry   10 ( 7 )   2012

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c1ob06500a

    researchmap

  • Copper(I)-Catalyzed Deacetylenative Coupling of Propargylic Amines: An Efficient Synthesis of Symmetric 1,4-Diamino-2-butynes

    Kim, Yongeun, Nakamura, Hiroyuki

    Chemistry-a European Journal   17 ( 45 )   2011

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/chem.201102710

    researchmap

  • Catalytic reactions of bis-pi-allylpalladium generated from allyltrifluoroborate

    Nakamura, Hiroyuki, Shimizu, Kazuki

    Tetrahedron Letters   52 ( 3 )   2011

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.tetlet.2010.11.082

    researchmap

  • Amphiphilic allylation of arylidene-1,3-oxazol-5(4H)-one using bis-[small pi]-allylpalladium complexes: an approach to synthesis of cyclohexyl and cyclohexenyl [small alpha]-amino acids

    Genady, Afaf R., Nakamura, Hiroyuki

    Organic & Biomolecular Chemistry   9 ( 20 )   2011

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c1ob05952a

    researchmap

  • m-Carborane-Based Chiral NBN Pincer-Metal Complexes: Synthesis, Structure, and Application in Asymmetric Catalysis

    El-Zaria, Mohamed E., Arii, Hidekazu, Nakamura, Hiroyuki

    Inorganic Chemistry   50 ( 9 )   2011

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/ic2002095

    researchmap

  • Supplementary Materials Synthesis and Biological Data of ortho-Carborane Analogs from 4-Aminobenzoic Acid and 4-Hydroxybenzoic Acid as a Potential Boron Neutron Capture Therapy Agent

    Lee, Seung Hwan, Chang, Yu Mi, Seo, Jin-soo, Nakamura, Hiroyuki, Yoon, Cheol Min

    Notes   32 ( 6 )   1 - 1   2011

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • Discovery of ortho-Carborane-Conjugated Triazines as Selective Topoisomerase I/II Inhibitors

    Nakamura, Hiroyuki, Shoji, Atsushi, Takeuchi, Ayano, Ban, Hyun Seung, Lee, Jong-Dae, Yamori, Takao, Kang, Sang Ook

    Australian Journal of Chemistry   64 ( 11 )   2011

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1071/CH11295

    researchmap

  • Facile Synthesis of 4-Substituted 3,4-Dihydro-1H-2,1,3-Benzothiadiazine 2,2-Dioxides

    Lee, Chai-Ho, Jin, Guo Fan, Lim, Hyun Wha, Yang, Eun Hye, Lee, Jong-Dae, Nakamura, Hiroyuki, Ban, Hyun Seung, Kang, Sang Ook

    Heteroatom Chemistry   22 ( 2 )   2011

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/hc.20670

    researchmap

  • Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004--2010)

    Ban, Hyun Seung, Uto, Yoshikazu, Nakamura, Hiroyuki

    Expert opinion on therapeutic patents   21 ( 2 )   131 - 146   2011

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Taylor \& Francis  

    DOI: 10.1517/13543776.2011.547477

    researchmap

  • Biological evaluation of dopamine analogues containing phenylboronic acid group as new boron carriers

    Ito, Y., Mizuno, T., Yoshino, K., Ban, H. S., Nakamura, H., Hiratsuka, J., Ishikawa, A., Ohki, H.

    Applied Radiation and Isotopes   69 ( 12 )   2011

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.apradiso.2011.04.004

    researchmap

  • Biodistribution of BSH-encapsulated boron liposome in mouse Glioma. Reviewed

    Yoshida, F, Nakai, K, Isobe, T, Inomata, R, Zaboronok, A, Yamamoto, Y, Shirakawa, M, Yamamoto, T, Matsumura, A, Nakamura, H

    Proceedings of 14th International congress on neutron capture therapy, (Ed) Liberman S   339   2010.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy Reviewed

    Ueno, Manabu, Ban, Hyun Seung, Nakai, Kei, Inomata, Ryu, Kaneda, Yasufumi, Matsumura, Akira, Nakamura, Hiroyuki

    Bioorganic & Medicinal Chemistry   18 ( 9 )   3059 - 3065   2010

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    closo-Dodecaborate lipid liposomes were developed as new vehicles for boron delivery system (BDS) of neutron capture therapy. The current approach is unique because the liposome shell itself possesses cytocidal potential in combination with neutron irradiation. The liposomes composed of closo-dodecaborate lipids DSBL and DPBL displayed high cytotoxicity with thermal neutron irradiation. The closo-dodecaborate lipid liposomes were taken up into the cytoplasm by endocytosis without degradation of the liposomes. Boron concentration of 22.7 ppm in tumor was achieved by injection with DSBL-25% PEG liposomes at 20 mg B/kg. Promising BNCT effects were observed in the mice injected with DSBL-25% PEG liposomes: the tumor growth was significantly suppressed after thermal neutron irradiation (1.8 x 10(12) neutrons/cm(2)). (c) 2010 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmc.2010.03.050

    Web of Science

    researchmap

  • Selective inhibition of EGFR and VEGFR2 tyrosine kinases controlled by a boronic acid substituent on 4-anilinoquinazolines

    Nakamura, Hiroyuki, Horikoshi, Ryoji, Usui, Taikou, Ban, Hyun Seung

    Medchemcomm   1 ( 4 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c0md00115e

    researchmap

  • Identification of HSP60 as a Primary Target of o-Carboranylphenoxyacetanilide, an HIF-1 alpha Inhibitor

    Ban, Hyun Seung, Shimizu, Kazuki, Minegishi, Hidemitsu, Nakamura, Hiroyuki

    Journal of the American Chemical Society   132 ( 34 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/ja104739t

    researchmap

  • Copper(I)-Catalyzed Substitution Reactions of Propargylic Amines: Importance of C(sp)-C(sp(3)) Bond Cleavage in Generation of Iminium Intermediates

    Sugiishi, Tsuyuka, Kimura, Akifumi, Nakamura, Hiroyuki

    Journal of the American Chemical Society   132 ( 15 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/ja9109055

    researchmap

  • Discovery of Carboranes as Inducers of 20S Proteasome Activity

    Ban, Hyun Seung, Minegishi, Hidemitsu, Shimizu, Kazuki, Maruyama, Minako, Yasui, Yuka, Nakamura, Hiroyuki

    Chemmedchem   5 ( 8 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/cmdc.201000112

    researchmap

  • Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1 alpha inhibitors

    Shimizu, Kazuki, Maruyama, Minako, Yasui, Yuka, Minegishi, Hidemitsu, Ban, Hyun Seung, Nakamura, Hiroyuki

    Bioorganic & Medicinal Chemistry Letters   20 ( 4 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bmcl.2009.12.037

    researchmap

  • Boron-Containing Protoporphyrin IX Derivatives and Their Modification for Boron Neutron Capture Therapy: Synthesis, Characterization, and Comparative In Vitro Toxicity Evaluation

    El-Zaria, Mohamed E., Ban, Hyun Seung, Nakamura, Hiroyuki

    Chemistry-a European Journal   16 ( 5 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/chem.200901532

    researchmap

  • Enhancement of EGFR tyrosine kinase inhibition by C-C multiple bonds-containing anilinoquinazolines

    Ban, Hyun Seung, Tanaka, Yuko, Nabeyama, Wataru, Hatori, Masako, Nakamura, Hiroyuki

    Bioorganic & Medicinal Chemistry   18 ( 2 )   870 - 879   2010

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    A series of 4-anilinoquinazolines with C-C multiple bond substitutions at the 6-position were synthesized and investigated for their potential to inhibit epidermal growth factor receptor (EGFR) tyrosine kinase activity. Among the compounds synthesized, alkyne 6d and allenes 7d and 7f significantly inhibited EGFR tyrosine kinase activity. These compounds inhibited EGF-mediated phosphorylation of EGFR in A431 cells, resulting in cell-cycle arrest and apoptosis induction. The C-C multiple bonds substituted at the C-6 position of the anilinoquinazoline framework were essential for the significant inhibitory activity. Compounds with long carbon chains (n = 3-6), such as 6c-f, 7c-f, 11, and 12, displayed prolonged inhibitory activity. (C) 2009 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmc.2009.11.035

    Web of Science

    researchmap

  • Salicylate restores transport function and anion exchanger activity of missense pendrin mutations

    Ishihara, Kenji, Okuyama, Shuhei, Kumano, Shun, Iida, Koji, Hamana, Hiroshi, Murakoshi, Michio, Kobayashi, Toshimitsu, Usami, Shinichi, Ikeda, Katsuhisa, Haga, Yoichi, Tsumoto, Kohei, Nakamura, Hiroyuki, Hirasawa, Noriyasu, Wada, Hiroshi

    Hearing Research   270 ( 1-2 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.heares.2010.08.015

    researchmap

  • Minimally Invasive Cytoselective Radiation Therapy Using Boron Neutron Capture Reaction

    NAKAMURA Hiroyuki

    YAKUGAKU ZASSHI   130 ( 12 )   1687 - 1694   2010

     More details

    Language:Japanese   Publisher:The Pharmaceutical Society of Japan  

    The cell-killing effect of boron neutron capture therapy (BNCT) is due to the nuclear reaction of two essentially nontoxic species, boron-10 (10B) and thermal neutrons, whose destructive effect is well observed in boron-loaded tissues. High accumulation and selective delivery of boron into tumor tissue are the most important requirements to achieve efficient neutron capture therapy of cancers. This review focuses on liposomal boron delivery system (BDS) as a recent promising approach that meet these requirements for BNCT. BDS involves two strategies: (1) encapsulation of boron in the aqueous core of liposomes and (2) accumulation of boron in the liposomal bilayer. In this review, recent development of liposomal boron delivery system is summarized.<br>

    DOI: 10.1248/yakushi.130.1687

    CiNii Books

    researchmap

    Other Link: https://jlc.jst.go.jp/DN/JALC/00359735769?from=CiNii

  • Undecahydro-closo-dodecaborates as good leaving groups in organic synthesis: generation of substituted styrenes via elimination of arylethyl dodecaborates

    Genady, Afaf R., Nakamura, Hiroyuki

    Organic & Biomolecular Chemistry   8 ( 19 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c005032f

    researchmap

  • Liposomal neutron capture therapy

    Ueno Manabu, Ban Hyun Seung, Nakamura Hiroyuki

    Drug Delivery System   25 ( 5 )   474 - 482   2010

     More details

    Language:Japanese   Publisher:THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM  

    The cell-killing effect of boron neutron capture therapy (BNCT) is due to the nuclear reaction of two essentially nontoxic species, boron-10 (10B) and thermal neutrons, whose destructive effect is well observed in boron-loaded tissues. Therefore, the high accumulation and selective delivery of 10B into the tumor tissue are the most important requirements to achieve efficient neutron capture therapy for cancer. BNCT has been applied clinically for the treatment of malignant brain tumors, malignant melanoma, head and neck cancer, and hepatoma using two boron compounds:sodium borocaptate (10BSH) and L-p-boronophenylalamine (L-10BPA). These low molecule compounds are easily cleared from the cancer cells and blood, therefore, high accumulation and selective delivery of boron compounds into tumor tissues are most important to achieve effective BNCT and to avoid damage of adjacent healthy cells. Recently, much attention has been focused on liposomal drug delivery system as an attractive intelligent technology of targeting and controlled release of 10B compounds.<BR>In this review, recent development of liposomal boron delivery system is summarized.

    DOI: 10.2745/dds.25.474

    CiNii Books

    researchmap

    Other Link: https://jlc.jst.go.jp/DN/JALC/00358080945?from=CiNii

  • Suppression of hypoxia-induced HIF-1 alpha accumulation by VEGFR inhibitors: Different profiles of AAL993 versus SU5416 and KRN633

    Ban, Hyun Seung, Uno, Masaharu, Nakamura, Hiroyuki

    Cancer Letters   296 ( 1 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.canlet.2010.03.010

    researchmap

  • Synthesis of triazolyl methyl-substituted amino- and oxy-undecahydrododecaborates for potential application in boron neutron capture therapy

    El-Zaria, Mohamed E., Genady, Afaf R., Nakamura, Hiroyuki

    New Journal of Chemistry   34 ( 8 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c0nj00046a

    researchmap

  • New Strategy for Synthesis of Mercaptoundecahydrododecaborate Derivatives via Click Chemistry: Possible Boron Carriers and Visualization in Cells for Neutron Capture Therapy

    El-Zaria, Mohamed E., Nakamura, Hiroyuki

    Inorganic Chemistry   48 ( 24 )   11896 - 11902   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    A new method that utilizes the click cycloaddition reaction to functionalize B(12)H(11)SH(2-) (BSH) with organic molecules was investigated. S,S-Dipropargyl-SB(12)H(11)(-) (1) and S-propargyl-SB(12)H(11)(2-) (4) were prepared from [(CH(3))(4)N](2)B(12)H(11)SH and [(CH(3))(4)N](2)B(12)H(11)S(CH(2))(2)CN (2) with propargyl bromide, respectively. Compound 1 or 4 reacted with various azides with mediation by Cu(II) ascorbate to give the corresponding bis-triazolo BSH derivatives (1-) or monotriazole BSH derivatives (2-), respectively, in excellent yields. The click cycloaddition reaction is very useful not only for the synthesis of various BSH-containing organic compounds for boron neutron capture therapy (BNCT) but also for the visualization of boron clusters in cells. We succeeded in the click cycloaddition reaction of compound 1 with Alexa Fluor 488 azide dye and found that 1 accumulated not in the cytoplasm but in the nuclei of HeLa cells.

    DOI: 10.1021/ic902033c

    Web of Science

    researchmap

  • 1-[4-(N-Benzylamino)phenyl]-3-phenylurea derivatives as a new class of hypoxia-inducible factor-1 alpha inhibitors

    Uno, Masaharu, Ban, Hyun Seung, Nakamura, Hiroyuki

    Bioorganic & Medicinal Chemistry Letters   19 ( 12 )   3166 - 3169   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    A series of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives 2a-r were synthesized as HIF-1 alpha inhibitors. Among the compounds synthesized, compound 2k was found to be a potent inhibitor against HIF-1 alpha accumulation under hypoxic condition and inhibited the hypoxia-induced HIF-1 transcriptional activity in HEK293 cells (IC(50) = 7.2 mu M). Furthermore, compound 2k suppressed the hypoxia-induced secretion of VEGF in HeLa cells (IC(50) = 15 mu M). (C) 2009 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2009.04.122

    Web of Science

    researchmap

  • Development of boron nanocapsules for neutron capture therapy

    Nakamura, H., Ueno, M., Ban, H. S., Nakai, K., Tsuruta, K., Kaneda, Y., Matsumura, A.

    Applied Radiation and Isotopes   67 ( 7-8 )   S84 - S87   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    High accumulation and selective delivery of boron into tumor tissues are the most important requirements to achieve efficient neutron capture therapy of cancers. We focused on liposomal boron delivery system in order to achieve a large amount of boron delivery to tumor. We synthesized the double-tailed boron cluster lipid 4c according to our reported procedure with modification. Size distribution of liposomes prepared from the boron cluster lipid 4c, DMPC, PEG-DSPE, and cholesterol was determined as 100 nm in diameter by an electrophoretic light scattering spectrophotometer. A high level of 1013 concentration (22 ppm) was observed in tumor tissue at 24 h after the administration of boron liposomes. (C) 2009 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.apradiso.2009.03.091

    Web of Science

    researchmap

  • Discovery of boron-conjugated 4-anilinoquinazoline as a prolonged inhibitor of EGFR tyrosine kinase

    Ban, Hyun Seung, Usui, Taikou, Nabeyama, Wataru, Morita, Hidetoshi, Fukuzawa, Kaori, Nakamura, Hiroyuki

    Organic & Biomolecular Chemistry   7 ( 21 )   4415 - 4427   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ROYAL SOC CHEMISTRY  

    Boron-conjugated 4-anilinoquinazolines were designed and synthesized as inhibitors of EGFR tyrosine kinase with possible covalent bond interactions between the boron atom and the nucleophilic groups of the EGFR kinase domain. Among the compounds synthesized, compounds 6c, 7b, and 7d reduced the EGF-mediated phosphorylation of EGFR tyrosine kinase and its downstream kinases including ERK and Akt in A431 cells. The cell growth was inhibited by these compounds through arrest of G1 cell cycle, which induced apoptosis. A time-dependent in vitro preincubation assay demonstrated the irreversible inhibition of compound 7d against EGFR tyrosine kinase. Quantum mechanical docking simulation revealed that the boronic acid moiety of compound 7d formed a covalent B-O bond with Asp800 in addition to hydrogen bonds with Asp800 and Cys797, which may cause the prolonged inhibition of compound 7d toward EGFR tyrosine kinase.

    DOI: 10.1039/b909504g

    Web of Science

    researchmap

  • Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors

    Nakamura, Hiroyuki, Watanabe, Mizuyoshi, Ban, Hyun Seung, Nabeyama, Wataru, Asai, Akira

    Bioorganic & Medicinal Chemistry Letters   19 ( 12 )   3220 - 3224   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    A series of boron peptides 11, 13, 15 and 17 were designed and synthesized as proteasome inhibitors based on the structure of Belactosin C. Matteson homologation was a key step in the synthesis of the boron peptides. Compounds 11a and 13 showed significant inhibition of 20S proteasome chymotrypsin-like (beta 5) activity (IC(50) = 0.28 and 0.51 mu M, respectively). Furthermore, like PS-341, compound 11a increased the G2/M cell distribution. A biparametric cytofluorimetric analysis with FITC-labeled annexin V and propidium iodide showed induction of apoptosis by compound 11a at &gt;1 mu M concentrations of compound. (C) 2009 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2009.04.103

    Web of Science

    researchmap

  • New types of potential BNCT agents, o-carboranyl aminoalcohols

    Lee, Chai-Ho, Jin, Guo Fan, Joung, Jung Gun, Lee, Jong-Dae, Ban, Hyun Seung, Nakamura, Hiroyuki, Cho, Jung-Keun, Kang, Sang Ook

    Tetrahedron Letters   50 ( 24 )   2960 - 2963   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    o-Carboranyl aminoalcohols were synthesized using a standard Mannich reaction, and were tested for their anticancer properties using an in vitro test for CT26 cancer cells. The polar periphery of the aminoalcohols benefited from the high boron uptake in CT26 cancer cells with low toxicity, indicating their potential as BNCT agents. (C) 2009 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tetlet.2009.03.207

    Web of Science

    researchmap

  • LIPOSOMAL BORON DELIVERY FOR NEUTRON CAPTURE THERAPY

    Hiroyuki Nakamura

    METHODS IN ENZYMOLOGY LIPOSOMES, PT G   465   179 - 208   2009

     More details

    Language:English   Publishing type:Part of collection (book)   Publisher:ELSEVIER ACADEMIC PRESS INC  

    Tumor cell destruction in boron neutron capture therapy (BNCT) is due to the nuclear reaction between B-10 and thermal neutrons. The thermal neutrons have an energy of 0.025 eV, clearly below the threshold energy required to ionize tissue components. However, neutron capture by B-10 produces lithium ion and helium (alpha-partictes), which are high linear energy transfer (LET) particles, and dissipate their kinetic energy before traveling one cell diameter (5-9 mu m) in biological tissues, ensuring their potential for precise cell killing. BNCT has been applied clinically for the treatment of malignant brain tumors, malignant melanoma, head and neck cancer, and hepatoma using two boron compounds: sodium borocaptate ((Na2B12H11SH)-B-10; (Na2BSH)-B-10) and L-P-boronophenylalanine (L-(10)BPA). These low molecular weight compounds are cleared easily from the cancer cells and blood. Therefore, high accumulation and selective delivery of boron compounds into tumor tissues are most important to achieve effective BNCT and to avoid damage of adjacent healthy cells. Much attention has been focused on the liposomal drug delivery system (DDS) as an attractive, intelligent technology of targeting and controlled release of B-10 compounds. Two approaches have been investigated for incorporation of B-10 into liposomes: (1) encapsulation of B-10 compounds into liposomes and (2) incorporation of B-10-conjugated lipids into the liposomal bilayer. Our laboratory has developed boron ion cluster lipids for application of the latter approach. In this chapter, our boron lipid liposome approaches as well as recent developments of the liposomal boron delivery system are summarized.

    DOI: 10.1016/S0076-6879(09)65010-2

    Web of Science

    researchmap

  • de novo Design and synthesis of N-benzylanilines as new candidates for VEGFR tyrosinekinase inhibitors International journal

    Hiroyuki Nakamura

    Organic & Biomolecular Chemistry   6 ( 6 )   979 - 981   2008.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:The Royal Society of Chemistry  

    N-Benzylanilines were designed and synthesized as vascular endothelial growth factor ( VEGF)-2 inhibitors using de novo drug design systems based on the X-ray structure of VEGFR-2 kinase domain. Among compounds synthesized, compound 3 showed the most potent inhibitory activity toward VEGFR-2 (KDR) tyrosine kinase and its IC(50) value was 0.57 mu M.

    DOI: 10.1039/B719959G

    Web of Science

    researchmap

  • 中性子捕捉治療に向けたホウ素ナノキャリア設計

    機能性DDSキャリアの製剤設計   279 - 288   2008

     More details

  • Triazinyl Architecture on Bifunctional Carboranyl Templates for the Production of Potential Neutron Capture Therapy Agents: Synthesis and Characterization of 1, 3, 5-Triazinylcarborane Derivatives

    Lee, Chai-Ho, Jin, Guo Fan, Yoon, Ji Ho, Kim, Sun Hee, Lee, Jong-Dae, Nakamura, Hiroyuki, Kang, Sang Ook

    Synthesis   2008 ( 08 )   1193 - 1200   2008

     More details

    Publishing type:Research paper (scientific journal)   Publisher:{\copyright} Georg Thieme Verlag Stuttgart{\textperiodcentered} New York  

    researchmap

  • Synthesis and characterization of o-carboranylthiolate substituted 1,3,5-triazines

    Lee, Chai-Ho, Jin, Guo Fan, Kim, Hyo-Suk, Nakamura, Hiroyuki, Lee, Jong-Dae

    Bulletin of the Korean Chemical Society   29 ( 3 )   2008

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • Nanoparticle Synthesis in Microreactors

    Nakamura, Hiroyuki

    Encyclopedia of Microfluidics and Nanofluidics   1437 - 1446   2008

     More details

    Publisher:Springer  

    researchmap

  • Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening

    Usui, Taikou, Ban, Hyun Seung, Kawada, Junpei, Hirokawa, Takatsugu, Nakamura, Hiroyuki

    Bioorganic & Medicinal Chemistry Letters   18 ( 1 )   285 - 288   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    A series of indenopyrazoles 8 and 9 were designed and synthesized as EGFR tyrosine kinase inhibitors by in silico high-throughput screening. Compounds 8b and 8d showed significant inhibition of A431 cell growth (GI(50) = 0.062 and 0.057 mu M, respectively). Compounds 8b and 9a showed inhibitory activity toward both EGFR and VEGFR-2 (KDR) tyrosine kinases, whereas 8d inhibited VEGFR-2 tyrosine kinase, exclusively. (C) 2007 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2007.10.084

    Web of Science

    researchmap

  • Preparation of boronated heterocyclic compounds using intramolecular cyclization reaction

    Lee, Chai-Ho, Jin, Guo Fan, Kim, Hyo-Suk, Nakamura, Hiroyuki, Chung, Yongseog, Lee, Jong-Dae

    Bulletin of the Korean Chemical Society   29 ( 2 )   2008

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • Synthesis and characterization of polar functional group substituted mono- and bis-(o-carboranyl)-1,3,5-triazine derivatives

    Lee, Chai-Ho, Jin, Guo Fan, Yoon, Ji Ho, Jung, Young Ju, Lee, Jong-Dae, Cho, Sungdong, Nakamura, Hiroyuki, Kang, Sang Ook

    Tetrahedron Letters   49 ( 1 )   159 - 164   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    Synthesis, structural characterization, and biological activity studies of o-carborane-substituted 1,3,5-triazines (9-12) containing polar functional groups such as methoxyethyl and t-butoxycarbonylmethyl amine units are described. De-methylation of di(methoxyethyl)amine functionalized triazines 9 and 10 resulted in the production of di(hydroxyethyl)amine derivatives 13 and 14. NNIR (H-1 and C-13) and X-ray crystallographic studies confirmed the structures derived from the sequential o-carborane substitution on the 1,3,5-triazine core. Preliminary in vitro studies revealed that compounds 9, 10, 13, and 14, despite their low cytotoxicity, accumulated at high levels in B-16 melanoma cells. (c) 2007 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tetlet.2007.10.145

    Web of Science

    researchmap

  • Synthesis of mono- and 1,3-disubstituted allenes from propargylic amines via palladium-catalysed hydride-transfer reaction

    Nakamura, Hiroyuki, Ishikura, Makoto, Sugiishi, Tsuyuka, Kamakura, Takaya, Biellmann, Jean-Francois

    Organic & Biomolecular Chemistry   6 ( 8 )   1471 - 1477   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ROYAL SOC CHEMISTRY  

    Mono- and 1,3-disubstituted allenes were synthesized from the corresponding propargylamines via palladium-catalysed hydride-transfer reaction. In the current transformation, propargylic amines can be handled as allenyl anion equivalents and introduced into various electrophiles to be transformed into allenes under palladium-catalyzed conditions.

    DOI: 10.1039/b718298h

    Web of Science

    researchmap

  • Liposomal boron delivery system for neutron capture therapy

    Nakamura, Hiroyuki

    Yakugaku Zasshi-Journal of the Pharmaceutical Society of Japan   128 ( 2 )   193 - 208   2008

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:PHARMACEUTICAL SOC JAPAN  

    Boron neutron capture therapy (BNCT) is a binary cancer treatment based on the nuclear reaction of two essentially nontoxic species, B-10 and thermal neutrons. High accumulation and selective delivery of boron into tumor tissue are the most important requirements to achieve efficient neutron capture therapy of cancers. This review focuses on the liposomal boron delivery system (BDS) as a recent promising approach that meets these requirements for BNCT. BDS involves two strategies: (1) encapsulation of boron in the aqueous core of liposomes and (2) accumulation of boron in the liposomal bilayer. Various boronated liposomes have been developed and significant boron accumulation into tumor tissue with high tumor/blood boron ratios has been achieved by BDS.

    DOI: 10.1248/yakushi.128.193

    Web of Science

    researchmap

  • Allene as an alternative functional group for drug design: Effect of C - C multiple bonds conjugated with on the inhibition of EGFR tyrosine kinase

    Ban, Hyun Seung, Onagi, Shinya, Uno, Masaharu, Nabeyama, Wataru, Nakamura, Hiroyuki

    Chemmedchem   3 ( 7 )   1094 - 1103   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-V C H VERLAG GMBH  

    A series of allenic quinazolines were synthesized as receptor tyrosine kinase inhibitors by using a simple protocol for palladium-catalyzed allene transformation. Among the compounds synthesized, two allenic 4-anilinoquinazolines selectively suppressed epidermal growth factor receptor (EGFR) tyrosine kinase activity in vitro. According to immunoblot analysis, the allenic quinazolines inhibited the EGF-mediated phosphorylation of EGFR and its downstream kinases in A431 cells. Furthermore, one of these allenic quinazolines decreased the proliferation of A437 cells through the induction of cell-cycle arrest and apoptosis.

    DOI: 10.1002/cmdc.200800073

    Web of Science

    researchmap

  • Synthesis of 1,2-dihydroisoquinolines via palladium(0)-catalyzed addition-cyclization of chloroform to ortho-alkynylaldimines

    Nakamura, Hiroyuki, Saito, Hiroyuki, Nanjo, Masato

    Tetrahedron Letters   49 ( 17 )   2697 - 2700   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    Addition-cyclization of chloroform to ortho-alkynylaldimines proceeded in the presence of PdCl(2)(PPh(3))(2)/dppe or Pd(2)dba(3)center dot CHCl(3)/ dppe at 100 degrees C to afford the corresponding 1-(trichloromethyl)-1,2-dihydi-oisoquinolines in good to high yields. (c) 2008 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tetlet.2008.02.156

    Web of Science

    researchmap

  • Molecular effects of the tissue-nonspecific alkaline phosphatase gene polymorphism (787T > C) associated with bone mineral density

    Sogabe, Natsuko, Oda, Kimimitsu, Nakamura, Hiroyuki, Orimo, Hideo, Watanabe, Hisashi, Hosoi, Takayuki, Goseki-Sone, Masae

    Biomedical Research-Tokyo   29 ( 4 )   213 - 219   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMEDICAL RESEARCH PRESS LTD  

    Based on studies of hypophosphatasia, which is a systemic skeletal disorder resulting from tissue-nonspecific alkaline phosphatase (TNSALP) deficiency, TNSALP was suggested to be indispensable for bone mineralization. Recently, we demonstrated that there was a significant difference in bone mineral density (BMD) among haplotypes, which was lowest among TNSALP (787T [Tyr246Tyr]) homozygotes, highest among TNSALP (787T &gt; C [Tyr246His]) homozygotes, and intermediate among heterozygotes. To analyze protein translated from the TNSALP gene 787T &gt; C, we performed the biosynthesis of TNSALPs using TNSALP cDNA expression vectors. TNSALP (787T) and TNSALP (787T &gt; C) were synthesized similarly as a high-mannose-type 66-kDa form, becoming an 80-kDa form. Expression of the human 787T &gt; C TNSALP gene using the cultured mouse marrow stromal cell line ST2 demonstrated that the protein translated from 787T &gt; C exhibited an ALP-specific activity similarly to that of 787T. Interestingly, the Km value for TNSALP in ST2 cells transfected with the 787T &gt; C TNSALP gene was decreased significantly compared to that of cells carrying the 787T gene (P &lt; 0.01). These results suggest that the significant difference in Km values between the proteins translated from 787T &gt; C and 787T may contribute to regulatory effects on bone metabolism.

    DOI: 10.2220/biomedres.29.213

    Web of Science

    researchmap

  • Boron delivery system for neutron capture therapy of cancer

    NAKAMURA Hiroyuki

    Rinsho Ketsueki   49 ( 5 )   294 - 301   2008

     More details

    Language:Japanese   Publisher:The Japanese Society of Hematology  

    DOI: 10.11406/rinketsu.49.294

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2008238080

  • Synthesis of allenes via CuBr-catalyzed homologation of alk-1-ynes accelerated by microwave

    Nakamura, Hiroyuki, Sugiishi, Tsuyuka, Tanaka, Yuko

    Tetrahedron Letters   49 ( 50 )   7230 - 7233   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    CuBr-catalyzed homologation of alk-1-ynes 1 with paraformaldehyde and N,N-diisopropylamine (or N,N-dicyclohexylamine) was accelerated by microwave irradiation at 150 degrees C to afford the corresponding allenes 2 in good to high yields in 1-10 min. Bisalkynes 5 and 7 were also converted to the corresponding bisallenes 6 and 8 in 63% and 61% yields, respectively, under the current condition. (C) 2008 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tetlet.2008.10.019

    Web of Science

    researchmap

  • Phase-Vanishing Methods Based on Fluorous Phase Screen: A Simple Way for Efficient Execution of Organic Synthesis

    Ryu, Ilhyong, Matsubara, Hiroshi, Nakamura, Hiroyuki, Curran, Dennis P.

    Chemical Record   8 ( 6 )   351 - 363   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JOHN WILEY & SONS INC  

    The phase-vanishing (PV) method is based on spontaneous reaction controlled by diffusion of reagents into fluorous media, such as perfluorohexanes (FC-72) and polyperfluoroethers. Thus, the original PV reaction utilizes a triphasic test tube method composed of a bottom reagent phase, a middle fluorous phase, and a top substrate phase. In such a triphasic system, the fluorous phase acts as a liquid membrane to transport the bottom reagents to the top organic phase containing substrates. In the end, the bottom layer disappears and two phases remain. Since the first demonstration of the PV method by bromination of alkenes with molecular bromine, a number of applications have been developed thus far. These include halogenation of alcohols with SOBr(2) and PBr(3), demethylation of methoxyarenes with BBr(3), cyclopropanation of alkenes by CH(2)I(2)-AlEt(3), and Friedel-Crafts acylation of aromatic compounds with SnCl(4). A fluorous triphasic U-tube method is effective for chlorination of alcohols based on lighter (less dense) reagents such as SOCl(2), and PCl(3). A system using a solution containing reagents as a bottom phase is useful for oxidation with m-CPBA, which may be defined as a new category for the "extractive PW method. Recent advances include a "quadraphasic" PV method, in which an aqueous 11 scavenger 11 phase is added to the original triphasic PV method to remove acidic by-products. (c) 2008 The Japan Chemical Journal Forum and Wiley Periodicals, Inc. Chem Rec 8: 351-363; 2008: Published online in Wiley InterScience (www.interscience.wiley.com) DOI 10.1002/tcr.20161

    DOI: 10.1002/tcr.20161

    Web of Science

    researchmap

  • ホウ素化合物デリバリーシステムを用いた中性子捕捉療法の基礎的検討

    中井,啓, 山本,哲哉, 鶴田,和太郎, 鶴淵,隆夫, 益子,良太, 吉田,文代, 松村,明, 中村,浩之, 潘,鉉承, 上野,学

    日本癌治療学会誌   42 ( 2 )   406 - 406   2007.9

     More details

    Language:Japanese   Publishing type:Research paper (international conference proceedings)  

    researchmap

  • 次世代ホウ素中性子捕捉療法のためのDDSの開発

    中村, 浩之, 金田, 安史, 松村, 明

    Drug delivery system   22 ( 3 )   304   2007.5

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    researchmap

  • Synthesis of closo-Dodecaboryl Lipids and their Liposomal Formation for Boron Neutron Capture Therapy

    Nakamura, Hiroyuki, Lee, Jong-Dae, Ueno, Manabu, Miyajima, Yusuke, Ban, HyunSeung

    NanoBiotechnology   3 ( 2 )   135 - 145   2007

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    High accumulation and selective delivery of boron into tumor tissues are the most important requirements to achieve efficient neutron capture therapy of cancers. We focused on liposomal boron delivery system to achieve a large amount of boron delivery to tumor. We succeeded in the synthesis of the double-tailed boron cluster lipids 4a-c and 5a-c, which has a B12H 11S-moiety as a hydrophilic function, by S-alkylation of B 12H11SH with bromoacetyl and chloroacetocarbamate derivatives of diacylglycerols. Size distribution of liposomes prepared from the boron cluster lipid 4b, dimyristoylphosphatidylcholine, polyethyleneglycol- conjugated distearoylphosphatidylethanolamine, and cholesterol was determined as 100 nm in diameter by an electrophoretic light scattering spectrophotometer. Calcein-encapsulation experiments revealed that these boronated liposomes are stable at 37°C in fetal bovine serum solution for 24 h. © 2008 Humana Press Inc.

    DOI: 10.1007/s12030-008-9000-6

    Scopus

    researchmap

  • Synthesis of dodecaborate-conjugated cholesterols for efficient boron delivery in neutron capture therapy

    Nakamura, Hiroyuki, Ueno, Manabu, Lee, Jong-Dae, Ban, Hyun Seung, Justus, Eugen, Fan, Ping, Gabel, Detlef

    Tetrahedron Letters   48 ( 18 )   3151 - 3154   2007

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    Dodecaborate-conjugated cholesterols 3a-c were synthesized for liposomal boron delivery systems in neutron capture therapy. The current synthesis is based on the S-alkylation protocol of the cyanoethyl-protected BSH with alkyl halides. The dodecaborate-conjugated cholesterol 3a liposome, which was prepared from dimyristoylphosphatidylcholine (DMPC), cholesterol, dodecaborate-conjugated cholesterol 3a, and polyethyleneglycol-conjugated distearoylphosphatidylethanolamine (PEG-DSPE) (1:0.5:0.5:0.1), exhibited higher cytotoxicity than BSH at the same boron concentration and IC50 values of the 3a liposome and BSH toward colon 26 cells were estimated as 25 and 78 ppm of boron concentration, respectively. (c) 2007 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tetlet.2007.03.043

    Web of Science

    researchmap

  • Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy

    Lee, Jong-Dae, Ueno, Manabu, Miyajima, Yusuke, Nakamura, Hiroyuki

    Organic Letters   9 ( 2 )   323 - 326   2007

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    [GRAPHIC]
    We succeeded in the synthesis of the double-tailed boron cluster lipids 4a-c and 5a-c, which have a B12H11S moiety as a hydrophilic function, by S-alkylation of B12H11SH (BSH) with bromoacetyl and chloroacetocarbamate derivatives of diacylglycerols for a liposomal boron delivery system on neutron capture therapy. Calcein encapsulation experiments revealed that the liposomes, prepared from the boron cluster lipid 4b, DMPC, PEG-DSPE, and cholesterol, are stable at 37 degrees C in FBS solution for 24 h.

    DOI: 10.1021/ol062840+

    Web of Science

    researchmap

  • Transferrin-loaded nido-carborane liposomes: Tumor-targeting boron delivery system for neutron capture therapy

    Miyajima, Yusuke, Nakamura, Hiroyuki, Kuwata, Yasuhiro, Lee, Jong-Dae, Masunaga, Shinichiro, Ono, Koji, Maruyama, Kazuo

    Bioconjugate Chemistry   17 ( 5 )   1314 - 1320   2006

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    The nido-carborane lipid 2 as a double-tailed boron lipid was synthesized from heptadecanol in five steps. The lipid 2 formed stable liposomes at 25% molar ratio toward DSPC with cholesterol. Transferrin was able to be introduced on the surface of boron liposomes (Tf(+)-PEG-CL liposomes) by the coupling of transferrin to the PEG-CO2H moieties of Tf(-)-PEG-CL liposomes. The biodistribution of Tf(+)-PEG-CL liposomes, in which I-125-tyraminyl inulins were encapsulated, showed that Tf(+)- PEG-CL liposomes accumulated in tumor tissues and stayed there for a sufficiently long time to increase tumor/blood concentration ratio, although Tf(-)-PEG-CL liposomes were gradually released from tumor tissues with time. A boron concentration of 22 ppm in tumor tissues was achieved by the injection of Tf(+)-PEG-CL liposomes at 7.2 mg/kg body weight boron in tumor-bearing mice. After neutron irradiation, the average survival rate of mice not treated with Tf(+)-PEG-CL liposomes was 21 days, whereas that of the treated mice was 31 days. Longer survival rates were observed in the mice treated with Tf(+)-PEG-CL liposomes; one of them even survived for 52 days after BNCT.

    DOI: 10.1021/bc060064k

    Web of Science

    researchmap

  • Selective inhibition of EGFR and VEGFR tyrosine kinases controlled by a boronic acid substituent on 4-anilinoquinazolines

    NAKAMURA, Hiroyuki, USUI, Taikou, HORIKOSHI, Ryoji, NABEYAMA, Wataru, BAN, HYUN SEUNG

    Yakugaku zasshi   126   164 - 165   2006

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Nihon Yakugakkai  

    researchmap

  • Synthesis and biological evaluation of allenic quinazolines using palladium-catalyzed hydride-transfer reaction

    Nakamura, H, Onagi, S

    Tetrahedron Letters   47 ( 15 )   2539 - 2542   2006

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    Allenic quinazolines 13a-h were designed as mimics of Tarceva, which is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, and synthesized from the corresponding 4-(iodoanilino)quinazolines or 4-(iodophenoxy)quinazolines with N,N-dicyclohexylprop-2-ynylamine by the Sonogashira coupling followed by palladium-catalyzed hydride-transfer reaction. Cell growth inhibition of 13a-h toward A431, Kato III, SKBR3, and HepG2 was examined. Among the compounds synthesized, 13a showed a similar cell growth inhibition to Tarceva. Moreover, 13d and 13h exhibited a specific growth inhibition toward Kato III cells (IC50 = 12 and 4.7 mu M, respectively), although a significant inhibition toward other three cell lines was not observed at a 100 mu M concentration of compounds. (c) 2006 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tetlet.2006.02.043

    Web of Science

    researchmap

  • Synthesis of THIQ derivatives as potential boron neutron capture therapy agents: N-functionalized o-carboranylmethyl benzopiperidines

    Lee, CH, Oh, JM, Lee, JD, Nakamura, H, Ko, J, Kang, SO

    Synlett   ( 2 )   275 - 278   2006

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:GEORG THIEME VERLAG KG  

    A method for synthesizing o-carborane substituted tetrahydroisoquinolines containing a polar functional group such as sulfonic or phosphoric acid on the nitrogen atom of the piperidine ring, starting from N-(2-arylethyl)sulfamic acid or 2-arylethylamidophosphate, is described. In vitro studies showed that the desired compounds 7a and 10b accumulate to high levels in B-16 melanoma cells despite low cytotoxicity.

    DOI: 10.1055/s-2006-926222

    Web of Science

    researchmap

  • Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerzation inhibitors

    Nakamura, Hiroyuki, Kuroda, Hirokazu, Saito, Hiroyuki, Suzuki, Ryo, Yamori, Takao, Maruyama, Kazuo, Haga, Tatsuya

    Chemmedchem   1 ( 7 )   729 - 740   2006

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-V C H VERLAG GMBH  

    A series of boronic acid containing cis-stilbenes as potent inhibitors of tubulin polymerization was synthesized by the introduction of boronic acid as an acceptor-type functional group into the aromatic ring B of the combretastatin framework. High cell-growth inhibition was observed with boron compounds 13c and 13d, in which a hydroxy group on the aromatic ring B of combretastatin A-4 was replaced with boronic acid; IC50 values toward B-16 and 1-87 cell lines are 0.48-2.1 mu M. Compounds 13 c and 13d exhibited significant inhibitory activity toward tubulin Polymerization (IC50=21-22 mu M). The carboxylic acid derivative 17, which con be considered as a mimic of boronic acid 13c, did not show significant inhibition of cell growth or tubulin polymerization. According to the FACScan analysis using Jurkat cells, apoptosis was induced after incubation for 8 h with 73 c at a concentration of &gt;10(-8) M. Growth inhibitory experiments against a panel of 39 human cancer cell lines revealed 13c to inhibit growth differently than combretastatin A-4; the correlation coefficient (r) between the two compounds was 0.553 in the COMPARE analysis.

    DOI: 10.1002/cmdc.200600068

    Web of Science

    researchmap

  • 1,2-Bis(diphenylphosphino)carborane as a dual mode ligand for both the sonogashira coupling and hydride-transfer steps in palladium-catalyzed one-pot synthesis of allenes from aryl iodides

    Nakamura, H, Kamakura, T, Onagi, S

    Organic Letters   8 ( 10 )   2095 - 2098   2006

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    One-pot allene synthesis from aryl iodides 1 and propargyldicyclohexylamine 2 proceeded in the presence of Pd-2(dba)(3)(CHCl3)-C-. Catalyst (2-5 mol %), 1,2-bis(diphenylphosphino)carborane 5 (10 mol %), Cul (15 mol %), and Et3N (150 mol %) to give the corresponding allenes 4 in good to high yields. Electron-deficient bidentate phosphines, such as 1,2-bis(diphenylphosphino)carborane 5 and (C6F5)(2)PC2H4P(C6F5)(2), play the role of a dual mode ligand for both the Sonogashira coupling and hydride-transfer reactions.

    DOI: 10.1021/ol060538v

    Web of Science

    researchmap

  • Synthesis and biological evaluation of benzamides and benzamidines as selective inhibitors of VEGFR tyrosine kinases

    Nakamura, Hiroyuki, Sasaki, Yusuke, Uno, Masaharu, Yoshikawa, Tomohiro, Asano, Toru, Ban, Hyun Seung, Fukazawa, Hidesuke, Shibuya, Masabumi, Uehara, Yoshimasa

    Bioorganic & Medicinal Chemistry Letters   16 ( 19 )   5127 - 5131   2006

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    A series of benzamidines and benzamides was synthesized as selective inhibitors of vascular endothelial growth factor receptor (VEGFR) tyrosine kinases, and tested for inhibitory activity toward autophosphorylation by the enzyme assay. Selective inhibition of VEGFR-2 tyrosine kinase was observed in the salicylic amide 4e and the anthranilic amidine 5a, and their percent inhibitions of VEGFR-2 tyrosine kinase were 44-60% at a 10 mu M concentration of compounds. The salicylic amide 4a showed inhibition of both VEGFR-1 and VEGFR-2 tyrosine kinases at a 10 mu M concentration. (c) 2006 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2006.07.075

    Web of Science

    researchmap

  • Synthesis of ene-allenes via palladium-catalyzed hydride-transfer reaction of propargylic amines under mild conditions

    Nakamura, H, Tashiro, S, Kamakura, T

    Tetrahedron Letters   46 ( 48 )   8333 - 8336   2005

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    The palladium-catalyzed allene transformation reaction from propargylic amines proceeded in the presence of Pd-2(dba)(3)(HCl3)-H-. (5 mol %) and (C6F5)(2)PC2H4P(C6F5)(2) (10 mol %) in CHCl3 at room temperature to give the corresponding allenes in good to high yields. Dicyclohexyl groups substituted on the nitrogen of propargylic amines were found to be effective for the current transformation and the conjugated ene-allenes 4 were synthesized from the corresponding propargylic amines 3 under mild conditions. (c) 2005 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tetlet.2005.09.169

    Web of Science

    researchmap

  • Synthesis and in vivo biodistribution of BPA-Gd-DTPA complex as a potential MRI contrast carrier for neutron capture therapy

    Takahashi, K, Nakamura, H, Furumoto, S, Yamamoto, K, Fukuda, H, Matsumura, A, Yamamoto, Y

    Bioorganic & Medicinal Chemistry   13 ( 3 )   735 - 743   2005

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    p-Boronophenylalanine (BPA) conjugated Gd-DTPA complex (3) was synthesized from the active methyne compound 6, the allylic carbonate 7, and BPA by the palladium-catalyzed allylation reaction followed by the DCC coupling reaction. The in vivo biodistribution of complex 3 was evaluated by prompt gamma-ray analysis and alpha-autoradiography using the tumor-bearing rats. High accumulation of gadolinium was observed in the kidney and the %ID values were 0.17 and 0.088 at 20 and 60 min after injection of 3, respectively. The accumulation was also observed in the tumor and the %ID values were 0.010 and 0.0025 at 20 and 60 min after injection, respectively. The visualization experiment of boron distribution in the tumor-bearing rat by alpha-autoradiography indicates that boron was accumulated in the tumor and the intestines at 20 min after injection. (C) 2004 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmc.2004.10.046

    Web of Science

    researchmap

  • Functional analysis of the single nucleotide polymorphism (787T > C) in the tissue-nonspecific alkaline phosphatase gene associated with BMD

    Goseki-Sone, M, Sogabe, N, Fukushi-Irie, M, Mizoi, L, Orimo, H, Suzuki, T, Nakamura, H, Hosoi, T

    Journal of Bone and Mineral Research   20 ( 5 )   773 - 782   2005

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BONE & MINERAL RES  

    Polymorphisms of the TNSALP gene have not previously been studied as a possible determinant for variations in BMD or as a predisposing genetic factor for osteoporosis. This study showed a significantly higher association between the 787T &gt; C (Tyr246His) TNSALP gene and BMD among 501 postmenopausal women. Furthermore, the effects of amino acid substitution on the catalytic property of the protein translated from the 787T &gt; C gene were examined.
    Introduction: Alkaline phosphatase (ALP) is present mainly on the cell membrane in various tissues and hydrolyzes a variety of monophosphate esters into inorganic phosphoric acid and alcohol. Human ALPs are classified into four types: tissue-nonspecific, intestinal, placental, and germ cell types. Based on studies of hypophosphatasia, which is a systemic skeletal disorder resulting from a tissue-nonspecific ALP (TNSALP) deficiency, TNSALP was suggested to be indispensable for bone mineralization.
    Materials and Methods: We explored the possibility that the TNSALP gene may contribute to age-related bone loss in humans by examining the association between TNSALP gene polymorphisms and BMD in 501 Japanese postmenopausal women. To analyze the protein translated from the TNSALP gene associated with BMD, we constructed a TNSALP cDNA expression plasmid.
    Results: We genotyped two single nucleotide polymorphisms (787T &gt; C[Tyr246His] and 876A &gt; G[Pro275Pro]), which proved to be in complete linkage disequilibrium. There was a significant difference in BMD and the BMD score adjusted for age and body weight (Z score) among haplotypes (p = 0.041), which was lowest among 787T/876A homozygotes, highest among 787T &gt; C/876A &gt; G homozygotes, and intermediate among heterozygotes. In subgroups divided by age, haplotypes were significantly associated with BMD in older postmenopausal women (&gt; 74 years; p = 0.001), but not in younger postmenopausal women (&lt; 74 years; p = 0.964). Expression of the 787T &gt; C TNSALP gene using COS-1 cells showed that the protein translated from 787T &gt; C had ALP-specific activity similar to that of 787T. Interestingly, the K-m value for TNSALP in cells transfected with the 787T &gt; C TNSALP gene was decreased significantly compared with that of cells bearing the 787T gene, reflecting the higher affinity.
    Conclusions: These results suggest that variation in TNSALP may be an important determinant of age-related bone loss in humans and that the phosphate metabolism pathway may provide a novel target for the prevention and treatment of osteoporosis.

    DOI: 10.1359/JBMR.041229

    Web of Science

    researchmap

  • Synthesis of Heterocyclic Allenes via Palladium-Catalyzed Hydride-Transfer Reaction of Propargylic Amines

    Nakamura, Hiroyuki, Onagi, Shinya, Kamakura, Takaya

    The Journal of Organic Chemistry   70 ( 6 )   2357 - 2360   2005

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    Propargylic diisopropylamines containing heterocycles, which were prepared readily from heterocyclic bromides and propargyldiisopropylamine by the Sonogashira coupling reaction, underwent the allene transformation reaction in the presence of Pd-2(dba)(3)(CHCl3)-C-. catalyst (2.5 mol %) and 1,2-bis [bis(pentafluorophenyl)phosphino] ethane (10 mol %) at 100 degrees C in CHCl3, giving the corresponding heterocyclic allenes in good to high yields via the palladium-catalyzed hydride-transfer reaction.

    DOI: 10.1021/jo0479664

    Web of Science

    researchmap

  • Synthesis and biological evaluation of benzamides and benzamidines: structural requirement of a pyrimidine ring for inhibition of EGFR tyrosine kinase

    Asano, T, Yoshikawa, T, Nakamura, H, Uehara, Y, Yamamoto, Y

    Bioorganic & Medicinal Chemistry Letters   14 ( 9 )   2299 - 2302   2004

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    The benzamides 1 and the benzamidines 2-3 were synthesized as the mimics of 4-anilinoquinazolines, which possess inhibition of epidermal growth factor receptor (EGER) tyrosine kinase, and tested for cytotoxicity toward A431 and inhibitory activity toward autophosphorylation by the enzyme assay. High cell growth inhibition was observed in a series of the cyclic benzamides 3: the IC50 values are 0.09-0.32 mM. The benzamidines 3a and 3b exhibited high inhibition of EGER tyrosine kinase at a 1.0 muM concentration, although the benzamides 1 and the benzamidines 2 did not show significant kinase inhibition at a 10 muM concentration. (C) 2004 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2004.02.001

    Web of Science

    researchmap

  • Synthesis and vesicle formation of a nido-carborane cluster lipid for boron neutron capture therapy

    Nakamura, H, Miyajima, Y, Takei, T, Kasaoka, S, Maruyama, K

    Chemical Communications   85-94 ( 17 )   1910 - 1911   2004

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ROYAL SOC CHEMISTRY  

    The nido-carborane lipid 2, which has a double-tailed moiety, was synthesized from heptadecanol in 5 steps. Analysis in a transmission electron microscope by negative staining with uranyl acetate showed that the lipid 2 formed a stable vesicle in which calcein was encapsulated. The lipid 2 was incorporated into distearoylphosphatidylcholine ( DSPC) liposomes at a very high concentration.

    DOI: 10.1039/b406141a

    Web of Science

    researchmap

  • Synthesis of N-functionalized 3,4-o-carboranylenepiperidines as potential Boron Neutron Capture Therapy agents

    Lee, CH, Yang, ID, Lee, JD, Nakamura, H, Ko, JJ, Kang, SO

    Synlett   1799-1801 ( 10 )   1799 - 1801   2004

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:GEORG THIEME VERLAG KG  

    A convenient method for o-carborane-substituted piperidines is described. Product compounds 5a, 5b, 5d, and 5e were found accumulate in B-16 melanoma cells with a significantly high level, although with low cytotoxicity.

    DOI: 10.1055/s-2004-829544

    Web of Science

    researchmap

  • Synthesis of 1,2-dihydroisoquinolines via the reaction of ortho-alkynylarylimines with bis-pi-allylpalladium

    Ohtaka, M, Nakamura, H, Yamamoto, Y

    Tetrahedron Letters   45 ( 39 )   7339 - 7341   2004

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    The reaction of the ortho-alkynylarylimines 1 with allyltributylstannane and allyl chloride in the presence of allyipalladium chloride dimer (5 mol %) and Cu(OAC)(2) (20 mol %) in CH(3)CN at 50 degreesC gave the 1,4-diallyl-1,2-dihydroisoquinolines 2 in good yields. Most probably, the reaction proceeds through tandem bis-allylation of the imine-alkyne functional groups with bis-pi-allylpalladium. (C) 2004 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.tetlet.2004.08.008

    Web of Science

    researchmap

  • ホウ素イオンクラスター脂質の合成とベジクル化:ホウ素中性子捕捉療法のためのホウ素送達システムへの応用 Reviewed

    中村浩之, 宮島祐介, 武井俊朗, 笠岡敏, 丸山一雄

    Progress in Drug Delivery System   13   85 - 94   2004

     More details

  • Synthesis of allenes via palladium-catalyzed hydrogen-transfer reactions: Propargylic amines as an allenyl anion equivalent

    Nakamura, H, Kamakura, T, Ishikura, M, Biellmann, JF

    Journal of the American Chemical Society   126 ( 19 )   5958 - 5959   2004

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    DOI: 10.1021/ja039175+

    Web of Science

    researchmap

  • Benzamides and benzamidines as specific inhibitors of epidermal growth factor receptor and v-Src protein tyrosine kinases

    Asano, T, Yoshikawa, T, Usui, T, Yamamoto, H, Yamamoto, Y, Uehara, Y, Nakamura, H

    Bioorganic & Medicinal Chemistry   12 ( 13 )   3529 - 3542   2004

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    The benzamides 1 and the benzamidines 2 as well as the cyclic benzamidines 3 were designed and synthesized as the mimics of 4-anilinoquinazolines for an inhibitor of EGFR tyrosine kinase. The specific inhibitions of EGFR tyrosine kinase were observed in the benzamides 1c and 1d, and the benzamidine 2a, whereas the specific inhibitions of v-Src kinase were observed in the benzamide 1j and the benzamidine 2d at a 10 mug/mL concentration of compounds. The cyclic benzamidines 3a and 3b showed potent kinase inhibition of EGFR at a 1.0 mug/mL concentration. According to the docking simulation using the X-ray structure of EGFR kinase domain in complex with erlotimb, the LigScore2 scoring function value of erlotimb was calculated as 5.61, whereas that of the benzamide 1c was 5.05. In a similar manner, the LigScore2 value of the cyclic benzamidine 3a was calculated as 5.10. (C) 2004 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmc.2004.04.030

    Web of Science

    researchmap

  • Design, synthesis, and biological evaluation of aminoboronic acids as growth-factor receptor inhibitors of EGFR and VEGFR-1 tyrosine kinases

    Asano, T, Nakamura, H, Uehara, Y, Yamamoto, Y

    Chembiochem   5 ( 4 )   483 - 490   2004

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-V C H VERLAG GMBH  

    A series of aminoboronic acids was synthesized abased on the structure of lavendustin pharmocophore 1. Their inhibitory activities against the epidermal growth-factor receptor (EGFR) and vascular endothelial growth-factor receptor-1 (VEGFR-1, Flt-1) protein tyrosine kinases, and various protein kinases, PKA, PKC, PTK, and eEF2K were evaluated. Selective inhibition activities were observed in a series of aminoboronic acids. 4-Methoxy-3-((2-methoxyphenylamino)methyl)phenylboronic acid 10 inhibited EGFR tyrosine kinase, whereas 4-(2,5-dihydroxybenzylamino)phenyl boronic acid 72 inhibited Flt-1 protein kinase, although lavendustin pharmacophore 1 inhibited both EGFR and Flt-1 kinases at a compound concentration of 1.0 mug mL(-1). The selective inhibition of EGFR by 70 is considered to be due to the substitution of the dihydroxy groups on the benzyl moiety for a boronic acid group at the para position, whereas the selective inhibition of Flt-1 by 12 is due to the substitution of the carboxyl group on the aniline moiety in the lavendustin pharmacophore 1 for a boronic acid group.

    DOI: 10.1002/cbic.200300748

    Web of Science

    researchmap

  • Fluorous solvent as a new phase-screen medium between reagents and reactants in the bromination and chlorination of alcohols

    Nakamura, H, Usui, T, Kuroda, H, Ryu, I, Matsubara, H, Yasuda, S, Curran, DP

    Organic Letters   5 ( 8 )   1167 - 1169   2003

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    A perfluorohexane layer regulates the rate of reagent transport in the bromination and chlorination of alcohols. A fluorous triphasic U-tube method is effective for lighter reagents; the thionyl chloride layer (yellow) vanishes, and the chlorides are obtained from the right top organic layer in the chlorination of alcohols.

    DOI: 10.1021/ol034060w

    Web of Science

    researchmap

  • o-Carboranyl derivatives of 1,3,5-s-triazines: structures, properties and in vitro activities

    Lee, CH, Lim, HG, Lee, JD, Lee, YJ, Jaejung, K, Nakamura, H, Kang, SO

    Applied Organometallic Chemistry   17 ( 6-7 )   539 - 548   2003

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JOHN WILEY & SONS LTD  

    Our objective was to design and synthesize substituted o-carboranes carrying the 1,3,5-s-triazine units as potential boron neutron capture therapy agents. The preliminary results indicated that selective substitution was successful, and the structural AB(2) (mono-o-carboranyl-1,3,5-s-triazine) or A(2)B (bis-o-carboranyl-1,3,5-s-triazine) type was used as the starting point for the generation of biologically active species. In the first series, the influence of the structural changes in the central core unit was investigated. Thus, a procedure for the sequential, selective derivatization of cyanuric chloride that allows for the incorporation of o-carborane was elucidated. As a result, a variety of mono-, di-, and tri-substituted triazines were produced in good yield. In the second series, the effect of additional amine substituents on the 1,3,5-s-triazine was studied. Copyright (C) 2003 John Wiley Sons, Ltd.

    DOI: 10.1002/aoc.483

    Web of Science

    researchmap

  • Palladium-Catalyzed Carbon Skeletal Rearrangements: Cope, Claisen, and Other [3, 3] Rearrangements

    Nakamura, Hiroyuki, Yamamoto, Yoshinori

    Handbook of Organopalladium Chemistry for Organic Synthesis   2919 - 2934   2003

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley Online Library  

    researchmap

  • Tandem nucleophilic allylation-alkoxyallylation of alkynylaldehydes via amphiphilic bis-pi-allylpalladium complexes

    Nakamura, H, Ohtaka, M, Yamamoto, Y

    Tetrahedron Letters   43 ( 42 )   7631 - 7633   2002

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    The tandem nucleophilic allylation-alkoxyallylation reaction of the alkynylaldehydes 3 with ally] chloride and allyltributylstannane proceeded very smoothly in the presence of catalytic amounts of allylpalladium chloride dimer in THE at room temperature to give the corresponding 5-exo-dig products 4 as the major product in good to high yields along with 6-endo-dig products 5 as the minor product. (C) 2002 Elsevier Science Ltd. All rights reserved.

    DOI: 10.1016/S0040-4039(02)01604-0

    Web of Science

    researchmap

  • Synthesis of carboranyl derivatives of a tetrahydroisoquinoline

    Lee, JD, Lee, CH, Nakamura, H, Lee, SH, Jun, B, Ko, J, Kang, SO, Sauerwein, W, Moss, R, Wittig, A

    Research and Development in Neutron Capture Therapy   2002

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • Palladium-catalyzed aminoallylation of activated olefins with allylic halides and phthalimide Reviewed

    Aoyagi, K, Nakamura, H, Yamamoto, Y

    Journal of Organic Chemistry   67 ( 17 )   5977 - 5980   2002

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    The three-component aminoallylation reaction of the activated olefins 2, with the phthalimide la and allyl chloride proceeded very smoothly in the presence of Pd(2)dba(3)-CHCl3 (5 mol %)/P(4-FC6H4)(3) (40 mol %) and CS2CO3 (3 equiv against 2) in dichloromethane at room temperature to give the corresponding aminoallylated products, N-pent-4-enylphthalimides 3, in 58-99% yields. The reaction of oxazolidinone 1b also proceeded very smoothly to give N-(2,2-dicyano-1-phenylpent-4-enyl)oxazolidinone in a quantitative yield; however, the Tsuji-Trost-type allylation products 4 were obtained in the case of dibenzylamine, N-tosylaniline, and pyrrolidin-2-one. Further, 2 underwent cycloaddition with N-tosylvinylaziridine 9a in the presence of Pd(2)dba(3)-CHCl3 (5 mol %)/P(4-FC6H4)3 (40 mol %) in THF at room temperature, giving the corresponding pyrrolidines 11 in 69-99% yields.

    DOI: 10.1021/jo025747h

    Web of Science

    researchmap

  • o-carboranyl derivatives of 1,3,5-triazines

    Lim, HG, Lee, JD, Lee, YJ, Lee, CH, Nakamura, H, Lee, SH, Jun, B, Ko, J, Kang, SO, Sauerwein, W, Moss, R, Wittig, A

    Research and Development in Neutron Capture Therapy   2002

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • A convenient synthesis of the novel carboranyl-substituted tetrahydroisoquinolines: application to the biologically active agent for BNCT

    Lee, JD, Lee, CH, Nakamura, H, Ko, JJ, Kang, SO

    Tetrahedron Letters   43 ( 31 )   5483 - 5486   2002

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    A convenient method for o-carborane-substituted tetrahydroisoquinolines (THIQ) is described; in particular, compound 8c accumulates in B-16 melanoma cells with a significantly high level although its cytotoxicity is significantly low. (C) 2002 Elsevier Science Ltd. All rights reserved.

    DOI: 10.1016/S0040-4039(02)01034-1

    Web of Science

    researchmap

  • Nucleophilic allylation-heterocyclization via bis-pi-allylpalladium complexes: Synthesis of five- and six-membered heterocycles

    Bao, M, Nakamura, H, Inoue, A, Yamamoto, Y

    Chemistry Letters   (), 158-159 ( 2 )   158 - 159   2002

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CHEMICAL SOC JAPAN  

    The reaction of the allylic halides 5-9 having an aldehyde or an imine moiety in the molecule with allyltributylstannane proceeded smoothly in the presence of Pd-2.dba(3)-CHCl3 (5 mol%) in DMF or THF, giving the corresponding heterocycles 10-14 in good to high yields. The Stille coupling product was not obtained under these reaction conditions.

    DOI: 10.1246/cl.2002.158

    Web of Science

    researchmap

  • Novel carboranes with a DNA binding unit for the treatment of cancer by boron neutron capture therapy

    Tietze, LF, Griesbach, U, Bothe, U, Nakamura, H, Yamamoto, Y

    Chembiochem   3 ( 2-3 )   219 - 225   2002

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-V C H VERLAG GMBH  

    The synthesis and biological evaluation of two ortho-carborane derivatives which contain a 5,6,7-trimethoxyindole (TMI) unit for use in boron neutron capture therapy is described. The TMI moiety is known to be the DNA-binding part of the highly potent anticancer agent duocarmycin A. The ortho-carborane derivatives were prepared from amino alkynes which were bound to a protected TMI carboxylic acid. Addition of decaborane(14) to the alkyne triple bond with subsequent removal of the tert-butoxy-carbonyl (Boc) and benzyl protecting groups gave the desired product. Boron uptake from the ortho-carborane derivatives into B-16 melanoma cells was higher and faster than that observed with L-p-boronophenylalanine (BPA), which is in use in the clinic.

    DOI: 10.1002/1439-7633(20020301)3:2/3<219::AID-CBIC219>3.0.CO;2-#

    Web of Science

    researchmap

  • Phase-vanishing reactions that use fluorous media as a phase screen. Facile, controlled bromination of alkenes by dibromine and dealkylation of aromatic ethers by boron tribromide

    Ryu, I, Matsubara, H, Yasuda, S, Nakamura, H, Curran, DP

    Journal of the American Chemical Society   124 ( 44 )   12946 - 12947   2002

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    DOI: 10.1021/ja027965y

    Web of Science

    researchmap

  • Preparation and characterization of ruthenium(II), rhodium(III) and iridium(III) complexes of isocyanide bearing the azo group Reviewed

    Y Yamamoto, H Nakamura, JF Ma

    JOURNAL OF ORGANOMETALLIC CHEMISTRY   640 ( 1-2 )   10 - 20   2001.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE SA  

    Reactions of [(eta (6)-arene)RuCl2](2) (1) (eta (6)-arene = p-cymene (1a), 1,3,5-Me3C6H3 (1b), 1,2,3-Me3C6H3 (1c) 1,2,3-Me4C6H2(1d), 1,2,3,5-Me4C6H2 (1e) and C6Me6 (1f)) or [Cp*MCl2](2) (M = Rh (2), Ir (3); Cp* = C5Me5) with 4-isocyanoazobenzene (RNC) and 4,4'-diisocyanoazobenzene (CN-R-NC) gave mononuclear and dinuclear complexes, [(eta (6)-arene)Ru(CNC6H4N=NC6H5)Cl-2] (4a-f). [Cp*M(CNC6H4N=NC6H5)Cl-2] (5: M = Rh; 6: M = Ir), [{(eta (6) -arene)RuCl2}(2){mu -CNC6H4N=NC6H4NC}] (8a-f) and [(Cp*MCl2)(2)(mu -CNC6H4N=NC6H4NC)}] (9: M = Rh; 10: M = Ir), respectively. It was confirmed by X-ray analyses of 4a and 5 that these complexes have trans-forms for the -N=N- moieties. Reaction of [Cp*Rh(dppf)(MeCN)](PF6)(2) (dppf = 1,1'-bis (diphenylphosphino)ferrocene) with 4-isocyanoazobenzene gave [Cp*Rh(dppf)(CNC6H4N=NC6H5)](PF6)(2) (7), confirmed by X-ray analysis. Complex 8b reacted with Ag(CF3SO3), giving a rectangular tetranuclear complex 11b, [{(eta (6)-1,3,5-Me3C6H3)Ru(mu -Cl}(4)(mu -CNC6H4N=NC6H4NC)(2)](CF3SO3)(4) bridged by four Cl atoms and two mu -diisocyanoazobenzene ligands. Photochemical reactions of the ruthenium complexes (4 and 8) led to the decomposition of the complexes, whereas those of 5, 7, 9 and 10 underwent a trans-to-cis isomerization. In the electrochemical reactions the reductive waves about -1.50 V for 4 and -1.44 V for 8 are due to the reduction of azo group, [-N=N-] [-N=N-]2 -. The irreversible oxidative waves at ca. 0.87 V for the 4 and at ca. 0.85 V for 8 came from the oxidation of Ru(II) Ru(III). (C) 2001 Elsevier Science B.V. All rights reserved.

    Web of Science

    researchmap

  • Fluorous triphasic reactions: Transportative deprotection of fluorous silyl ethers with concomitant purification

    Nakamura, H, Linclau, B, Curran, DP

    Journal of the American Chemical Society   123 ( 41 )   10119 - 10120   2001

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    DOI: 10.1021/ja011716c

    Web of Science

    researchmap

  • ortho-Carboranyl glycosides for the treatment of cancer by boron neutron capture therapy

    Tietze, LF, Bothe, U, Griesbach, U, Nakaichi, M, Hasegawa, T, Nakamura, H, Yamamoto, Y

    Bioorganic & Medicinal Chemistry   9 ( 7 )   2001

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/S0968-0896(01)00061-X

    researchmap

  • Catalytic amphiphilic allylation via bis-pi-allylpalladium complexes and its application to the synthesis of medium-sized carbocycles

    Nakamura, H, Aoyagi, K, Shim, JG, Yamamoto, Y

    Journal of the American Chemical Society   123 ( 3 )   372 - 377   2001

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    The reaction of certain activated alkenes 3 with allyltributylstannane (4) and allyl chloride (5a) in the presence of palladium catalyst gave the bis-allylation products, 1,7-octadiene derivatives 6a-k, in good to high yields. The reaction of certain imines 9 with 4 and 5a under similar conditions as above afforded the bis-allylated amines, N-allyl-N-3-butene-1-amine derivatives 10a-f, in good to high yields. The bis-allylation reactions most probably proceed through bis-pi -allylpalladium intermediate 2. The above intermolecular bisallylation was extended to the intramolecular reaction. The reaction of 8-chloro-2,6-octadienyltributylstannane (17a) with activated alkenes 3 gave a mixture of regioisomeric cycloadducts, [8+2] and [4+2] cycloaddition products. The regioisomeric ratio was dependent on solvent and the electron density at the P-position of activated alkenes. In general, the [8+2] cycloadducts 18 were obtained predominantly in CH2Cl2, whereas the [4+2] adducts 24 and 25 were produced predominantly in DMF. The reaction of 7-chloro-2,8-nonadienyltributylstannane (17b) with activated alkenes gave selectively the [9+2] cycloadducts 19 and 22: the regioisomeric [5+2] and [7+2] adducts were not obtained at all. The reaction of 10-chloro-2,8-decadienyltributylstannane (17c) with activated alkene 3a afforded the [10+2] cycloadducts 20 and 23 in low yields. The mechanism on the intramolecular bis-allylation reaction is discussed.

    DOI: 10.1021/ja002931g

    Web of Science

    researchmap

  • Carboranyl bisglycosides for the treatment of cancer by boron neutron capture therapy

    Tietze, LF, Bothe, U, Griesbach, U, Nakaichi, M, Hasegawa, T, Nakamura, H, Yamamoto, Y

    Chembiochem   2 ( 5 )   2001

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/1439-7633(20010504)2:5<326::AID-CBIC326>3.3.CO;2-P

    researchmap

  • The fate of Bis(eta(3)-allyl)palladium complexes in the presence of aldehydes (or imines) and allylic chlorides: Stille coupling versus allylation of aldehydes (or imines)

    Nakamura, H, Bao, M, Yamamoto, Y

    Angewandte Chemie-International Edition   40 ( 17 )   3208 - +   2001

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-V C H VERLAG GMBH  

    DOI: 10.1002/1521-3773(20010903)40:17<3208::AID-ANIE3208>3.0.CO;2-U

    Web of Science

    researchmap

  • Facile Allylative Dearomatization Catalyzed by Palladium

    Bao, Ming, Nakamura, Hiroyuki, Yamamoto, Yoshinori

    Journal of the American Chemical Society   123 ( 4 )   759 - 760   2001

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    DOI: 10.1021/ja003718n

    Web of Science

    researchmap

  • Biological Evaluation of ortho-Carboranyl Glycosides for the Selective Treatment of Cancer by Boron Neutron Capture Therapy L. F. Tietze, U. Bothe, U. Griesbach, M. Nakaichi, T. Hasegawa, H. Nakamura, Y. Yamamoto

    Bioorg. Med. Chem.   9(), 1747-1752   2001

     More details

  • Formation of cyclic ethers via the palladium-catalyzed cycloaddition of activated olefins with allylic carbonates having a hydroxy group at the terminus of the carbon chain

    Sekido, M, Aoyagi, K, Nakamura, H, Kabuto, C, Yamamoto, Y

    Journal of Organic Chemistry   66 ( 21 )   7142 - 7147   2001

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    The reaction of the activated olefins 1 with the allylic carbonate 2, having a hydroxy group at the terminus of the carbon chain, in the presence of catalytic amounts of Pd(2)dba(3)(.)CHCl(3);l and dppe in THF at room temperature gave the corresponding cycloaddition products, tetrahydrofuran derivatives 5, in good to very high yields. The diastereoselectivities (trans/cis ratios) of the products were in the range of ca. 60-70/40-30. The reaction of 1 with the hydroxy allylic carbonate 3 in the presence of catalytic amounts of Pd(2)dba(3)(.)CHCl(3) and (o-tolyl)(3)P in THF at 50 degreesC afforded the corresponding cycloaddition products, tetrahydropyran derivatives 6, in good to high yields. The trans/cis ratios of the products were in the range of ca. 0-40/99-80. The reaction of la with the hydroxy allylic carbonate 4 needed higher reaction temperatures (similar to 100 degreesC) to give the cycloaddition product, the oxepane 7a, in 31% yield with low diastereoselectivity. Next, catalytic asymmetric syntheses of tetrahydrofuran and -pyran derivatives were carried out. With the Trost ligand 15, good to high ees were accomplished in the cycloaddition, although the diastereoselectivities were of low level. With the Hayashi ligand 16, good to high ees were also achieved in the cycloaddition. The absolute stereochemistries of the major enantiomers of 51, 5m, and 6d were determined unambiguously by X-ray crystallographic analysis: trans-(2R,4R)-51, cis-(2S,4R)-51, 4R-5m, trans(2S,4S)-6d, and cis-(2R,4S)-6d were major enantiomers. Based upon the absolute stereochemistries of the major enantiomers, the mechanism of catalytic asymmetric induction in the cycloaddition reaction is discussed.

    DOI: 10.1021/jo0158332

    Web of Science

    researchmap

  • Preparation and application of a polymer-supported chiral π-allylpalladium catalyst for the allylation of imines

    Bao, Ming, Nakamura, Hiroyuki, Yamamoto, Yoshinori

    Tetrahedron Letters   41 ( 1 )   131 - 134   2000

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    The polymer-supported chiral pi-allylpalladium catalyst 8 was applied to the asymmetric allylation reaction of imines 9 with allyltributylstannane. The catalyst was very stable and could be reused several times with high catalytic activity, although the enantioselectivity was not necessarily high. (C) 1999 Elsevier Science Ltd. All rights reserved.

    DOI: 10.1016/S0040-4039(99)02032-8

    Web of Science

    researchmap

  • Hydrofurylation of Alkylidenecyclopropanes Catalyzed by Palladium.

    H. Nakamura, S. Saito, Y. Yamamoto

    J. Am. Chem. Soc.   122   2661 - 2662   2000

     More details

  • In vivo evaluation of carborane gadolinium-DTPA complex as an MR imaging boron carrier

    Nakamura, H, Fukuda, H, Girald, F, Kobayashi, T, Hiratsuka, J, Akaizawa, T, Nemoto, H, Cai, J, Yoshida, K, Yamamoto, Y

    Chemical & Pharmaceutical Bulletin   48 ( 7 )   1034 - 1038   2000

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:The Pharmaceutical Society of Japan  

    The evaluation of the Gd-carborane complex 2 as an MR imaging and boron carrier agent was carried out in vivo using tumor-bearing Donryu rats, MRI, ICP-AES, and α-autoradiography. The MR imaging revealed that the carborane Gd-DTPA 2 was metabolized slower in the body than Gd-DTPA 1. The results of the ICP-AES method indicated that compound 2 was incorporated into normal tissues and metabolized quickly, whereas it was not accumulated into tumor or brain tissue. The α-autoradiography showed that a high level of boron was obtained in the internal organs and in the necrosis of tumor tissue.

    CiNii Books

    researchmap

  • Synthesis and in Vivo Evaluation of Carborane Gadolinium-DTPA Complex as an MR Imaging Boron Carrier. H. Nakamura, H. Fukuda, F. Girard, T. Kobayashi, H. Nemoto, J. Cai, K. Yoshida, Y. Yamamoto

    Chem. Pharm. Bull.   48(), 1034-1038   2000

     More details

  • Palladium-catalyzed cyanoallylation of activated olefins

    Nakamura, Hiroyuki, Shibata, Hitoshi, Yamamoto, Yoshinori

    Tetrahedron Letters   41 ( 16 )   2000

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/S0040-4039(00)00284-7

    researchmap

  • A practical method for the synthesis of enantiomerically pure 4-borono-L-phenylalanine

    Nakamura, H, Fujiwara, M, Yamamoto, Y

    Bulletin of the Chemical Society of Japan   73 ( 1 )   231 - 235   2000

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CHEMICAL SOC JAPAN  

    Enantiomerically pure L-BPA (4-borono-L-phenylalanine) was synthesized from L-tyrosine or 4-iodo-L-phenylalanine derivatives using the palladium-catalyzed cross-coupling reaction of pinacolborane (2,3-dimethyl-2,3-butanediolatoboron). Cbz-Tyr(Nf)-OBzl (2b) underwent the cross-coupling reaction with pinacolborane (1) in the presence of [PdCl2(PPh3)(2)] catalyst to give N-benzyloxycarbonyl-3-(2,3-dimethyl-2,3-butanediolatoboryl)-L-phenylalanine benzyl ester (3a) in 58% yield. The reaction of the 4-iodo-L-phenylalanine derivatives, such as N-benzyloxycarbonyl-3-iodo-L-phenylalanine benzyl ester (2c), N,N-dibenzyl-4-iodo-L-phenylalanine benzyl ester (2d), (4S)-3-benzyloxycarbonyl-4-(4-iodobenzyl)-5-oxazolidinone (2e), and (4S)-3-1-butyroxycarbonyl-4-(4-iodobenzy)-5-oxazolidinone (2f), with 1 proceeded very smoothly in the presence of [PdCl2(dppf)] catalyst, giving N-benzyloxycarbonyl-4-(2,3-dimethyl-2,3-butanediolatoboryl)-L-phenylalanine benzyl ester (3a), N,N-dibenzyl-4-(2,3-dimethyl-2,3-butanediolatoboryl)-L-phenylalanine benzyl ester (3b), (4S)-3-benzyloxycarbonyl-4-[3-(2,3-dimethyl-2,3-butanediolatoboryl)benzyl]-5-oxazolidinone (3c), and (4S)-3-butyloxycarbonyl-4-[4-(2,3-dimethyl-2,3-butanediolatoboryl)benzyl]-5-oxazolidinone (3d), respectively, in high yields. Deprotection of 3a-d gave enantiomerically pure L-BPA in high total yields.

    DOI: 10.1246/bcsj.73.231

    Web of Science

    researchmap

  • Palladium(0)-catalyzed cope rearrangement of acyclic 1,5-dienes. Bis(pi-allyl)palladium(II) intermediate

    Nakamura, H, Iwama, H, Ito, M, Yamamoto, Y

    Journal of the American Chemical Society   121 ( 46 )   10850 - 10851   1999

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    DOI: 10.1021/ja992117x

    Web of Science

    researchmap

  • Relaxation properties of a dual-labeled probe for MRI and neutron capture therapy

    Tatham, AT, Nakamura, H, Wiener, EC, Yamamoto, Y

    Magnetic Resonance in Medicine   42 ( 1 )   1999

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/(SICI)1522-2594(199907)42:1<32::AID-MRM6>3.0.CO;2-5

    researchmap

  • Synthetic utility of o-carborane: novel protective group for aldehydes and ketones

    Nakamura, H, Aoyagi, K, Yamamoto, Y

    Journal of Organometallic Chemistry   574 ( 1 )   1999

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/S0022-328X(98)00922-X

    researchmap

  • Novel addition and [3+2] cycloaddition reactions of stannyl- and silyl-ortho-carboranes to carbonyl compounds Reviewed

    Nakamura, H, Yamamoto, Y

    Collection of Czechoslovak Chemical Communications   64 ( 5 )   829 - 846   1999

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:INST ORGANIC CHEM AND BIOCHEM  

    Stannyl- and silyl-ortho-carboranes serve as an ortho-carborane carbanion equivalents in the addition reaction to aldehydes. The reaction of (tributylstannyl)-ortho-carborane 2 with aldehydes 4 in the presence of palladium(0) catalysts gave the corresponding (ortho-carboranyl) carbinols 5 in good to high yields. The reaction of (trimethylsilyl) -ortho-carborane 3 with aldehydes 4 in the presence of tetrabutylammonium fluoride (TBAF) gave the corresponding (ortho-carboranyl) carbinols 5 in high yields. Furthermore, (trimethylsilyl)-ortho-carborane 3 underwent a facile [3+2] annulation reaction with various alpha,beta-unsaturated enals and enones in the presence of tetrabutylammonium fluoride, giving the corresponding five-membered carboracyclic products 14 in good to high yields.

    DOI: 10.1135/cccc19990829

    Web of Science

    researchmap

  • Chiral pi-allylpalladium-catalyzed asymmetric allylation of imines: Replacement of allylstannanes by allylsilanes

    Nakamura, K, Nakamura, H, Yamamoto, Y

    Journal of Organic Chemistry   64 ( 8 )   1999

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/jo9901081

    researchmap

  • The synthesis of a carborane gadolinium-DTPA complex for boron neutron capture therapy

    Nemoto, H, Cai, JP, Nakamura, H, Fujiwara, M, Yamamoto, Y

    Journal of Organometallic Chemistry   581 ( 1-2 )   170 - 175   1999

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE SA  

    Five-carboxylate DTPA derivatives (5 and 10) were synthesized via the palladium-catalyzed reaction of allyl ethyl carbonate 9 with diethylenetriamine-N-ethoxycarbonyl acetic-N,N',N ",N "-tetraacetic acid hexaethyl ester 7. This method can be applied to the synthesis of a Gd-carborane complex. The reaction of the hexaethyl ester 7 with carboranyl allyl carbonate 13a proceeded very smoothly under Pd(dba)(2)/2dppe catalyst (10 mol%) in THF at 50 degrees C, giving the C-C bond formation product 14 in 74% yield. Hydrolysis of the ethyl esters in 14 was carried out with UOH in aqueous methanol followed by treatment with diluted hydrochloric acid (IN) to afford the corresponding pentaacid 15 in 68% yield. Treatment of the carborane containing DTPA derivative 15 with gadolinium(III) chloride hexahydrate gave the desired Gd-DTPA carborane complex 16 in quantitative yield. (C) 1999 Elsevier Science S.A. All rights reserved.

    DOI: 10.1016/S0022-328X(99)00049-2

    Web of Science

    researchmap

  • Synthesis of a new amphiphilic ortho-carborane as a potential BNCT agent: 4-[N,N-formyl-(ortho-carboranylmethyl)-amino]benzoyl-L-glutamic acid

    Rho, Kee Yoon, Cho, Young Jin, Yoon, Cheol Min, Nakamura, Hiroyuki

    Tetrahedron Letters   40 ( 26 )   4821 - 4824   1999

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    A 1,2-dicarba-closo-dodecaboranyl derivative (8) and its disodium salt (9) were prepared from 4-aminobenzoic acid (1). The water solubility and the biological data (toxicity and cell-uptake) of the disodium salt (9) were identified to be enough for clinical trial. (C) 1999 Elsevier Science Ltd. All rights reserved.

    DOI: 10.1016/S0040-4039(99)00853-9

    Web of Science

    researchmap

  • A concise and stereospecific one-shot synthesis of bicyclo[3.3.1]nonenols from dimethyl 1,3-acetonedicarboxylate and enals via the sequential Michael addition - Intramolecular aldolization

    Aoyagi, K, Nakamura, H, Yamamoto, Y

    Journal of Organic Chemistry   64 ( 11 )   1999

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/jo9903306

    researchmap

  • Characterization of a Dual Labeled Probe for MRI and Neutron Capture Therapy A. T. Tatham, H. Nakamura, E. C. Wiener, Y. Yamamoto

    Mag. Res. Med.   42(), 32-36   1999

     More details

  • The renaissance of pi-allylpalladium-catalyzed organic synthesis

    Nakamura, H, Yamamoto, Y

    Journal of Synthetic Organic Chemistry Japan   56 ( 5 )   1998

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • Palladium-catalyzed alkoxyallylation of activated olefins

    Nakamura, H, Sekido, M, Ito, M, Yamamoto, Y

    Journal of the American Chemical Society   120 ( 27 )   1998

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/ja980959a

    researchmap

  • Tetrabutylammonium fluoride promoted novel reactions of o-carborane: Inter- and intramolecular additions to aldehydes and ketones and annulation via enals and enones Reviewed

    Nakamura, H, Aoyagi, K, Yamamoto, Y

    Journal of the American Chemical Society   120 ( 6 )   1167 - 1171   1998

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    The addition of o-carborane (1) to aldehydes 2 proceeded very smoothly in the presence of aqueous tetrabutylammonium fluoride (TBAF; 3 equiv) at room temperature, giving the corresponding carbinols 3 in high yields. The TBAF-mediated reaction was applied to the intramolecular cycloaddition of o-carboranyl aldehydes and ketones 4, and the corresponding five-, six-, and seven-membered carboracycles were obtained in good-to-high yields. Further, [3 + 2] annulation between o-carborane (dianionic C-2 synthons) and alpha,beta-unsaturated aldehydes and ketones (dicationic C-3 synthons) proceeded very smoothly in the presence of TBAF to give the corresponding five-membered carbocycles in good-to-high yields. Detailed mechanistic studies revealed that the [3 + 2] annulation proceeded through kinetically controlled 1,2-addition and thermodynamically controlled 1,4-addition.

    DOI: 10.1021/ja973832e

    Web of Science

    researchmap

  • A concise synthesis of enantiomerically pure L(4-boronophenyl)alanine from L-tyrosine

    Nakamura, H, Fujiwara, M, Yamamoto, Y

    Journal of Organic Chemistry   63 ( 21 )   1998

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/jo980818r

    researchmap

  • Catalytic asymmetric allylation of imines via chiral bis-pi-allylpalladium complexes

    Nakamura, H, Nakamura, K, Yamamoto, Y

    Journal of the American Chemical Society   120 ( 17 )   1998

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/ja973540d

    researchmap

  • Palladium catalyzed regioselective beta-acetonation alpha-allylation of activated olefins in one shot

    Shim, JG, Nakamura, H, Yamamoto, Y

    Journal of Organic Chemistry   63 ( 23 )   1998

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/jo981719g

    researchmap

  • A novel [3+2] annelation between ortho-carboranyltrimethylsilane and conjugated carbonyl compounds

    Nakamura, H, Aoyagi, K, Singaram, B, Cai, JP, Nemoto, H, Yamamoto, Y

    Angewandte Chemie-International Edition in English   36 ( 4 )   367 - 369   1997

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-V C H VERLAG GMBH  

    DOI: 10.1002/anie.199703671

    Web of Science

    researchmap

  • o-Carborane as a Novel Protecting Group of Aldehydes and Ketones. H. Nakamura, K. Aoyagi, Y. Yamamoto

    J. Org. Chem.   62(), 780-781   1997

     More details

  • o-Carborane as a novel protective group for aldehydes and ketones

    Nakamura, H, Aoyagi, K, Yamamoto, Y

    Journal of Organic Chemistry   62 ( 4 )   1997

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/jo962130p

    researchmap

  • Eine Neuartige [3+2]-Anellierung eines ortho-Carboranyltrimethylsilanes an Konjugierte Carbonylverbindungen H. Nakamura, K. Aoyagi, B. Singaram, J. Cai, H. Nemoto, and Y. Yamamoto

    Angew. Chem.   109(), 399-401   1997

     More details

  • Amphiphilic catalytic allylating reagent, bis-pi-allylpalladium complex

    Nakamura, H, Shim, JG, Yamamoto, Y

    Journal of the American Chemical Society   119 ( 34 )   1997

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/ja971599e

    researchmap

  • Synthesis of carboranes containing an azulene framework and in vitro evaluation as boron carriers

    Nakamura, H, Sekido, M, Yamamoto, Y

    Journal of Medicinal Chemistry   40 ( 18 )   2825 - 2830   1997

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    3-(0-Carboranylhydroxymethyl)-7-isopropylazulene sodium carboxylate (1) and 3-(o-carboranylmethyl)-7-isopropylazulene sodium sulfonate (2) were synthesized from the palladium-catalyzed addition reaction of 1-carboranyltributylstannnane (4) to azulene aldehydes (3 and 9). Although the water solubility of 1 was of the order of 10(-6) M, that of 2 was bf the order of 10(-3) M and was enough for clinical use. The cytotoxicity of 1 (IC50) toward B-16 melanoma cells was of the order of 10(-5) M, whereas that of 2 was of the order of 10(-4) M. This value was close to that of BPA (similar to 9 x 10(-3) M) which is utilized for clinical use. The boron uptake by B-16 cells was 0.17 mu g of B/10(6) cells for 1 and 0.25 mu g of B/10(6) cells for 2. It is clear that compound 2 accumulates in B-16 melanoma cells with a significantly high level although it is highly water soluble and its cytotoxicity is significantly low.

    DOI: 10.1021/jm970023x

    Web of Science

    researchmap

  • Palladium- and platinum-catalyzed addition of aldehydes and imines with allylstannanes. Chemoselective allylation of imines in the presence of aldehydes

    Nakamura, H, Iwama, H, Yamamoto, Y

    Journal of the American Chemical Society   118 ( 28 )   6641 - 6647   1996

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    The reaction of allylstannanes 1 with aldehydes 2 in THF was catalyzed by Pd(II) or Pt(II) complexes (10 mol %) either at room temperature or at reflux, giving the corresponding homoallylic alcohols 3 in high to good yields. Among the catalysts examined, PtCl2(PPh(3))(2) gave the best result. No only allyltribitylstannane but also methallyl- and crotyltributylstannane could be utilized in this transition metal catalyzed reaction. Detailed mechanistic studies of the Pd(II)-catalyzed allylation, using NMR spectroscopy, revealed that the bis-pi-allylpalladium complex is a key intermediate for the catalytic cycle and it exhibits nucleophilic reactivity. The nucleophilic reactivity of the intermediate is in marked contrast to the electrophilic reactivity of ordinary pi-allylpalladium complexes (pi-allylPdX, X = OAc, halogen, OCO(2)R, etc.). The addition of allyl-, crotyl-, and methallylstannanes to various imines 4 proceeded very smoothly to give the corresponding allylated products (homoallylic amines 5) in good to high yields. The reactivities of allylstannanes to imines were higher than those to aldehydes under the catalytic conditions, although it is known that the reactivity of allylstannanes to aldehydes is higher than that to imines under the Lewis acid promoted condition. Imines were chemoselectively allylated in the presence of aldehydes and the highest selectivities were obtained using pi-allylpalladium chloride dimer 11 as a catalyst.

    DOI: 10.1021/ja9608858

    Web of Science

    researchmap

  • Unprecedented highly chemoselective allylation of imines in the presence of aldehydes via a palladium catalysed allylstannane reaction

    Nakamura, H, Iwama, H, Yamamoto, Y

    Chemical Communications   (), 1459-1460 ( 12 )   1459 - 1460   1996

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ROYAL SOC CHEMISTRY  

    Imines are allylated chemoselectively in the presence of aldehydes using allylstannanes with pi-allylpalladium chloride dimer catalyst.

    DOI: 10.1039/cc9960001459

    Web of Science

    researchmap

  • Tetrabutylammonium fluoride promoted regiospecific reactions of trimethylsilyl-o-carborane with aldehydes

    Cai, JP, Nemoto, H, Nakamura, H, Singaram, B, Yamamoto, Y

    Chemistry Letters   (), 791-792 ( 9 )   791 - 792   1996

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CHEMICAL SOC JAPAN  

    Trimethylsilyl-o-carborane serves as o-carborane carbanion upon fluoride ion promoted reaction with carbonyl compounds. Thus, in the presence of tetrabutylammonium fluoride, trimethylsilyl-o-carborane undergoes facile, unprecedented, carbodesilylation with aromatic and aliphatic aldehydes.

    DOI: 10.1246/cl.1996.791

    Web of Science

    researchmap

  • POLYOLS OF A CASCADE TYPE AS A WATER-SOLUBILIZING ELEMENT OF CARBORANE DERIVATIVES FOR BORON NEUTRON-CAPTURE THERAPY (VOL 57, PG 435, 1992)

    H NEMOTO, JG WILSON, H NAKAMURA, Y YAMAMOTO

    JOURNAL OF ORGANIC CHEMISTRY   60 ( 5 )   1478 - 1478   1995.3

     More details

    Language:English   Publisher:AMER CHEMICAL SOC  

    Web of Science

    researchmap

  • PALLADIUM- AND PLATINUM-CATALYZED ADDITION OF ALDEHYDES WITH ALLYLSTANNANES

    NAKAMURA, H, ASAO, N, YAMAMOTO, Y

    Journal of the Chemical Society-Chemical Communications   (), 1273-1274 ( 12 )   1995

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c39950001273

    researchmap

  • SYNTHESIS OF NETROPSIN AND DISTAMYCIN ANALOGS BEARING O-CARBORANE AND THEIR DNA RECOGNITION

    YAMAMOTO, Y, CAI, JP, NAKAMURA, H, SADAYORI, N, ASAO, N, NEMOTO, H

    Journal of Organic Chemistry   60 ( 11 )   3352 - 3357   1995

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    Netropsin and distamycin A analogues containing o-carborane framework, 4a-c and 5a-c, respectively, were synthesized to investigate DNA binding sequence of these molecules. Cascade type polyols were attached to the carboranes in certain cases; 4b and 5b had the diol unit and 4c and 5c possessed the tetraol unit, whereas 4a and 5a had no hydroxy group. MPE . Fe(II) footprinting on the 216 base pair Pvu I/ Bam HI restriction fragment from pBLUESCRIPT KS(+1-) (bp 2958) indicated that 4a and 5a bound only slightly to the DNA fragment, whereas 4b and 5b bearing two hydroxy groups bound to the A,T-rich base pairs. The compounds containing four; hydroxy groups 4c and 5c bound most selectively to the DNA fragments. In general, the compounds 5 containing three pyrrole rings in their molecules bound to the DNA more selectively than the corresponding two pyrrole ring-bearing compounds 4.

    DOI: 10.1021/jo00116a018

    Web of Science

    researchmap

  • PALLADIUM-CATALYZED ADDITION OF 1-CARBORANYLTRIBUTYLTIN TO ALDEHYDES

    NAKAMURA, H, SADAYORI, N, SEKIDO, M, YAMAMOTO, Y

    Journal of the Chemical Society-Chemical Communications   (), 2581-2582 ( 22 )   1994

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c39940002581

    researchmap

  • B-11 NMR OF BORON-COMPOUNDS IN THE PRESENCE OF CANCER-CELLS

    YAMAMOTO, Y, TAKAMATSU, S, NAKAMURA, H

    Journal of Magnetic Resonance Series B   101 ( 2 )   198 - 200   1993

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS  

    DOI: 10.1006/jmrb.1993.1032

    Web of Science

    researchmap

  • Synthesis and biological activity of a water-soluble p-boronophenylalanine derivatives

    Iwamoto, Satoshi, Nemoto, Hisao, Nakamura, Hiroyuki, Yamamoto, Yoshinori

    1993

     More details

  • Molecular design of new boron carriers covalent bond formations among o-carborane, water-solubilizing elements, and organic moiety having affinity to cancer cells

    Nemoto, Hisao, Cai, J, Sadase, Naoki, Nakamura, Hiroyuki, Willson, JG, Yamamoto, Yoshinori

    1993

     More details

  • Regio- and stereo-selective ring opening of epoxides with amide cuprate reagents

    Yamamoto, Yoshinori, Asao, Naoki, Meguro, Masaki, Tsukada, Naofumi, Nemoto, Hisao, Sadayori, Naoki, Wilson, J. Gerald, Nakamura, Hiroyuki

    Journal of the Chemical Society, Chemical Communications   ( 15 )   1993

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c39930001201

    researchmap

  • A NEW WATER-SOLUBLE P-BORONOPHENYLALANINE DERIVATIVE FOR NEUTRON-CAPTURE THERAPY

    NEMOTO, H, IWAMOTO, S, NAKAMURA, H, YAMAMOTO, Y

    Chemistry Letters   (), 465-468 ( 3 )   465 - 468   1993

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CHEMICAL SOC JAPAN  

    A p-boronophenylalanine (BPA) derivative, that is ca. thousand times more water-soluble and is incorporated with higher tumour/normal cell ratio than BPA itself, has been synthesized.

    DOI: 10.1246/cl.1993.465

    Web of Science

    researchmap

  • 1-CARBORANYL-3-(2-METHYLAZIRIDINO)-2-PROPANOL - SYNTHESIS, SELECTIVE UPTAKE BY B-16 MELANOMA, AND SELECTIVE CYTOTOXICITY TOWARD CANCER-CELLS

    YAMAMOTO, Y, NAKAMURA, H

    Journal of Medicinal Chemistry   36 ( 15 )   1993

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/jm00067a021

    researchmap

  • 99 DESIGN AND SYNTHESIS OF BORON-10 CARRIERS FOR NEUTRON CAPTURE THERAPY OF CANCER

    Nemoto H., Cai J., Nakamura H., Iwamoto S., Yamamoto Y.

    Symposium on the Chemistry of Natural Products, symposium papers   ( 34 )   763 - 769   1992.9

     More details

    Language:Japanese   Publisher:Symposium on the chemistry of natural products  

    Several new methods for the synthesis of boron-10 carriers have been developed for boron neutron capture therapy (BNCT). Two new methods for the synthesis of nucleosides having arylboronic moiety have been developed (Scheme 1 and 2). Chemistry of o-carborane has been studied since it is a nice candidate for BNCT in order to deliver sufficient quantity of boron atoms to tumor cells. The carbon-carbon bond formation reaction to o-carboranes proceeding under essentially neutral conditions has been accomplished for the first time (Scheme 3). o-Carboranes having a cascade type of polyglycerols 5 have been synthesized since o-carborane itself has strong lipophilic nature which causes a serious problem for the design of its derivatives (Scheme 4). The water solubility of 6 and 7 is 0.67M and 5.44M, respectively. Nucleoside derivatives having o-carborane moiety have been synthesized via palladium catalyzed coupling reaction and o-carborane formation reaction with decaborane-14 (Scheme 5). The biological activity of 11a, and 11b have been examined in vitro using B16 melanoma cells and TIG-I-20 Fibroblast cells. The boron atom is selectively concentrated in B16 Melanoma cells (model of a cancer cell), compared with in Hybroblast cells (model of a normal cell).

    DOI: 10.24496/tennenyuki.34.0_763

    CiNii Books

    researchmap

  • SYNTHESIS OF CARBORANES CONTAINING NUCLEOSIDE BASES

    YAMAMOTO, Y, SEKO, T, NAKAMURA, H, NEMOTO, H

    Heteroatom Chemistry   3 ( 3 )   239 - 244   1992

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JOHN WILEY & SONS INC  

    The carboranes containing uridine derivatives (9a, b, c), and purine base (8) were prepared by the reaction of decaborane with the corresponding acetylene precursors (3a, 3b, 2c and 5b, respectively).

    DOI: 10.1002/hc.520030308

    Web of Science

    researchmap

  • POLYOLS OF A CASCADE TYPE AS A WATER-SOLUBILIZING ELEMENT OF CARBORANE DERIVATIVES FOR BORON NEUTRON-CAPTURE THERAPY

    NEMOTO, H, WILSON, JG, NAKAMURA, H, YAMAMOTO, Y

    Journal of Organic Chemistry   57 ( 2 )   435 - 435   1992

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    A practical method for the synthesis of polyols of a cascade type, as a water-solubilizing element of carborane derivatives for boron neutron capture therapy (BNCT), was developed. The carborane attached to the tetraol 6a was dissolved in water in a concentration of 5.44 M.

    DOI: 10.1021/jo00028a010

    Web of Science

    researchmap

  • SYNTHESIS OF CARBORANES CONTAINING NUCLEOSIDE BASES - UNEXPECTEDLY HIGH CYTOSTATIC AND CYTOCIDAL TOXICITY TOWARDS CANCER-CELLS

    YAMAMOTO, Y, SEKO, T, NAKAMURA, H, NEMOTO, H, HOJO, H, MUKAI, N, HASHIMOTO, Y

    Journal of the Chemical Society-Chemical Communications   ( 2 )   1992

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1039/c39920000157

    researchmap

▼display all

Books

  • trans-1,2-Dibromocyclohexane. The Phase Vanishing Bromination with FC-72 as a Screen Phase.

    The Handbook of Fluorous Chemistry, J. A. Gladysz, D. P. Curran, I. T. Horvath, Eds. Wiley-VCH, Weinheim  2004 

     More details

MISC

  • Combination of Convection-enhanced delivery (CED) and the novel boron carrier for boron neutron capture therapy

    辻野晃平, 川端信司, 柏木秀基, 香山諒, 藤川喜貴, 福尾祐介, 平松亮, 高田卓志, 田中浩基, 鈴木実, 宮武伸一, 呼尚徳, 中井啓, 西村開, 中村浩之, 鰐渕昌彦

    日本脳腫瘍学会学術集会プログラム・抄録集   41st   2023

  • アルブミンを基盤としたホウ素中性子捕捉療法用DDS薬剤のラット悪性神経膠腫モデルを用いた基礎研究

    辻野晃平, 川端信司, 柏木秀基, 香山諒, 藤川喜貴, 福尾祐介, 竹内孝治, 平松亮, 高田卓志, 田中浩基, 鈴木実, 呼尚徳, 宮武伸一, 西村開, 中村浩之, 鰐渕昌彦

    日本分子脳神経外科学会プログラム・抄録集   23rd   2023

  • インテグリン標的を有した新規ホウ素化合物を使用するホウ素中性子捕捉療法

    辻野 晃平, 川端 信司, 柏木 秀基, 吉村 亘平, 香山 諒, 福尾 祐介, 竹内 孝治, 平松 亮, 西村 開, 田中 浩基, 渡邉 翼, 鈴木 実, 宮武 伸一, 中村 浩之, 鰐渕 昌彦

    日本癌治療学会学術集会抄録集   60回   P25 - 3   2022.10

     More details

    Language:English   Publisher:(一社)日本癌治療学会  

    researchmap

  • Basic research of boron neutron capture therapy using a novel boron compound targeted to integrin

    辻野晃平, 川端信司, 柏木秀基, 吉村亘平, 香山諒, 福尾祐介, 金光拓也, 平松亮, 呼尚徳, 宮武伸一, 西村開, 高田卓志, 田中浩基, 鈴木実, 中村浩之, 鰐渕昌彦

    日本脳腫瘍学会学術集会プログラム・抄録集   40th   2022

  • インテグリン標的を有したcRGD-MID-ACを使用するホウ素中性子捕捉療法の可能性

    辻野晃平, 川端信司, 柏木秀基, 吉村亘平, 香山諒, 福尾祐介, 竹内孝治, 平松亮, 西村開, 川井一貴, 田中浩基, 渡邉翼, 鈴木実, 宮武伸一, 中村浩之, 鰐渕昌彦

    日本分子脳神経外科学会プログラム・抄録集   22nd   2022

  • Boron neutron capture therapy using maleimide-functionalized closo-dodecaborate albumin conjugate

    柏木秀基, 川端信司, 吉村亘平, 福尾祐介, 金光拓也, 竹内孝治, 二村元, 平松亮, 西村開, 川井一輝, 高田卓士, 田中浩基, 渡邉翼, 鈴木実, 小野公二, 宮武伸一, 中村浩之, 鰐渕昌彦

    日本脳腫瘍学会プログラム・抄録集   39th   2021

  • 新規光感受性薬剤とDDS 新規ホウ素化ポルフィリン・クロリンのconvection enhanced deliveryを用いたPDTおよびBNCTの有用性

    平松 亮, 川端 信司, 中村 浩之, Vicente M.G.H., 田中 浩基, 櫻井 良憲, 小野 公二, 黒岩 敏彦, 鰐渕 昌彦

    日本レーザー医学会誌   40 ( Suppl. )   S42 - S42   2019.11

     More details

    Language:Japanese   Publisher:(NPO)日本レーザー医学会  

    researchmap

  • 新規光感受性薬剤とDDS 新規ホウ素化ポルフィリン・クロリンのconvection enhanced deliveryを用いたPDTおよびBNCTの有用性

    平松 亮, 川端 信司, 中村 浩之, Vicente M.G.H., 田中 浩基, 櫻井 良憲, 小野 公二, 黒岩 敏彦, 鰐渕 昌彦

    日本レーザー医学会誌   40 ( Suppl. )   S42 - S42   2019.11

     More details

    Language:Japanese   Publisher:(NPO)日本レーザー医学会  

    researchmap

  • ホウ素クラスター化合物の生細胞への取り込みの誘導ラマンイメージング

    浅井卓也, LIU Hanqin, 小関泰之, 林智広, 佐藤伸一, 中村浩之

    応用物理学会春季学術講演会講演予稿集(CD-ROM)   66th   2019

  • Development and application of catalytic tyrosine modification

    Sato, S., Tsushima, M., Nakamura, K., Nakamura, H.

    Yakugaku Zasshi   138 ( 1 )   39 - 46   2018

     More details

    © 2018 The Pharmaceutical Society of Japan. The chemical labeling of proteins with synthetic probes is a key technique used in chemical biology, protein-based therapy, and material science. Much of the chemical labeling of native proteins, however, depends on the labeling of lysine and cysteine residues. While those methods have significantly contributed to native protein labeling, alternative methods that can modify different amino acid residues are still required. Herein we report the development of a novel methodology of tyrosine labeling, inspired by the luminol chemiluminescence reaction. Tyrosine residues are often exposed on a protein's surface and are thus expected to be good targets for protein functionalization. In our studies so far, we have found that 1) hemin oxidatively activates luminol derivatives as a catalyst, 2. N-methyl luminol derivative specifically forms a covalent bond with a tyrosine residue among the 20 kinds of natural amino acid residues, and 3) the efficiency of tyrosine labeling with N-methyl luminol derivative is markedly improved by using horseradish peroxidase (HRP) as a catalyst. We were able to use molecular oxygen as an oxidant under HRP/NADH conditions. By using these methods, the functionalization of purified proteins was carried out. Because N-methyl luminol derivative is an excellent protein labeling reagent that responds to the activation of peroxidase, this new method is expected to open doors to such biological applications as the signal amplification of HRP-conjugated antibodies and the detection of protein association in combination with peroxidase-tag technology.

    DOI: 10.1248/yakushi.17-00186-1

    Scopus

    PubMed

    researchmap

  • ホウ素高集積化リポソームを指向した内封ホウ素薬剤開発

    中村 浩之, 立川 将士, Vinas Clara, 鈴木 実, 小野 公二

    日本DDS学会学術集会プログラム予稿集   31回   159 - 159   2015.6

     More details

    Language:Japanese   Publisher:日本DDS学会  

    researchmap

  • Hemagglutinating virus of Japan envelope (HVJ-E) allows targeted and efficient delivery of photosensitizer for photodynamic therapy against advanced prostate cancer

    Mizuho Inai, Masaya Yamauchi, Norihiro Honda, Hisanao Hazama, Shoji Tachikawa, Hiroyuki Nakamura, Tomoki Nishida, Hidehiro Yasuda, Yasufumi Kaneda, Kunio Awazu

    Optical Molecular Probes, Imaging and Drug Delivery, OMP 2015   2015.1

     More details

    © OSA 2015. Selective and efficient photosensitizer delivery was accomplished by utilizing inactivated Sendai virus particle. Drug delivering mechanism was addressed via transmission electron microscope and photocytotoxic activity was investigated thorough performing photodynamic therapy on cultured cells.

    Scopus

    researchmap

  • がん光線力学療法のためのDDS薬剤の開発 : ポルフィリン脂質の開発とナノキャリアへの応用 (特集 がんを抑え込む光線治療)

    立川 将士, 中村 浩之

    光アライアンス   25 ( 9 )   12 - 16   2014.9

     More details

    Language:Japanese   Publisher:日本工業出版  

    CiNii Books

    researchmap

  • ナノテクが未来医療を変える!!

    鈴木亮, 中村浩之

    第133回日本薬学会(横浜)講演ハイライト   52   2013.3

     More details

  • ナノテクノロジーを駆使した革新的診断・治療システムの構築に向けて

    鈴木亮, 中村浩之

    薬事日報   2013.3

     More details

  • 中性子捕捉療法のためのホウ素コレステロールの開発 リポソーム化と細胞内イメージング

    中村 浩之, 三好 達郎, 立川 将士, 小金井 逸人, 鈴木 実, 小野 公二

    日本DDS学会学術集会プログラム予稿集   28回   170 - 170   2012.6

     More details

    Language:Japanese   Publisher:日本DDS学会  

    researchmap

  • ホウ素脂質リポソームの中性子照射における抗腫瘍効果

    小金井 逸人, 立川 将士, 三好 達郎, 鈴木 実, 小野 公二, 中村 浩之

    日本薬学会年会要旨集   132年会 ( 4 )   186 - 186   2012.3

     More details

    Language:Japanese   Publisher:(公社)日本薬学会  

    researchmap

  • A217 Transport of Pendrin Mutant Causing Sensorineural Hearing Loss to Plasma Membrane by Salicylate Derivatives

    SAKAI Natsuki, KOYAMA Shin, MURAKOSHI Michio, HIRASAWA Noriyasu, NAKAMURA Hiroyuki, ISHIHARA Kenji, WADA Hiroshi

    Proceedings of the ... JSME Conference on Frontiers in Bioengineering   2011 ( 22 )   111 - 112   2011.10

     More details

    Language:Japanese   Publisher:The Japan Society of Mechanical Engineers  

    CiNii Books

    researchmap

  • がん中性子捕捉療法のための高集積ホウ素ナノデバイスの開発

    立川 将士, 猪俣 竜, 三好 達郎, 潘 鉉承, 李 千萬, 柳衛 宏宣, 鈴木 実, 小田 雄介, 丸山 一雄, 中村 浩之

    Drug Delivery System   26 ( 3 )   328 - 328   2011.5

     More details

    Language:Japanese   Publisher:日本DDS学会  

    researchmap

  • がん中性子補促療法のためのホウ素リポソーム製剤の開発

    立川将士, 猪俣竜, 潘鉉承, 小田雄介, 丸山一雄, 中村浩之

    日本薬学会年会要旨集   131st ( 4 )   230   2011.3

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • ホウ素ナノデバイス型中性子捕捉治療

    中村 浩之, 松村 明, 李 千萬, 鈴木 実, 丸山 一雄, 柳衛 宏宣

    新しい医療機器研究   16   35 - 37   2011.3

     More details

    Language:Japanese   Publisher:(財)医療機器センター情報サービス部  

    researchmap

  • Development of Boron Delivery System for Neutron Capture Therapy of Cancer

    H. Nakamura

    Progress in Drug Delivery System XVII   19 - 24   2008

     More details

  • Synthesis and Liposome Formation of B-10 Enriched B12H11S-Substituted Lipid for Boron Delivery System on BNCT

    J.-D. Lee, H. Nakamura

    Advances in Neutron Capture Therapy   238 - 241   2006

     More details

  • Synthesis and intracellular targeting of transferrin-conjugated nido-carborane liposomes to solid tumors for boron neutron capture therapy.

    Nakamura H, Miyajima Y, Kuwata Y, Masunaga S, Ono K, Maruyama K

    KURRI Progress Report 2005   206   2006

     More details

    Language:English   Publishing type:Rapid communication, short report, research note, etc. (bulletin of university, research institution)  

    researchmap

  • Transferrin-Loaded nido-Carborane Liposomes: Synthesis and Intracellular Targeting to Solid Tumors for Boron Neutron Capture Therapy

    H. Nakamura, Y. Miyajima, Y. Kuwata, S. Masunaga, K. Ono, K. Maruyama

    Advances in Neutron Capture Therapy,   195 - 198   2006

     More details

  • A New NEDO Reseach Project Toward Hospital Based Accelerator BNCT using Advanced DDS system

    A. Matsumura, Y. Mori, Y. Kaneda, K. Hashimoto, K. Nakai, T. Yamamoto, H. Nakamura, K. Akamatsu, T. Asano, S. Lee, Y. Sakurai, H. Kumada, K. Yamamoto, Y. Shibata, T. Shibata, T. Nakahara, M. Mutoh, H. Sakae, Y. Yuasa, Y. Satoh, H. Sakurabata, S. Muraki, T. Nagayama

    Advances in Neutron Capture Therapy,   74 - 76   2006

     More details

  • 新規ホウ素クラスターリポソームの開発と腫よう組織への高濃度ホウ素集積化 Reviewed

    宮島祐介, 中村浩之, 武井俊朗, 桑田康宏, 丸山一雄

    日本薬学会年会要旨集   125th ( 2 )   142   2005.3

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Transferrin-Conjugated Boron Liposomes as a Potent Boron Delivery System for Neutron Capture Therapy

    Progress in Drug Delivery System XIV   45-53   2005

     More details

  • Synthesis and Liposome Formation of a Boron Ion Cluster Lipid

    MIYAJIMA YUSUKE, TAKEI TOSHIAKI, NAKAMURA HIROYUKI, KASAOKA SATOSHI, MARUYAMA KAZUO

    日本化学会講演予稿集   84th ( 1 )   300   2004.3

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Visualization of DNA double-strand breaks as a new in vivo evaluation method of boron carriers for boron neutron capture therapy

    H. Nakamura, T. Yoshikawa, S. Masunaga, K. Ono

    KURRI Progress Report   135   2004

     More details

    Language:English   Publishing type:Rapid communication, short report, research note, etc. (bulletin of university, research institution)  

    researchmap

  • IX.2.1 1. Cope, Claisen, and Other [3,3] Rearrangements

    H. Nakamura, Y. Yamamoto

    Handbook of Organopalladium Chemistry for Organic Synthesis   2919 - 2934   2002

     More details

  • IX.2.1 1. Cope, Claisen, and Other [3,3] Rearrangements H. Nakamura, Y. Yamamoto

    Handbook of Organopalladium Chemistry for Organic Synthesis, E. Negishi Ed., Wiley   (), 2919-2934   2002

     More details

  • V.2.1.9. Pd-Catalyzed Reactions of Soft Carbon Nucleophiles with Dienes, Vinylcyclopropanes and Related Compounds H. Nakamura, Y. Yamamoto

    Handbook of Organopalladium Chemistry for Organic Synthesis, E. Negishi Ed., Wiley   (), 1833-1844   2002

     More details

  • V.2.1.9. Pd-Catalyzed Reactions of Soft Carbon Nucleophiles with Dienes, Vinylcyclopropanes and Related Compounds

    H. Nakamura, Y. Yamamoto

    Handbook of Organopalladium Chemistry for Organic Synthesis   2919 - 2934   2002

     More details

  • In vitro uptake study of 5-carboranyl uridine and its derivatives

    Hasegawa, T, Nakaichi, MA, Nakama, S, Nakamura, H, Yamamoto, Y, Takagaki, M, Takeuchi, A, Hawthorne, MF, Shelly, K, Wiersema, RJ

    Frontiers in Neutron Capture Therapy, Vols 1 and 2   (), 1003-1008   1003 - 1008   2001

     More details

    Language:English   Publisher:KLUWER ACADEMIC/PLENUM PUBL  

    Web of Science

    researchmap

  • A Concise Synthesis of Chiral L-(4-Boronophenyl)alanine from L-Tyrosine H. Nakamura, M. Fujiwara, Y. Yamamoto

    Frontiers in Neutron Capture Therapy, Eds M. F. Hawthorn, K. Shelly, R. J. Wiersema Kluwer Academic/Plenum Publishers, New York   (), 765-768   2001

     More details

  • In vitro Uptake Study of 5-Carboranyluridine and Its Derivatives T. Hasegawa, M. Nakaichi, S. Nakama, H. Nakamura, Y. Yamamoto, M. Takagaki, A. Takeuchi

    Frontiers in Neutron Capture Therapy, Eds M. F. Hawthorn, K. Shelly, R. J. Wiersema Kluwer Academic/Plenum Publishers, New York   (), 1003-1008   2001

     More details

  • A Concise Synthesis of Chiral L-(4-Boronophenyl)alanine from L-Tyrosine H. Nakamura, M. Fujiwara, Y. Yamamoto

    Frontiers in Neutron Capture Therapy, Eds M. F. Hawthorn, K. Shelly, R. J. Wiersema Kluwer Academic/Plenum Publishers, New York   (), 765-768   2001

     More details

  • 遷移金属が炭素?炭素結合を切る!

    中村浩之

    月刊「化学」   54   64 - 65   1998

     More details

  • π-アリルパラジウム錯体

    中村浩之

    有機合成化学協会誌   56   453   1998

     More details

  • Tetrabutylammonium Fluoride Promoted Regiospecific Reaction of Trimethylsilyl-o-carborane with Carbonyl Compounds. J. Cai, H. Nemoto, H. Nakamura, B. Singaram, Y. Yamamoto

    Advances in Boron Chemistry, Ed. W. Siebert, The Royal Society of Chemistry   (), 112-115   1997

     More details

  • MR imaging of rat tumor with a B-10 carborane gadolinium complex

    Girard, F, Fukuda, H, Nakamura, H, Yamamoto, K, Yoshida, K, Larsson, B, Crawford, J, Weinreich, R

    Advances in Neutron Capture Therapy, Vols I and Ii   1132   B271 - B275   1997

     More details

    Language:English   Publisher:ELSEVIER SCIENCE BV  

    Web of Science

    researchmap

  • A new synthetic method of all carboxylate-free DTPA derivatives and its application to the synthesis of Gd-carborane complex

    Yamamoto, Y, Cai, JP, Nemoto, H, Nakamura, H, Girard, F, Yoshida, K, Fukuda, H, Larsson, B, Crawford, J, Weinreich, R

    Advances in Neutron Capture Therapy, Vols I and Ii   1132   B436 - B439   1997

     More details

    Language:English   Publisher:ELSEVIER SCIENCE BV  

    Web of Science

    researchmap

  • Synthesis of Carborane Containing Azlene Framework Using New Palladium Catalyzed Reaction. H. Nakamura, M. Sekido, Y. Yamamoto

    Advances in Neutron Capture Therapy, Eds. B. Larsson, J. Crawford, R. Weinreich, Plenum Press, New York   (), 42-45   1997

     More details

  • Tetrabutylammonium Fluoride Promoted Regiospecific Reaction of Trimethylsilyl-o-carborane with Carbonyl Compounds. J. Cai, H. Nemoto, H. Nakamura, B. Singaram, Y. Yamamoto

    Advances in Boron Chemistry, Ed. W. Siebert, The Royal Society of Chemistry   (), 112-115   1997

     More details

  • Rat Tumor Imaging with B-10 Carborane Gadolinium Complex. F. Girard, H. Nakamura, H. Fukuda, Y. Yamamoto, K, Yoshida

    Recent Advances in Biomedical Imaging, Ed. Y. Ishii et al., Elsevier Science   (), 201-207   1997

     More details

  • MR Imaging of Rat Tumor with 10B Carborane Gadolinium Complex. F. Girard, H. Fukuda, H. Nakamura, Y. Yamamoto, K. Yoshid

    Advances in Neutron Capture Therapy, Eds. B. Larsson, J. Crawford, R. Weinreich, Plenum Press, New York   (), 271-275   1997

     More details

  • A new synthetic method of all carboxylate-free DTPA derivatives and its application to the synthesis of Gd-carborane complex

    Y Yamamoto, JP Cai, H Nemoto, H Nakamura, F Girard, K Yoshida, H Fukuda

    ADVANCES IN NEUTRON CAPTURE THERAPY, VOLS I AND II   1132   B436 - B439   1997

     More details

    Language:English   Publisher:ELSEVIER SCIENCE BV  

    Web of Science

    researchmap

  • Rat Tumor Imaging with B-10 Carborane Gadolinium Complex. F. Girard, H. Nakamura, H. Fukuda, Y. Yamamoto, K, Yoshida

    Recent Advances in Biomedical Imaging, Ed. Y. Ishii et al., Elsevier Science   (), 201-207   1997

     More details

  • Synthesis of carboranes containing azulene framework using a new palladium catalyzed reaction

    Nakamura, H, Sekido, M, Yamamoto, Y, Larsson, B, Crawford, J, Weinreich, R

    Advances in Neutron Capture Therapy, Vols I and Ii   1132   B42 - B45   1997

     More details

    Language:English   Publisher:ELSEVIER SCIENCE BV  

    Web of Science

    researchmap

  • Netropsin and distamycin analogues bearing ortho-carborane

    Yamamoto, Y, Cai, JP, Nakamura, H, Sadayori, N, Nemoto, H, Mishima, Y

    Cancer Neutron Capture Therapy   (), 177-182   177 - 182   1996

     More details

    Language:English   Publisher:PLENUM PRESS DIV PLENUM PUBLISHING CORP  

    Web of Science

    researchmap

  • Synthesis of New 10B Carriers and Their Selective Uptake by Cancer Cells. Y. Yamamoto, H. Nemoto, H. Nakamura, S. Iwamoto in "Current Topics in the Chemistry of Boron", Ed. G. Kabalka

    The Royal Society of Chemistry   (), 149-154   1994

     More details

  • Synthesis of New 10B Carriers and Their Selective Uptake by Cancer Cells. Y. Yamamoto, H. Nemoto, H. Nakamura, S. Iwamoto in "Current Topics in the Chemistry of Boron

    Ed. G. Kabalka, The Royal Society of Chemistry   (), 149-154   1994

     More details

  • SYNTHESIS AND BIOLOGICAL PROPERTIES OF CARBORANYLAZIRIDINE

    YAMAMOTO, Y, NAKAMURA, H, NEMOTO, H, Soloway, AH, Barth, RF, Carpenter, DE

    Advances in Neutron Capture Therapy   (), 305-308   1993

     More details

  • Synthesis and Biological Properties of Carboranylaziridine. Y. Yamamoto, H. Nakamura, H. Nemoto

    Advances in Neutron Capture Therapy, Eds. A.H. Soloway, R.F. Barth, D.E. Carpenter, Plenum Press, New York   (), 305-308   1993

     More details

▼display all

Works

  • PEGを用いないリポソームの開発研究

    2005

     More details

  • ホウ素元素を導入した新しい医薬品の創製

    2003 - 2004

     More details

Awards

  • SPACC Award

    2022.12  

     More details

  • Asian Core Program Lectureship Award

    2018.11  

     More details

  • がん分子標的治療研究会奨励賞

    2007  

     More details

    Country:Japan

    researchmap

  • 日本化学会 進歩賞

    1999  

     More details

    Country:Japan

    researchmap

Research Projects

  • MRIプローブによる記憶形成メカニズムの解明

    Grant number:24K01643  2024.4 - 2027.3

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    岡田 智, 中村 浩之, 三浦 一輝

      More details

    Grant amount:\18590000 ( Direct Cost: \14300000 、 Indirect Cost:\4290000 )

    researchmap

  • Technology platform for clinical application of multi-targeted neutron capture therapy for brain tumors

    Grant number:23H03024  2023.4 - 2026.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Grant amount:\18720000 ( Direct Cost: \14400000 、 Indirect Cost:\4320000 )

    researchmap

  • Framework for Implementing Multi-Target Neutron Capture Therapy for Brain Tumors

    Grant number:23K27715  2023.4 - 2026.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Grant amount:\18720000 ( Direct Cost: \14400000 、 Indirect Cost:\4320000 )

    researchmap

  • Development of 3D skeleton compound library targeting protein-protein interaction

    Grant number:22K19104  2022.6 - 2024.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Research (Exploratory)

      More details

    Grant amount:\6370000 ( Direct Cost: \4900000 、 Indirect Cost:\1470000 )

    researchmap

  • 神経活動履歴を可視化する磁性ナノプローブの開発

    Grant number:22K19103  2022.6 - 2024.3

    日本学術振興会  科学研究費助成事業  挑戦的研究(萌芽)

    岡田 智, 中村 浩之, 三浦 一輝, 盛田 大輝

      More details

    Grant amount:\6500000 ( Direct Cost: \5000000 、 Indirect Cost:\1500000 )

    researchmap

  • 難治性悪性脳腫瘍の中性子捕捉療法薬剤の開発

    Grant number:22ym0126070h0001  2022.5 - 2024.3

    日本医療研究開発機構(AMED)  橋渡し研究プログラム 

    川端信司, 中井啓

      More details

    Authorship:Principal investigator 

    researchmap

  • Development of Endogenous Albumin-Based Novel Boron Delivery System

    Grant number:21H02066  2021.4 - 2025.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Grant amount:\17160000 ( Direct Cost: \13200000 、 Indirect Cost:\3960000 )

    researchmap

  • Development of Endogenous Albumin-Based Novel Boron Delivery System

    Grant number:23K21154  2021.4 - 2025.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Grant amount:\17160000 ( Direct Cost: \13200000 、 Indirect Cost:\3960000 )

    researchmap

  • 生活環境リスクを可視化する抗体センサーの開発

    2021

    科学技術振興機構  産学が連携した研究開発成果の展開 研究成果展開事業 研究成果最適展開支援プログラム(A-STEP) トライアウト トライアウトタイプ(標準) 

    中村 浩之

      More details

    Authorship:Principal investigator 

    新型コロナウイルスを始め、これまで存在しなかった病原性ウイルスを検出するデバイスを迅速に構築するしくみは、日本国内のみならず、世界中で喫緊に求められる技術である。申請者らは、すでに抗体の抗原認識部位への選択的迅速化学修飾法を確立し、抗体にセンサー機能を付与できることを明らかにしてきた。本提案では、この抗体センサー技術を基軸に、さらに申請者らが最近見出した新しいセンシング現象をデバイス機能に融合することで、抗体のセンシング能の高感度化技術を確立し、ウイルスのみならず生活環境を脅かすリスクファクターを可視化する高感度抗体センサーの開発を目指す。

    researchmap

    J-GLOBAL

  • Investigation of normal cell fraction in the liver triggering radiatino inudced liver disease

    Grant number:20K07994  2020.4 - 2023.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

      More details

    Grant amount:\3900000 ( Direct Cost: \3000000 、 Indirect Cost:\900000 )

    researchmap

  • Establishment of multi-target neutron capture therapy with multiple boron drugs for brain tumor

    Grant number:20H03797  2020.4 - 2023.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

      More details

    Grant amount:\17810000 ( Direct Cost: \13700000 、 Indirect Cost:\4110000 )

    researchmap

  • Investigation regarding the progress of therapeutic effect of BNCT using folate receptor-targeted boron compound which be administered by convection enhanced delivery

    Grant number:20K09399  2020.4 - 2023.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    researchmap

  • Development of photo labeling technology that enables analysis of intracellular protein-protein interaction

    Grant number:20H04699  2020.4 - 2022.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)  Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)

      More details

    Grant amount:\4940000 ( Direct Cost: \3800000 、 Indirect Cost:\1140000 )

    researchmap

  • BPA非感受性腫瘍の中性子捕捉療法適応拡大に向けた次世代ホウ素薬剤開発

    Grant number:20cm0106262h0002  2019.7 - 2021.3

    日本医療研究開発機構(AMED)  次世代がん医療創生研究事業(P-CREATE) 

    川端信司、中井啓

      More details

    Authorship:Principal investigator 

    researchmap

  • Boron distribution study for newly developed BNCT agents

    Grant number:19K08194  2019.4 - 2022.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Nakai Kei

      More details

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    1. Regarding the tumor growth inhibitory effect of intravascular boron, the non-leakage Liposome group showed almost the same tumor growth as the irradiation alone group, suggesting that boron in the blood contributes little to tumor growth inhibition even by neutron irradiation. This may be due to the fact that particle beams do not reach the vascular endothelium in blood vessels more proximal than capillaries, or the degree of damage is not strong enough to block blood flow.
    2. In the visualization of boron distribution using CR39, alpha rays generated in the range of 5-10 micrometers from the CR39 surface can be visualized in cells attached to CR39. Based on this result, it is considered possible to estimate the intracellular boron distribution.

    researchmap

  • Development of new small molecules for Met stimulator and building up foundations of medical application

    Grant number:18H02685  2018.4 - 2021.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    Shinomiya Nariyoshi

      More details

    Grant amount:\17420000 ( Direct Cost: \13400000 、 Indirect Cost:\4020000 )

    Met is a membrane receptor tyrosine kinase involved in liver regeneration and tissue repair. Based on the structures of the candidate low molecular weight compounds of Met stimulator obtained so far, we designed and synthesized new compounds with lower toxicity, and confirmed their Met stimulating activity on cells. In addition, through the investigation of the relationship between the molecular structure and Met stimulating activity, it was confirmed that the dimethyl-amino group in the side chain is important for the expression of activity. Currently, we are trying to further improve the structure from the viewpoint of in silico drug designing for practical use.

    researchmap

  • タンパク質夾雑空間解析を可能とする光触媒ー近接標識法の開発

    Grant number:18H04542  2018.4 - 2020.3

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    中村 浩之

      More details

    Grant amount:\5720000 ( Direct Cost: \4400000 、 Indirect Cost:\1320000 )

    平成31年度は細胞内でのPPI解析を可能にするタンパク質ラベル化法の開発を行った。本研究では、タンパク質と共有結合を形成するラベル化剤のラジカル特性の制御が鍵となる。PPI解析を可能にするラベル化剤に求められる性能として、有機光触媒でラジカル化できること、触媒周辺数十nmでのラベル化が可能なことが求められる。すでに、APEX法でも使用されるtyramide以外にも、細胞外のモデル実験の系で、tyramideのラベル化効率を上回る数種類のラベル化剤を見出しており、それぞれのラジカル活性種は異なるラベル化有効距離を持つことも示唆されている。
    まず、我々が開発したラベル化剤MAUraをはじめN-Methylluminol誘導体にビオチンを結合させた分子をそれぞれ合成した。次に、リガンドに結合する複数の標的タンパク質を網羅的に修飾する手法を開発した。本手法を用いて糖鎖リガンド・レクチンに結合する複数のタンパク質を修飾、二次元電気泳動による解析を行ったところ、複数の標的タンパク質を一挙にラベル化することに成功した。これらのラベル化タンパク質のうち、既知のPPIパートナーのラベル化の検証はウエスタンブロットで確認し、未知のものについては酵素消化後、質量分析による網羅的解析を行ったところ、細胞内に非常に低い濃度で発現しているgalectin-1およびgalectin-3を同定することに成功した。このように、レクチンと非常に弱い親和力(Kd = ~10*3)を持つタンパク質を同定できる技術を構築できたことは非常に高く評価されている。

    researchmap

  • Development of Highly Functionalized Serum Albumins as Boron Delivery Carries to Tumor for Neutron Capture Therapy

    Grant number:17H02202  2017.4 - 2021.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    Nakamura Hiroyuki

      More details

    Grant amount:\17160000 ( Direct Cost: \13200000 、 Indirect Cost:\3960000 )

    Boron neutron capture therapy (BNCT) has been approved in Japan in March 2020 as the world's first treatment for head and neck tumors by combining the boron agent BPA with an accelerator neutron source. In this study, we focused on human serum albumin (HSA) as a boron carrier to apply BNCT to patients with BPA-insensitive cancers.
    In order to achieve high boron accumulation in tumors, we focused on integrins, which are highly expressed on the surface of many tumor cells, and developed boronated albumin cRGD-HSA-MID with tumor targeting function. cRGD-HSA-MID showed high accumulation against human brain tumor U87MG cells, which are BPA-insensitive and high integrin expressing cells, and high BNCT anti-tumor effect was observed in the U87MG brain tumor Xenograft model.

    researchmap

  • Usefulness of a super selective arterial infusion therapy of a novel boronated porphyrin for BNCT and PDT

    Grant number:17K16666  2017.4 - 2019.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)  Grant-in-Aid for Young Scientists (B)

    Hiramatsu Ryo, Ono Koji, Kirihata Mitsunori, Miyatake Shin-Ichi, Nakamura Hiroyuki, Kawabata Shinji, Furuse Motomasa, Nonoguchi Naosuke, Ikeda Naokado

      More details

    Grant amount:\4030000 ( Direct Cost: \3100000 、 Indirect Cost:\930000 )

    We used BNH2-PpIX via CED and carotid arterial infusion therapy in combination with the disruption of BBB. The boron concentrations following CED of BNH2-PpIX to the F98 rat glioma-bearing brain tumor models at 24 h after termination of CED were also observed at different BNH2-PpIX doses (0.125, 0.25, and 0.5 mg BNH2-PpIX /rat). The tumor boron concentrations showed the highest concentrations at a dose of 0.25 mg BNH2-PpIX /rat; the boron concentrations at a dose of 0.125, 0.25, and 0.5 mg BNH2-PpIX /rat were 4.09 ± 0.56, 20.21 ± 8.05, and 17.76 ± 11.71 20μg10B/g, respectively. But the boron concentrations following carotid arterial infusion therapy could not showed the highest concentration. Additionally, we were cut off the supply of boronated porphyrins from the research collaborators. So, we could not showed the efficacy of BNH2-PpIX of carotid arterial infusion therapy in combination with the disruption of BBB, as a DDC, during this study period.

    researchmap

  • Construction of dynamic prediction model of EGFR tyrosine kinase inhibitors efficacy for mutated EGFR based on protein three-dimensional structure analysis

    Grant number:15K08652  2015.4 - 2019.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Ohnishi Hiroaki

      More details

    Grant amount:\4940000 ( Direct Cost: \3800000 、 Indirect Cost:\1140000 )

    Non-small cell lung cancer(NSCLC) patients harboring the epidermal growth factor receptor (EGFR) mutations benefit from therapies by the EGFR tyrosine kinase inhibitors (TKIs). We developed a new dynamic prediction model of TKIs efficacy using computed simulation of binding of mutated EGFR protein and TKIs. We were able to correctly predict the responsiveness of various TKIs to NSCLC with EGFR mutation. Especially, this computer dynamic simulation calculates that third generation EGFR TKIs will be more effective than 1st and 2nd generation EGFR TKIs. It was also predictable that most TKIs are not effective against the rare V843I+L858R mutant. Our new model is very promising for appropriate selection of various existing TKIs for various EGFR mutants as well as discovery of new TKIs by application of dynamic molecular simulation technology.

    researchmap

  • Investigation of effects of boron neutron capture therapy (BNCT) on normal tissues

    Grant number:26293275  2014.4 - 2018.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    Suzuki Minoru

      More details

    Grant amount:\16640000 ( Direct Cost: \12800000 、 Indirect Cost:\3840000 )

    Investigation of the effects of boron neutron capture therapy (BNCT) on normal lung and liver was carried out for expanding of applicaiton of BNCT for body trunk cancers, such as lung cancer or liver cancers. Since the research reactor had stopped for long period, the experiments with neutron irradiaition had done during five months in the last year. In the research of the effects of BNCT on normal lung, X-ray and BNCT irradiations to the whole lung were carried out. A incidence of death on radiation pneumonitis is under observation. In the research of the effects of BNCT on normal liver, the fatty hepatocytes in the livers one week after BNCT irradiation were analyzed since the fatty hepatocytes were reported to couse lately liver fibrosis. The amount of trigricerid correlated with neutron fluence. This method is promissing way of evaluation of BNCT-induced liver fibrosis

    researchmap

  • Development of Boronated Cholesterols and their Highly Functionalized Nano Carriers for New Generation Neutron Capture Therapy

    Grant number:26293007  2014.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    Nakamura Hiroyuki

      More details

    Grant amount:\17030000 ( Direct Cost: \13100000 、 Indirect Cost:\3930000 )

    Boronated cholesterols were successfully synthesized. Using these cholesterol, high content boron liposomes were developed for new generation neutron capture therapy. A counter cation of boron ion clusters (closo-dodecaborates) was found to be essential for the encapsulation efficacy of boronated liposomes: a sperimidinium form of closo-dodecaborates was highly encapsulated into liposomes prepared from phospholipids. Furthermore, boron imaging technologies in the cells have been developed using a combination of in cell click fluorescent imaging technique and Raman imaging technology.
    Biopolymer-based boron delivery system was also developed for selective and efficient delivery of boron to tumor in vivo based on the EPR effect. Maleimide-closo-dodecaborate (MID) was successfully synthesized. MID conjugated not only a free SH group of cysteine residues but also lysine residues in proteins and its serum albumin conjugates were found to be accumulated into tumor selectively.

    researchmap

  • Analysis of pathophysiology of brain radiation necrosis and establishment of novel treatment strategy

    Grant number:26293327  2014.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    Miyatake Shin-Ichi

      More details

    Grant amount:\15990000 ( Direct Cost: \12300000 、 Indirect Cost:\3690000 )

    1)Establishment of model rat and mouse of radiation necrosis in the brain:Wister rats were irradiated with 65 Gy X-ray. Five to 6 months after X-ray irradiation brain radiation necrosis was confirmed almost all rats by MRI and autopsy specimen.To establish smaller sized model, mice were irradiated with 70MeV proton with 60Gy-equivalent. The irradiated mice were treated with 2 different kinds of HIF-1 inhibitors (YC-1 and GN44028). Now these mice were observed with periodic MRI. Another couple of months will be mandatory to elucidate some conclusions.
    2)Seven recurrent malignant glioma patients were treated with boron neutron capture therapy with the simultaneous use of bevacizumab to prevent the occurrence of symptomatic radiation necrosis. All cases showed favorable prolongation of overall survival without radiation necrosis.

    researchmap

  • リガンド結合型光触媒を用いた生体内標的タンパクノックダウン法の開発

    Grant number:26102721  2014.4 - 2016.3

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    中村 浩之

      More details

    Grant amount:\5850000 ( Direct Cost: \4500000 、 Indirect Cost:\1350000 )

    26年度の研究成果において、生体環境調和性の高い光触媒、Ru(bpy)3で一電子酸化反応を誘起することによってペプチドやタンパク質が分解すること、ペプチド分解にはアミノ酸配列に依存性があることを見出した。そこで、平成27年度にかけて、細胞内に送達されて機能するタンパク質分解光触媒を開発すべく、標的へのリガンドを連結した触媒の合成、細胞内標的タンパク質の発現量変化の解析を行った。
    標的タンパク質として、上皮細胞増殖因子チロシンキナーゼ(EGFR-TK)を選択し、そのリガンドとしてアニリノキナゾリン骨格を有するイレッサを選択し、イレッサにRu(boy)3を結合させたリガンド結合型光触媒を分子設計し、その合成に成功した。この光触媒を用いて、EGFR-TKに対する標的タンパク質ノックダウン実験を行った。N,N-dimethylamino-N’-acyl phenylenediamine(TRT)の非存在下では、リガンド連結型のRu(bpy)3光触媒は一重項酸素の生成による酸化的なタンパク質ノックダウンを誘導することを見出した。一方で、同化合物存在下では、その反応は抑制されつつ、チロシン残基上でのタンパク質ラベル化反応が進行した。また、細胞内のタンパク質を標的にした実験系においても、標的のタンパク質ノックダウンとラベル化反応を外部刺激により制御できることが分かった。

    researchmap

  • DDS型次世代中性子捕捉療法

    2013

    産学が連携した研究開発成果の展開 研究成果展開事業 研究成果最適展開支援プログラム(A-STEP) 探索タイプ 

    中村 浩之

      More details

    BNCTは、低エネルギーである熱・熱外中性子がホウ素との核反応により生ずる強力な粒子線を用いるものであり、がん部位へホウ素デリバリーと中性子線のダブルターゲティングが可能であることから、低毒性のホウ素化合物を用いるため化学療法のような重篤な副作用はなく、また放射線療法のような照射場内の正常組織へのダメージもきわめて低い治療法で治療後の患者への負担が極めて小さい特徴をもつ。 BNCTでは、如何にがん細胞のみ選択的にかつ効果的濃度でホウ素薬剤を送り込むかがその治療効果のカギとなる。現在治験に用いられているBPAは、個々の患者によって腫瘍選択性が異なるだけでなく、血中滞留性が低いため腫瘍からのクリアランスが非常に速く、薬剤投与を継続し血中ホウ素濃度を持続させながら中性子照射を行う必要がある。本研究では、BNCTのためのホウ素デリバリーシステムを開発するものであり、ホウ素薬剤の血中滞留性を高めるだけでなく、BPA非感受性がん患者に対するBNCT適応疾患拡大を実現するものである。本申請者は、リポソームの二分子膜を形成している生体リン脂質の構造に着目し、世界で初めてホウ素脂質の合成に成功し、ホウ素二分子膜からなるリポソームの開発に成功している(特許第4972352号)。一方で、本申請者は非常に安定かつ高濃度でリポソームにホウ素薬剤を内封できる技術を既に開発している(特願2011-128379)。その結果、調製可能リポソーム製剤はホウ素濃度10,000ppmまで飛躍的に高濃度化することに成功している。 本研究では、これまでに開発したホウ素脂質と内封ホウ素薬剤の2つの特許技術を集結し、ホウ素高集積化リポソーム製剤を開発する。具体的には、皮下腫瘍移植マウスを用いて、腫瘍内集積性および中性子照射による治癒効果を照射後2ヶ月間観察する。具体的目標として、照射2週間後の腫瘍の消失ならびに60日以上の延命効果を80%以上のマウスで達成する。本研究提案は、COIビジョン「少子高齢化先進国としての持続性確保:Smart Life Care、Ageless Society」の実現に大きく貢献するものである。

    researchmap

    J-GLOBAL

  • Basic measurement of biomembranes: characterization as two-dimensional reaction field

    Grant number:24350012  2012.4 - 2015.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    IWATA Koichi, TAKAYA Tomohisa, NAKAMURA Hiroyuki, NOJIMA Yuki, MOHRI Goh, KITAMURA Sho

      More details

    Grant amount:\18720000 ( Direct Cost: \14400000 、 Indirect Cost:\4320000 )

    We examine lipid bilayer membranes as a field of chemical reactions, by estimating their thermal diffusivity, viscosity, and polarity, with time-resolved spectroscopies. Picosecond time-resolved Raman spectroscopy of trans-stilbene solubilized in lipid bilayer membranes reveals that the rate of energy transfer changes when the phospholipid that forms the lipid bilayer or the temperature changes. Picosecond time-resolved fluorescence spectroscopy indicates that there are two environments with viscosity different by 30 to 290 times in the lipid bilayer membranes. We have developed new phospholipids by introducing fluorophores into phosphatidylcholines for examining the properties of lipid bilayer membranes at a fixed depth.

    researchmap

  • 天然物とホウ素クラスターのハイブリッド分子プローブ開発とがんの低酸素応答機構解明

    Grant number:24102526  2012.4 - 2015.3

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    中村 浩之

      More details

    Grant amount:\6890000 ( Direct Cost: \5300000 、 Indirect Cost:\1590000 )

    (1)エトポシドトリエン誘導体が有する熱ショックタンパク60(HSP60)シャペロン阻害活性を模倣したホウ素クラスター分子の設計と合成・活性評価
    本申請者は、すでにHIF-1α タンパクの安定化機構を阻害するホウ素クラスター含有化合物の開発に成功しており、その分子標的タンパク質がHSP60であることを明らかにしている。一方、HSP60のシャペロン活性阻害化合物としてエトポシドトリエン誘導体であるETBが唯一報告されている。そこで、本研究では、本申請者が既に開発したホウ素クラスター含有化合物のHSP60のシャペロン活性阻害活性について、その評価系を構築して調べた。さらに、構造活性相関を行い、更に活性の高い化合物を見い出した。
    (2)三環縮環系複素環骨格を有するHIF-1転写阻害剤開発とその作用機序解明
    本申請者は、三環縮環系複素環骨格を有するインデノピラゾール誘導体が低酸素環境下において誘導されるHIF-1αの転写活性を阻害することを見出した。そこで、インデノピラゾール誘導体の活性相関を検討し非天然型HIF-1阻害剤として、もっとも高い活性を有する化合物を見い出すとともに、その誘導体のケミカルプローブ化を検討した。合成したケミカルプローブを用いて、その結合タンパクをインゲル消化法を用いて標的タンパク質同定を試みたが、同定は出来なかった。一方、構造活性相関研究の過程で、非常に高い細胞増殖抑制を示すインデノピラゾール誘導体を見出した。そこで、理化学研究所の長田研究室で開発されたMorphoBase プロファイリング法ならびにChemProteoBase プロファイリング法を用いて、同研究グループの川谷氏と共同研究により、標的タンパク質の探索を行った。その結果、このインデノピラゾール誘導体の標的タンパク質がチューブリンであることを突き止め、チューブリン重合を阻害することによって、高い細胞増殖阻害を示すことを明らかにした。

    researchmap

  • Development of Boron Delivery System for Neutron Capture Therapy as a Minimally Invasive Cancer Therapy

    Grant number:23390013  2011.4 - 2015.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    NAKAMURA Hiroyuki, SATO Shinichi, SUZUKI Minoru, BAN Hyun Seung

      More details

    Grant amount:\18590000 ( Direct Cost: \14300000 、 Indirect Cost:\4290000 )

    Boron neutron capture therapy (BNCT) is based on the capture reaction of thermal neutrons and nonradioactive 10B, which produces an α-particle and a lithium-7 nuclei ion with approximately 2.4 MeV. We developed the liposomes with high boron contents as efficient boron delivery vehicles for BNCT. We optimized DSBL contents in the liposome preparation and found that 10% DSBL liposome is stable in blood circulation. Furthermore, we succeeded in encapsulation of BSH into the vacant inner of the 10% DSBL liposomes, producing the liposomes with high boron contents. We examined boron biodistribution in the tumor-bearing mice by injection of BSH-encapsulating DSBL liposomes via the tail vein. High boron accumulation was observed in the tumor tissue 36 h after injection of the liposomes. Significant tumor growth suppression was observed in the boron-loaded mice after neutron irradiation.

    researchmap

  • Discovery of innovative molecular targeted drugs based on Cancer Cell Informatics

    Grant number:22240092  2010 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (A)  Grant-in-Aid for Scientific Research (A)

    YAMORI Takao, DAN Shingo, KAWADA Manabu, NAKAMURA Hiroyuki, SHIINA Isamu, KOJIMA Naoto, HIRONO Syuichi

      More details

    Grant amount:\50440000 ( Direct Cost: \38800000 、 Indirect Cost:\11640000 )

    We improved Cancer Cell Informatics that we originally developed to discover new anticancer drugs, and found a novel anticancer compound AMF-26. It destroyed Golgi apparatus, which controls membrane traffic, and inhibit the growth of cancer cells. AMF-26 induced complete regression of BSY-1 human breast cancer xenograft in nude mice by oral administration. Its toxicity was weak and recoverable. Therefore, AMF-26 is a promising novel anticancer drug candidate targeting Golgi apparatus

    researchmap

  • Boron uptake enhancement by redox control in boron neutron capture therapy

    Grant number:22591605  2010 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    YOSHIDA Fumiyo, YAMAMOTO Tetsuya, NAKAI Kei, NAKAMURA Hiroyuki

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    In the previous study, we reported that combined use of sodium borocaptate (BSH) and buthionine sulfoximine (BSO) in BNCT enhanced tissue boron uptake in the rat subcutaneous tumor model, where BSO and BSH were administered simultaneously. In the present study, we used a brain tumor model, and rats were pretreated with BSO before BSH injection. By this method, the blood boron concentration was about 20 times higher in comparison with the BSO- (minus) group, and in other tissues (brain tumor, subcutaneous tumor, muscles, liver, kidney) the same tendency of increasing concentration was observed. We suggest that tumor-specific redox regulatory mechanisms are necessary to enhance tumor uptake of boron.

    researchmap

  • Development of HIF inhibitor as anti-angiogenic agents

    Grant number:22790113  2010 - 2011

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)  Grant-in-Aid for Young Scientists (B)

    BAN Hyunseung, NAKAMURA Hiroyuki

      More details

    Grant amount:\4030000 ( Direct Cost: \3100000 、 Indirect Cost:\930000 )

    In this research, we developed HIF inhibitors as anti-angiogenic agents and clarified the mechanism of action. We found that compound GN26361 suppressed HIF-1αprotein level via inhibition of HSP60 under hypoxic conditions.

    researchmap

  • 炭素-窒素結合活性化による高度分子変換反応の開発

    Grant number:09F09240  2009 - 2011

    日本学術振興会  科学研究費助成事業 特別研究員奨励費  特別研究員奨励費

    中村 浩之, KIM Y., KIM Yongeun

      More details

    Grant amount:\2000000 ( Direct Cost: \2000000 )

    本研究では、炭素窒素結合活性化による高度分子変換反応の開発を目的とし、医薬中間体合成への効率的合成手法の確立を目的に研究を進めている。
    23年度は、22年度に見出した銅触媒を用いたプロパルギルアミンの脱アセチレン化カップリング反応のスコープとリミテーションについて検討した。従来、銅触媒を用いるアセチレンの反応では、末端アセチレンの場合、ジメチルアミノピリジンのような塩基存在下、末端アセチレン同士のホモカップリング反応が進行することが知られている。しかしながら、プロパルギルアミンにおいては、ジメチルアミノピリジン存在下では、同様のホモカップリング反応が進行するのに対し、塩基非存在下では、一方のプロパルギルアミンからアセチレンが脱離し得られたイミニウムイオンに対し、もう一つのプロパルギルアミンが求核付加反応し、対称1,4-ジアミノ-2-ブチン誘導体が得られることを見出した。一般的な対称1,4-ジアミノ-2-ブチン誘導体の合成法は、ほとんど確立されていないことから、本手法は有機合成において医薬品中間体合成などに応用できる簡便かつ重要な合成法となることが期待される。さらに、銅触媒存在下、プロパルギルアミンと様々な末端アセチレンの脱アセチレン化を伴うカップリング反応が高収率で進行することを見出した。従来、炭素-炭素シグマ結合の切断は容易ではないが、本反応条件下では容易に切断され、アセチレン交換反応が進行した。この新しい反応は、有機合成化学において新しい領域を切り開くトリガーになると考えられる。

    researchmap

  • 中性子捕捉治療のためのがん標的ホウ素ポルフィリンの開発

    Grant number:08F08363  2008 - 2010

    日本学術振興会  科学研究費助成事業 特別研究員奨励費  特別研究員奨励費

    中村 浩之, EI-ZARIA M.E., EL-ZARIA M.E., EL-ZARIA M. E.

      More details

    Grant amount:\1900000 ( Direct Cost: \1900000 )

    ホウ素中性子捕捉療法(BNCT)は脳腫瘍および皮膚がんの治療に用いられてきたが、最近頭頸がんの治療にも成功しその応用範囲の拡大が注目されている。現在わが国では、小型加速器の開発が進んでおり、これまでの原子炉依存型から病院併設型BNCTの実現が近い将来可能となってきている。本研究では、ポルフィリンの腫瘍親和性と光感受性に着目し、ポルフィリンにホウ素イオンクラスターを導入したホウ素キャリアーを新たに開発し、BNCTと光線力学療法(PDT)の組み合わせによる本治療法の適応拡大を目的とした。21年度に開発に成功したホウ素イオンクラスター含有ポルフィリンのヒト子宮がん細胞HeLaに対する毒性をMTT法で調べた結果、本研究で合成した化合物が既知のカルボラン含有ポルフィリンBOPPより低毒性を示した。細胞内へのホウ素取り込みはBOPPに比べて約5倍亢進した。さらに、HeLa細胞において光線力学的治療効果を解析した結果、IC_<50>=0.21μMとBOPP(IC_<50>=4.83μM)より23倍強い活性を示した。これらの結果から、化合物11は低毒性で高い細胞内取り込み活性及び光線力学治療効果を有することが明らかになり、BNCTとPDTのコンビネーションセラピーに有用である可能性が示唆された。さらに、アセチレン部位を有するホウ素イオンクラスターと様々な有機アジドの銅触媒を用いるクリック付加環化反応に成功した。この手法により、様々なホウ素イオンクラスター有機化合物の合成が容易に行えることができた。例えば、細胞膜を形成するリン脂質を模倣したホウ素脂質の開発にも成功した。

    researchmap

  • 中性子捕捉治療のための次世代DDS型ホウ素ナノカプセルの開発

    Grant number:20015041  2008 - 2009

    日本学術振興会  科学研究費助成事業 特定領域研究  特定領域研究

    中村 浩之, 潘 鉉承

      More details

    Grant amount:\10200000 ( Direct Cost: \10200000 )

    本年度は、21年度までに明らかにしてきたホウ素ナノカプセルの生体内挙動および各臓器内ホウ素蓄積濃度の時間依存的な変化に関するデータを基に、22年度では、研究計画期間内に実験が行えなかった原子炉での中性子照射実験を中心に行った。本研究期間を含め過去3年間日本原子力研究機構の原子炉(JRR4)ならびに京都大学原子炉実験所の原子炉(KUR)が燃料などの運搬および燃料棒の不具合の問題からいずれも稼働してなかったが、22年6月より稼働したことから主に腫瘍移植マウスを用いたモデル動物への中性子照射実験を行った。その結果、非常に高い抗腫瘍効果が得られた。ホウ素ナノカプセルを100mg/kg,30mg/kgのホウ素濃度で投与したマウスだけでなく、15mg/kg投与したマウスでも、ほぼ100%の中性子照射マウスで、腫瘍の委縮が1週間後に見られ、照射2週間後には、腫瘍が完全に消失した。また、21年度に開発に成功したホウ素ナノカプセルに修飾できるよう長鎖炭素鎖を導入したプロトポルフィリンIX(PP9)を用いて、ホウ素ナノデバイス化に行い、腫瘍移植マウスを用いたモデル動物への半導体レーザーを用いた光線力学療法を行ったところ、非常に高い抗腫瘍効果が得られた。さらに、このプロトポルフィリン融合ホウ素ナノデバイスを用いて、中性子捕捉治療効果を検討したところ、非常に高い抗腫瘍効果が得られた。本研究成果は、光線力学療法(PDT)と中性子捕捉療法の複合治療を動物レベルで初めて成功したものであり、この複合療法の有用性を示した初めての研究例である。今後、実用化に向けた検討を進めたい。

    researchmap

  • 炭素―窒素結合の活性化に基づく触媒的分子変換法の開発

    Grant number:19020063  2007 - 2009

    日本学術振興会  科学研究費助成事業 特定領域研究  特定領域研究

    中村 浩之

      More details

    Grant amount:\4200000 ( Direct Cost: \4200000 )

    本研究では遷移金属触媒を用いるヒドリド転移反応を利用して、中性条件下でC-N結合の活性化に基づく高度分子変換法の開発を目的とし研究を行ってきた。平成20年10月にC-N結合の活性化に基づく高度分子変換反応の有機合成への応用の研究過程において"がんの増殖シグナル"を非常に強く、また非可逆的に阻害する有機化合物を偶然発見した。平成21年度は、以下の2つに関して研究を進めた。
    (1) 本プロパルギルアミンの変換反応を利用し、アニリノキナゾリン骨格に導入することで、アレン化合物への変換が容易に行えることを見出した。In vitro上皮細胞増殖因子受容体チロシンキナーゼ阻害活性試験を行った結果、既存の化合物より活性保持時間が長いことを見出した。これにより、アレン部位に基づく非可逆的相互作用の可能性を見出した。本成果は、「Enhancement of EGFR Tyrosine Kinase Inhibition by C-C Multiple Bonds-Containing Anilinoquinazolines」という題で国際ジャーナル「Bioorg. Med. Chem.」に報告した。
    (2) 銅触媒を用いて、プロパルギルアミンの炭素-炭素結合活性化を伴うアルデヒド、第2級アミンとの3成分交換法を検討した。その研究途上で、新たにアセチレン化合物を加えることで、炭素一炭素切断反応を伴うアセチレン置換反応を見出した。本成果は「Copper(I)-Catalyzed Substitution Reactions of Propargylic Amines : Importance of Csp-Csp3 Bond Cleavage in Generation of Iminium Intermediates」という題でアメリカ化学会誌「J. Am. Chem. Soc.」に報告した。

    researchmap

  • Development of Tyrosine Kinase Inhibitors Based on the Structures of Target Protein

    Grant number:18350090  2006 - 2008

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    NAKAMURA Hiroyuki, BAN Hyonsun, NABEYAMA Wataru

      More details

    Grant amount:\14490000 ( Direct Cost: \12600000 、 Indirect Cost:\1890000 )

    researchmap

  • パラジウム触媒を用いたヒドリド転移型アレン変換反応の開発と応用

    Grant number:18037066  2006

    日本学術振興会  科学研究費助成事業 特定領域研究  特定領域研究

    中村 浩之

      More details

    Grant amount:\2200000 ( Direct Cost: \2200000 )

    アレン化合物はその炭素-炭素二重結合の特異な反応性から有機合成上重要なビルディングブロックの1つとして注目されている。一般に、アレン化合物はプロパルギルエステル誘導体と有機銅試薬のS_N2'反応により合成される。しかし、この従来法は低温条件でカルバニオンを発生させる必要があることから、その置換基には制限がある。我々は、様々な有機ハライドに対しアレニル基導入が行えるより一般的な汎用性の高い分子変換反応の開発を目指して、研究を進めてきた結果、プロパルギルアミンがパラジウム触媒下、アレンに変換されることを見出した。本反応では、窒素に隣接するC-Hσ結合にパラジウムが酸化的付加し、生成したヒドリドが炭素-炭素三重結合へS_N2'反応することでアレン化合物に変換されるため、プロパルギルアミンをアレン等価体として扱うことができ、様々な有機ハライドに対して園頭反応を利用してプロパルギルアミンを導入後、アレン変換できる非常に汎用性の高い分子変換反応である。しかしながら、本反応では園頭反応とアレン変換反応の2段階反応が必要であった。そこで、本特定領域研究(平成18年度)公募研究では、様々な有機ハライドに対して直接アレニル基を導入できる高度分子変換反応を検討した。我々は高度に電子不足ホウ素クラスターであるカルボラン骨格に注目し、新たにカルボラン含有二座型電子不足りん配位子をジリチオ化オルトカルボランから合成し反応を検討したところ、それぞれアレン化合物のみを60〜99%の収率で得ることに成功した。

    researchmap

  • 次世代DDS型悪性腫瘍治療システムの開発

    2005 - 2007

    新エネルギー技術研究開発費 

      More details

    Grant type:Competitive

    researchmap

  • ホウ素元素の特性を活かした創薬研究と中性子捕捉治療への応用

    Grant number:05F05141  2005 - 2006

    日本学術振興会  科学研究費助成事業 特別研究員奨励費  特別研究員奨励費

    中村 浩之, LEE Jong Dae

      More details

    Grant amount:\2400000 ( Direct Cost: \2400000 )

    中性子照射によって薬物キャリアーからの薬物放出を制御するためのDDS開発を目的として、ホウ素デリバリーシステムを開発した。具体的には、生体膜構成脂質の1つであるホスファチジルコリンの構造に着目して、現在臨床に用いられている低毒性ホウ素イオンクラスター(BSH)を水溶性部位に導入し分子設計した同じ不斉炭素立体構造を有するミリストイル型(C14)、パルミトイル型(C16)、ステアロイル型(C18)のそれぞれエステルリンカー型(DMBL, DPBL, DSBL)、カーバメイトリンカー型(DMCBL, DPCBL, DSCBL)の6種類の光学活性なホウ素含有脂質の合成に成功した。また、ホウ素コレステロールに関してもエステルリンカー型、カーバメイトリンカー型の2種類の合成に成功し、これらを含む粒子径100nmのリポソームを構築した。このリポソームにはポリエチレングリコール(PEG)を修飾し、生体血管内でのステルス性の向上を狙った。リポソームの安定性試験を実施し、ホウ素脂質の至適量を決定した。
    細胞レベルでの新たな評価系の開発を目的として、ハイスループットスクリーニング法を中性子照射実験系で初めて行えるシステム「Cyborg488」を開発した。このシステムでは、96ウェル細胞プレートをMTTアッセイ法を組み合わせたもので、1回の照射に約500検体を評価することが出来る。30分ホウ素リポソームとcolon26マウス大腸がん細胞を接触させた後、細胞培地を交換し、ホウ素薬剤が培地に存在しない状態で約1時間培養後、30分の中性子照射を行った。アッセイ結果を図2に示す。パルミトイル型ホウ素脂質(DPBL、DPCBL)ならびにステアリル型ホウ素脂質(DSBL)を用いたホウ素PEGリポソームで高い細胞成長阻害活性を示すことを見出した。

    researchmap

  • 酵素阻害剤の開発

    2004 - 2005

    科学研究費補助金 

      More details

    Grant type:Competitive

    researchmap

  • ホウ素元素の特性を活かしたチロシンキナーゼ阻害分子の開発

    Grant number:16685017  2004 - 2005

    日本学術振興会  科学研究費助成事業 若手研究(A)  若手研究(A)

    中村 浩之

      More details

    Grant amount:\11960000 ( Direct Cost: \9200000 、 Indirect Cost:\2760000 )

    細胞分裂が異常に活発である悪性腫瘍では様々な増殖因子とその受容体が大量に産生されている。本研究では、その中でも近年注目されている上皮細胞増殖因子受容体(EGFR)チロシンキナーゼ阻害剤および血管増殖因子受容体(VEFGR)チロシンキナーゼ阻害剤の開発を行った。Quinazoline誘導体はこれまで報告されているEGFRチロシンキナー阻害分子の中で最も阻害活性の高い分子であり、2002年に認可された薬剤Iressa^<TM>も本誘導体の1つである。EGFR-チロシンキナーゼ阻害活性を有するQuinazoline骨格の側鎖部位は、標的タンパク酵素活性部位へのもう一つの重要な作用部位であることから、この側鎖部位にホウ酸基を導入することでirreversibleな阻害活性剤の開発を行った。合成したホウ素化合物群からIressaよりもEGFRチロシンキナーゼ阻害が高い化合物を見出した(IC_<50>=18nM)。また細胞成長阻害活性評価では、GI_<50>がA-431細胞で20μM、B-16で11μM、SKBR3細胞で7.2μM、KATOIII細胞で6.6μMであることが分かった。また、aniline部位にホウ素を導入した化合物はVEGFR2チロシンキナーゼに対し高い阻害能を有することがわかり、その阻害活性はAAL993と同等であった。AAL993はanthranilamide骨格を有するが、本研究においてamidine骨格を新たに導入しその構造活性相関を検討した。その結果、AAL993はVEGFR1およびVEGFR2チロシンキナーゼに対し同等の阻害活性を有するのに対し、類縁体であるanthranilamidineおよびsalicylamide化合物はVEGFR2チロシンキナーゼに対して特異的に阻害作用を有することが分かった。

    researchmap

  • ホウ素中性子捕捉療法のための有機化学的アプローチ

    Grant number:12217015  2000

    日本学術振興会  科学研究費助成事業 特定領域研究(C)  特定領域研究(C)

    中村 浩之

      More details

    Grant amount:\4900000 ( Direct Cost: \4900000 )

    researchmap

  • 求核的不斉ビス-π-アリルパラジウム触媒反応の開発

    Grant number:11740398  1999 - 2000

    日本学術振興会  科学研究費助成事業 奨励研究(A)  奨励研究(A)

    中村 浩之

      More details

    Grant amount:\2300000 ( Direct Cost: \2300000 )

    アルカロイド、ペプチド、β-ラクタムをはじめとする含窒素化合物の中には、有用な生理活性を有するものが多い。その多くは光学活性化合物であり、これらの化合物の合成には光学活性アミノ化合物が有用な中間体となる。アリルスズのイミンへの付加反応は、これらの有機合成における非常に重要な反応の一つである。本申請者はこの反応がパラジウム触媒下で進行し、その反応活性中間体が求核的ビスーπ-アリルパラジウムであることを明かにしている。本研究では、この求核的性質を持つビス-π-アリルパラジウム錯体の一方に不斉源として、ピネン由来のπ-アリル基を導入することにより、これまで困難であったイミンへの触媒的不斉アリル化反応に初めて成功した。このように、求核的性質を持つビス-π-アリルパラジウム錯体の非対称なアリル基の反応性を制御し、その一方のアリル基にイミンの不斉面の認識をさせることにより、光学活性なホモリルアミンの選択的不斉合成が可能となった。さらに、不斉面の認識部位であるアリル基を高分子ポリマーに結合させることにより、容易に回収可能な触媒の開発に成功した。

    researchmap

  • 求核的不斉π-アリルパラジウム触媒の設計とイミンへの触媒的不斉アリル化反応の開発

    Grant number:10874105  1998 - 1999

    日本学術振興会  科学研究費助成事業 萌芽的研究  萌芽的研究

    山本 嘉則, 中村 浩之

      More details

    Grant amount:\2100000 ( Direct Cost: \2100000 )

    アリルスズのアルデヒドおよびイミンへの付加反応は、有機合成における非常に重要な反応の一つである。本申請者はこの反応が、パラジウム及び白金触媒下で進行し、その反応活性中間体が求核的ビスーπーアリルパラジウムであることを明かにしている。
    本研究では、この求核的性質を持つビスーπーアリルパラジウム錯体の一方に不斉源として、ピネン由来のπーアリル基を導入することにより、これまで困難であったイミンへの触媒的不斉アリル化反応に初めて成功した。このように、求核的性質を持つビスーπーアリルパラジウム錯体の非対称なアリル基の反応性を制御し、その一方のアリル基にイミンの不斉面の認識をさせることにより、光学活性なホモリルアミンの選択的不斉合成が可能となった。さらに、不斉面の認識部位であるアリル基を高分子ポリマーに結合させることにより、容易に回収可能な触媒の開発に成功した。

    researchmap

  • Synthesis and Application of Carborane Containing MR Imaging Agent

    Grant number:09554034  1997 - 1999

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    YAMAMOTO Yoshinori, NAKAMURA Hiroyuki

      More details

    Grant amount:\11800000 ( Direct Cost: \11800000 )

    In order to improve and optimize efficient neutron capture therapy (NCT) treatment, it is necessary to follow the distribution of a carrier in the body in real time. However, it has been difficult to estimate the boron content of the tumor using technologies available. We succeeded to synthesize the carborane containing gadolinium-dimethylenetriamine pentaacetic acid (DTPA) unit which is commercially available under the trade name of Magnevist and is used as an MR imaging contrast medium. The evaluation of the Gd-carborane complex as an MR imaging and boron carrier agent was carried out in vivo using tumor-bearing Donryu rats by means of MRI, ICP-AES, and α-autoradiography. The MR imaging revealed that the carborane Gd-DTPA was metabolized slower in the body in comparison with Gd-DTPA. The results of ICP-AES method indicated that compound was incorporated into normal tissues and metabolized quickly, whereas it was not accumulated into tumor and brain tissue. The α-autoradiography showed that a high level of boron was obtained in the internal organs and in the necrosis of tumor tissue.

    researchmap

  • 求核的π-アリルパラジウム触媒反応の開発

    Grant number:09740545  1997 - 1998

    日本学術振興会  科学研究費助成事業 奨励研究(A)  奨励研究(A)

    中村 浩之

      More details

    Grant amount:\2200000 ( Direct Cost: \2200000 )

    アルカロイド、ペプチド、β-ラクタムをはじめとする含窒素化合物の中には、有用な生理活性を有するものが多く、天然にも数多く存在する。その多くは光学活性化合物であり、これらの化合物の合成には光学活性アミノ化合物が有用な中間体となる。本申請者はアリルスズのアルデヒドおよびイミンへの付加反応が、パラジウム及び白金触媒下で進行することを既に見い出しており、その反応活性中間体が求核的ビス-π-アリルパラジウムであることを明かにしている。
    本研究では、この求核的性質を持つビス-π-アリルパラジウム錯体の一方に不斉源として、ピネン由来のπ-アリル基を導入することにより、これまで困難であったイミンへの触媒的不斉アリル化反応に初めて成功した。この反応に於いてビス-π-アリルパラジウム錯体の不斉アリル基は、イミンとは反応せず、パラジウム上に固定されており、一方のアリル基のみが反応に関与し、求核的にイミンに対し、反応していることが分かった。このように、求核的性質を持つビス-π-アリルパラジウム錯体の非対称なアリル基の反応性を制御し、その一方のアリル基にイミンの不斉面の認識をさせることにより、光学活性なアミン化合物の選択的不斉合成が可能となった。従来、様々な不斉配位子が開発されてきたが、本研究のように、π-アリル基を不済配位子に持つ触媒反応は、これが初めての例である。

    researchmap

  • New Synthetic Method for Chiral B-Lactams

    Grant number:07044305  1995

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for International Scientific Research.  Grant-in-Aid for International Scientific Research.

    YAMAMOTO Yoshinori, GYOUNG Young Soo, NAKAMURA Hiroyuki, KADOTA Isao, ASAO Naoki, NEMOTO Hisao

      More details

    Amide cuprate reagents, (R_2N)_2CuLi and higher order cyano cuprates (R_2N)_2Cu(CN)Li_2, have been developed as a new class of nitrogen nucleophiles. These reagents underwent regioselective 1,4-addition to alpha, beta, gamma, delta-dienoates whereas R_2NH gave a 1,6-addition product and the lithium reagent R_2NLi afforded a mixture of 1,4-and 1,2-addition products. The amide cuprates were added to chiral alpha, beta, gamma, delta-dienoates having a 8-phenylmenthyl or bornanesultam chiral auxiliary to produce 1,4-adducts in good to high diastereoselectivity. The addition of [BnN(TMS)]_2CuLi and [BnN(TMS)]_2Cu(CN)Li_2 to 8-phenylmenthyl 5-phenyl-2,4-pentadienoate or 5-phenyl-2,4-pentadienoylbornanesultam produced (R) -chirality at the beta-position. The 1,4-addition of [BnN(TMS)]_2Cu(CN)Li_2 to the bornanesultam followed by trapping withacetaldehyde gave the alpha-(1-hydroxyethyl)-beta-amino derivative as a single isomer in good yield. This three component coupling was used in an asymmetric synthesis of a beta-lactam.
    Conjugate addition of N-benzyl-N-((R)-1-Phenylethyl)amine to (R)-(E)-tert-butyl 5-((tert-butyldimethylsilyl)oxy)-4-methyl-2-pentenoate produced the (3S,4R)-syn-adduct with essentially 100% de in 84% yield, whereas the addition of (S)-amine to the pentenoate afforded the (3R,4R) -anti-adduct with essentially 100% de in 95% yield. The syn adduct was converted upon sequential treatment with lithium diisopropylamide-methylaluminum dichloride-acetaldehyde to the key intermediate ; the diastereoisomer ratio of the key intermediate : the diastereoisomer ratio of the key intermediate to other diasteroisomers was 80 : 20. Conversion to a 1beta-methylcarbapenem key intermediate was carried out readily according to the known procedures.

    researchmap

  • 低酸素における細胞シグナル

      More details

    Grant type:Competitive

    researchmap

  • Development of Kinase Inhibitor

      More details

    Grant type:Competitive

    researchmap

▼display all

Media Coverage

  • 少量で悪性脳腫瘍消失 Newspaper, magazine

    日刊工業新聞  朝刊21面  2023.7

     More details

    Author:Other 

    researchmap